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ABSTRACT 
In recent years there has been an increase in obesity and diabetes mellitus (DM). 
These conditions have for a long time been associated with infertility. Obesity is 
characterized by high levels of circulating leptin and cytokines as well as insulin 
resistance. Type I DM is associated with low or no insulin whereas, Type II DM is 
characterised by insulin resistance. As the prevalence of obesity and DM continues 
to rise, it is likely that the incidence of infertility associated with these pathological 
conditions will likewise increase. The effects of insulin and leptin on male 
reproductive function have been reported on the endocrine and spermatogenesis 
level, but their effects on cellular level of human ejaculated spermatozoa are yet to 
be elucidated. 
 
This study presents data on the role of insulin and leptin on human ejaculated 
spermatozoa and their interaction with cytokines and nitric oxide. In the first part of 
the study, we established the suitable concentrations of glucose, insulin and leptin 
that could be administered to human spermatozoa in vitro.  Glucose concentration of 
5.6 mM was chosen as the suitable concentration to be administered to human 
spermatozoa because it has previously been reported in the literature; furthermore, it 
is within the range of the physiological glucose levels found in the blood of fasting 
humans. Insulin and leptin concentrations of 10 µIU and 10 nmol were chosen 
respectively because they gave much improved sperm function and this was within 
the range of insulin and leptin levels previously measured in human ejaculated 
spermatozoa. This was followed by investigating the signalling pathway of insulin and 
its beneficial effects on human spermatozoa function. Endogenous insulin secretion 
from human ejaculated spermatozoa was blocked by nifedipine and its receptor 
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tyrosine phosphorylation effects were inhibited by erbstatin while phosphatidylinositol 
3-kinase (PI3K) phosphorylation activity was inhibited by wortmannin. Exogenous 
insulin administration significantly increased human sperm motility parameters as 
well as the sperm ability to acrosome react. The inhibition of endogenous insulin 
release from spermatozoa as well as the inhibition of the insulin receptor substrate 
(IRS) tyrosine phosphorylation significantly decreased motility parameters and the 
ability of spermatozoa to acrosome react.   
 
The study also investigated the effects of insulin and leptin on human sperm motility, 
viability, acrosome reaction and nitric oxide (NO) production. Both insulin and leptin 
significantly increased sperm motility parameters, acrosome reaction and NO 
production. The NO production induced by insulin and leptin was via PI3K signalling 
as evidenced by a reduction in NO levels when PI3K activity was inhibited by 
wortmannin. To investigate whether insulin and leptin could improve motility 
parameters of asthernozoospermic and teratozoospermic spermatozoa, the 
spermatozoa were separated into two fractions by means of a double density 
gradient technique. The gradient system was able to separate spermatozoa into high 
morphologically abnormal and less motile spermatozoa similar to that of 
asthernozoospermic and teratozoospermic patients as well as a more motile fraction. 
Insulin and leptin significantly increased the motility parameters of spermatozoa from 
the immature and less motile fraction.  
 
The fourth part of the study was aimed at investigating the effects of the cytokines, 
tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6), on human sperm 
motility, viability, acrosome reaction and NO production. The study shows that TNF-α 
and IL-6 significantly reduced motility parameters and acrosome reaction in a dose- 
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and time-dependent manner. These cytokines were also shown to significantly 
increase NO production from human spermatozoa. The decreased motility 
parameters induced by these cytokines could be attributed to their ability to induce 
excessive NO production. It is not yet clear how they inhibit spermatozoa to undergo 
the acrosome reaction.  
 
The fifth part of the study was to investigate the expression and localization of 
glucose transporter 8 (GLUT8) in human spermatozoa. This study shows that GLUT8 
is constitutively expressed and located in the midpiece region of the human 
spermatozoa. The study also showed that stimulating spermatozoa with insulin led to 
an increase in GLUT8 expression as well as translocation to the acrosomal region. 
 
In the last part of the study we wanted to investigate why the increase in NO 
generation by spermatozoa due to insulin and leptin stimulation is accompanied with 
increased sperm function whereas NO increased due to TNF-α and IL-6 stimulation 
is accompanied with decreased sperm function. We observed that TNF-α and IL-6 
not only increased NO production but also ROS production. This study speculates 
that the decrease in sperm motility and acrosome reaction when TNF-α and IL-6 
were administered was due to the concomitant high increase in NO and ROS they 
induced.  
 
In conclusion, this study has established in vitro beneficial effects of insulin and leptin 
in normozoospermic and asthernozoospermic human sperm function. These 
hormones influence sperm function via the PI3K signalling pathway in two ways. 
Firstly, by increasing GLUT8 expression and translocation thereby possibly 
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increasing glucose uptake and metabolism and secondly, by increasing NO 
production. The study has also established that TNF-α and IL-6 have detrimental 
effects on human spermatozoa in a dose and time dependent manner. These effects 
are mediated via their ability to stimulate both NO and ROS production in human 
spermatozoa. This study reports that GLUT8 is expressed in the midpiece region of 
human spermatozoa and that insulin stimulation upgrades its expression and leads to 
its translocation to the acrosomal region.  
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OPSOMMING 
Oor die afgelope jare was daar `n toename in obesiteit en diabetes mellitus (DM). 
Hierdie toestande word reeds vir ’n geruime tyd geassosieer met onvrugbaarheid. 
Obesiteit word gekenmerk deur verhoogde sirkulerende vlakke van leptiene en 
sitokiene sowel as insulien weerstandigheid. Tipe I DM word geassosieer met lae of 
geen insulien terwyl Tipe II DM gekenmerk word deur insulien weerstandigheid. Soos 
wat die voorkoms van obesiteit en DM toeneem, is dit waarskynlik dat die insidensie 
van onvrugbaarheid wat met hierdie patologiese toestande geassosieer word, 
gevolglik ook sal toeneem. Die effek van insulien en leptien op die manlike 
voortplantingsfunksie is alreeds aangetoon op endokriene en spermatogenese vlak, 
maar hul effekte op sellulêre vlak van menslike geëjakuleerde spermatosoë is nog 
onduidelik. 
 
Die studie vertoon data oor die rol van insulien en leptien op die menslike 
geëjakuleerde spermatosoë en hul interaksie met sitokiene en stikstofoksied (NO). In 
die eerste gedeelte van die studie, het ons ’n toepaslike konsentrasie van insulien en 
leptien bepaal wat aan menslike spermatosoë in vitro toegedien kan word. Glukose 
konsentrasies van 5,6 mM is bepaal as die gepaste konsentrasie om aan menslike 
spermatosoë toe te dien, omdat dit beter resultate tot gevolg het; verder is dit 
vergelykbaar met fisiologiese glukose vlakke in die bloed van `n vastende persoon. 
Insulien en leptien konsentrasies is op 10 µIU en 10 nm onderskeidelik vasgestel, 
aangesien dit tot beter resultate gelei het, en omdat dit vergelykbaar was met 
insulien en leptien vlakke wat reeds voorheen in menslike geëjakuleerde 
spermatosoë gemeet is. Dit was gevolg deur `n ondersoek na die insulien 
seintransduksie pad en sy voordelige effekte op menslike spermatosoë funksie. 
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Endogene insulien afskeiding deur menslike geëjakuleerde spermatosoë was deur 
nifedipien geïnhibeer en sy reseptor tirosien fosforilasie effekte was deur erbstatin 
geïnhibeer terwyl fosfatidielinositol 3-kinase (PI3K) fosforilasie deur wortmannin 
geïnhibeer is. Eksogene insulien toediening het menslike sperm-motiliteit parameters 
betekenisvol laat toeneem asook die vermoë van sperme om die akrosoomreaksie te 
ondergaan. Die inhibisie van endogene insulien afskeiding deur spermatosoë sowel 
as die inhibisie van die insulien reseptor substraat (IRS) tirosien fosforilasie het die 
motiliteit parameters en die akrosoomreaksievermoë van spermatosoë verlaag. 
 
Die studie het ook die effekte van insulien en leptien op menslike sperm-motiliteit,  
-lewensvatbaarheid, -akrosoomreaksie en -NO produksie nagevors. Beide insulien 
en leptien het sperm-motiliteit parameters, -akrosoomreaksie en -NO produksie 
betekenisvol verhoog. NO produksie is deur insulien en leptien via PI3K 
seintransduksie geïnduseer, soos bewys deur die verlaging waargeneem in NO 
vlakke toe PI3K aktiwiteit deur wortmannin geïnhibeer was. Om vas te stel of insulien 
en leptien die motiliteit parameters van asthenozoospermiese en teratozoospermiese 
spermatosoë kon verbeter, het ons spermatosoë in twee fraksies met ’n dubbel 
digtheid gradiënt geskei. Die gradiënt sisteem was daartoe instaat om die 
spermatosoë in ’n onvolwasse, (morfologies abnormaal en minder motiel - soortgelyk 
aan dié van asthenozoospermiese en teratozoospermiese pasiënte), sowel as ’n 
volwasse meer motiele fraksie te skei. Insulien en leptien het die motiliteit parameters 
van spermatosoë van die onvolwasse en minder motiele fraksie verhoog. 
 
Die vierde gedeelte van die studie was daarop gemik om die effekte van die sitokiene 
tumor nekrose faktor alfa (TNF-α) en interleukin-6 (IL-6) op menslike sperm-motiliteit, 
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-lewensvatbaarheid, -akrosoomreaksie en -NO produksie, te ondersoek. Die studie 
het getoon dat TNF-α en IL-6 motiliteit parameters en akrosoomreaksie in ’n tyd- en 
dosis-afhanklike wyse betekenisvol verlaag het. Hierdie sitokiene was ook in staat 
om NO produksie in menslike spermatosoë te verhoog. Die verlaging in motiliteit 
parameters wat deur hierdie sitokiene geïnduseer is, kan toegeskryf word aan hul 
vermoë om die produksie van oormatige hoeveelhede NO te stimuleer. Dit is nog nie 
duidelik hoe hulle die akrosoomreaksie in spermatosoë kan inhibeer nie.  
 
Die vyfde gedeelte van die studie het dit ten doel gehad om die uitdrukking en 
lokalisering van die glukose transporter 8 (GLUT8) in menslike spermatosoë te 
ondersoek. Hierdie studie kon aantoon dat GLUT8 konstitutief uitgedruk is en in die 
middelstuk van die menslike spermatosoë voorkom. Die studie bewys ook dat 
stimulering van die spermatosoë met insulien tot `n toename in GLUT8 uitdrukking 
sowel as translokasie na die akrosomale area, lei. 
 
In die finale gedeelte van die studie wou ons ondersoek waarom die toename in NO 
produksie in spermatosoë (as gevolg van insulien en leptien stimulasie) deur `n 
toename in spermfunksie gekenmerk word, terwyl die toename in NO produksie (as 
gevolg van TNF-α en IL-6 stimulasie) deur ’n afname in spermfunksie gekenmerk 
word. Ons het waargeneem dat TNF-α en IL-6 nie alleen NO produksie nie, maar ook 
reaktiewe suurstof spesies (ROS) produksie verhoog het. Ons vermoed dat die 
afname in sperm motiliteit en akrosoomreaksie met TNF-α en IL-6 toediening, die 
gevolg van die gelyktydige verhoging in NO en ROS was. 
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In gevolgtrekking kan ons sê dat hierdie studie die voordelige in vitro effekte van 
insulien en leptien op asthenozoospermiese en teratozoospermiese menslike 
spermfunksie aangetoon het. Hierdie hormone beïnvloed spermfunksie via die PI3K 
seintransduksie pad op twee maniere. Eerstens, deur `n toename in GLUT8 
uitdrukking en translokasie, met die gevolg dat glukose opname en metabolisme 
moontlik verhoog is, en tweedens, deur die toename in NO produksie. Die studie het 
ook vasgestel dat TNF-α en IL-6 nadelige effekte op menslike spermatosoë in `n 
dosis- en tyd-afhanklike wyse het. Hierdie effekte vind plaas a.g.v. hul vermoë om 
beide NO en ROS produksie in menslike spermatosoë te induseer. Die studie toon 
aan dat GLUT8 uitdrukking in die middelstuk van die menslike spermatosoon 
voorkom en dat insulien stimulasie GLUT8 uitdrukking opreguleer en tot translokasie 
na die akrosomale area lei. 
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 26
CHAPTER 1: INTRODUCTION AND STATEMENT OF THE PROBLEM 
 
1.1 Introduction  
Until recently, the relationship between obesity and male infertility has been largely 
ignored (Hedly et al., 2004; Mokdad et al., 1999). This recent surge in interest in 
obesity has brought to light the detrimental effects of obesity on people’s health in 
general, as well as on the reproductive function in particular. Obesity which leads to a 
condition known as the metabolic syndrome is associated with pathologies such as 
insulin resistance which culminates into Type 2 diabetes mellitus (DM) (Kasturi et al., 
2008), hyperleptinemia (Sahu, 2004), high levels of circulating cytokines (Marcos-
Gόmez et al., 2008), dyslipidemia and hypertension (Kasturi et al., 2008) among 
others. Population-based studies have shown an elevated risk for subfertility among 
couples in which the male partner is obese and an increased likelihood of abnormal 
semen parameters among obese men (Hammoud et al., 2008).  
 
DM is characterized by poor glucose control leading to hyperglycemia. There are two 
types of DM: Type I DM, also known as insulin-dependent diabetes mellitus (IDDM), 
is a condition in which there is an absolute or relative lack of insulin due to 
autoimmune destruction of the insulin secreting β-cells in the islets of Langerhans in 
the pancreas; Type II DM, also known as non-insulin dependent diabetes mellitus 
(NIDDM), is characterized by cellular insulin insensitivity despite sufficient insulin 
levels (Atkinson and Maclaren, 1994). Both Type I and II DM are well recognized as 
a cause of sexual dysfunction, which in turn also contributes to infertility (Agbaje et 
al., 2007). DM is thought to affect the male reproductive function at multiple levels 
due to its effects on the endocrine control of the spermatogenesis process, 
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spermatogenesis itself, as well as impairing penile erection and ejaculation (Sexton 
and Jarow, 1997). Many studies involving diabetic animal models have demonstrated 
that there is an impairment of sperm quality (Amaral et al., 2006; Scarano et al., 
2006) which leads to a reduction in fertility (Murray et al., 1983; Cameron et al., 1990; 
Ballester et al., 2004; Scarano et al., 2006). Furthermore, it has been reported that 
men affected with IDDM have sperm with severe structural defects, significantly lower 
motility (Baccetti et al., 2002) and decreased ability to penetrate zona free hamster 
eggs (Shrivastav et al., 1989). 
 
Obesity is characterized by elevated leptin levels, whereas DM is characterized by 
decreased insulin levels or insulin insensitivity. There is a large body of evidence 
suggesting that insulin and leptin play a role in the physiology of human reproduction. 
Insulin and leptin deficiencies have been shown to negatively affect reproductive 
function in both human and animal models. These hormones are thought to affect 
male reproduction at multiple levels due to their effects on endocrine control of 
spermatogenesis and spermatogenesis itself. The discovery that ejaculated human 
spermatozoa secrete their own insulin and leptin opened a new and interesting field 
in reproductive biology. It has therefore become imperative to investigate the role of 
these hormones in ejaculated human spermatozoa.  
 
1.2 Hypothesis 
We hypothesize that insulin and leptin play a role in enhancing the fertilization 
capability of human spermatozoa and that this may be mediated through the increase 
in glucose uptake as well as increase in NO production. 
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1.3 Objectives of the study  
The general objective of this study is to present data that will shed more light and 
understand better the factors that might be involved in preserving the fertilizing 
capacity of ejaculated spermatozoa. Specifically, this study was aimed at 
investigating: 
(1) The in vitro effects of insulin and leptin on ejaculated human sperm motility 
parameters, viability, acrosome reaction and nitric oxide generation.  
(2) The effects of insulin and leptin on asthenozoospermic and teratozoospermic 
spermatozoa’s motility parameters.  
(3) The expression and localization of glucose transporter 8 (GLUT8) in human 
spermatozoa and how insulin affects its expression and localization.  
(4) The effects of cytokines (TNF-α and IL-6) on human sperm motility, viability, 
acrosome reaction and nitric oxide production and the mechanisms involved.  
 
1.4 Plan of study         
As a background to the study, a broad overview of the current literature on insulin, 
leptin, cytokines and nitric oxide and how they affect male reproduction is provided in 
chapter two. This is followed by the basic materials and methods in chapter three 
where detailed protocols of how the experiments were conducted are outlined.  
 
The fourth chapter comprises of the results obtained in this study. They are 
presented in the form of tables, graphs and pictures. The fifth chapter is the 
discussion, where the results are interpreted, explained and discussed. The appendix 
consists of all publications that have resulted from this study.  
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1.5 Conclusion    
The increasing prevalence of obesity and DM requires a vigilant awareness of their 
effects on fertility, better understanding of the underlying mechanisms, as well as 
avenues for mitigation or treatment. Therefore, understanding how insulin, leptin and 
cytokines function on the cellular level of human spermatozoa would go a long way in 
achieving this.  
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Insulin 
2.1.1 Introduction 
Insulin is the most potent anabolic hormone and is essential for appropriate tissue 
development, growth, and maintenance of whole-body glucose homeostasis (Pessin 
and Saltiel, 2000). This hormone is secreted by the β-cells of the pancreatic islets of 
Langerhans in response to increased circulating levels of glucose and amino acids 
after a meal. Insulin regulates glucose homeostasis at many sites, by reducing 
hepatic glucose output (via decreased gluconeogenesis and glycogenolysis) and 
increasing the rate of glucose uptake (Saltiel and Kahn, 2001). In muscle and fat 
cells, the clearance of circulating glucose depends on the insulin-stimulated 
translocation of the GLUT4 isoform to the cell membrane (Shulman, 2000).  
 
Insulin also affects lipid metabolism, increased lipid synthesis in the liver and fat 
cells, and attenuating fatty acid release from triglycerides in fat and muscle tissue 
(Pessin and Saltiel, 2000). Decreased secretion of insulin or lack of insulin secretion 
results in Type 1 DM whereas, the resistance to its actions, results in Type 2 DM, a 
devastating disease that is reaching epidemic proportions (Saltiel, 2001). Even in the 
absence of diabetes, insulin resistance is often associated with central obesity, 
hypertension, polycystic ovarian syndrome, dyslipidemia and atherosclerosis (Kasturi 
et al., 2008).  
 
At the cellular level, insulin action is characterized by diverse affects, including 
changes in vesicle trafficking, stimulation of protein kinases and phosphatases, 
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promotion of cellular growth and differentiation and activation or repression of 
transcription (Pessin and Saltiel, 2000). This complexity suggests that insulin action 
must involve multiple signaling pathways that diverge at or near the activation of its 
tyrosine kinase receptor.  
 
2.1.2 The insulin receptor 
Insulin action is initiated through the binding to and activation of its cell-surface 
receptor. The receptor is a tyrosine kinase that catalyses the phosphorylation of 
several intracellular substrates, including the insulin receptor substrate (IRS) proteins 
(White, 1998), Grb 2-associated binder 1 (GAB-1) (Holgado-Madruga et al., 1996), 
Shc (Sasaoka et al., 1994), adapter protein with Pleckstrin Homology and Src 
Homology 2 domains (APS) (Moodie et at., 1999), p60dok (Noguchi et al., 1999), 
signal regulatory proteins (SIRPs) (Khatitonenkov et al., 1997) and c-Cbl (Ribon and 
Saltiel, 1997) (Fig 1). Each of these substrates recruits a distinct subset of signaling 
proteins containing Src homology 2 (SH2) domains, which interact specifically with 
sequences surrounding the phosphotyrosine residue.  
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Figure 1. Substrates of the insulin receptor. The insulin receptor is a tyrosine kinase 
that undergoes autophosphorylation upon binding insulin, resulting in increased 
kinase activity of intracellular substrates. Several substrates have been identified, 
including the insulin receptor substrate proteins (IRS1–IRS4), Shc, Gab-1, Cbl and 
APS. Upon tyrosine phosphorylation (Y-P), each of these substrates interacts with a 
series of signaling proteins containing Src-homology 2 (SH2) domains, leading to 
initiation of different signaling pathways. Each of these pathways plays a separate 
role in the different cellular effects of insulin (Modified from Satiel and Pessin, 2002). 
 
2.1.3 Insulin signaling 
A key action of insulin is to stimulate glucose uptake into cells by inducing 
translocation of the GLUT4 from intracellular storage to the plasma membrane (Czeh 
and Coevera, 1999). Several studies have suggested that phosphatidylinositol 3-
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kinase (PI3-K) and protein kinase B (PKB/Akt) are known to play a role in GLUT4 
translocation (Lizcano and Alessi, 2002; Pessin and Saltiel, 2000). 
 
As illustrated in Figure 2, at basal state, GLUT4 slowly recycles between the plasma 
membrane and vesicular compartments within the cell, where most of the GLUT4 
resides. Insulin stimulates the translocation of a pool of GLUT4 to the plasma 
membrane through a process of targeted exocytosis (Satoh, 1993; Jhun et al., 1992). 
At the same time, the rate of GLUT4 endocytosis is somewhat attenuated (Yang and 
Holman, 1993). The large increase in GLUT4 exocytosis coupled with a smaller 
decrease in the rate of plasma membrane internalization results in a dramatic 
accumulation of plasma-membrane-localized GLUT4 protein. Thus, the rate of 
glucose transport into fat and muscle cells is primarily governed by the concentration 
of GLUT4 at the cell surface and the time for which the protein is maintained at the 
site.  
 
Although there is overwhelming evidence showing that GLUT4 exists in specialized 
vesicles sequestered within the cell, the precise intracellular location and trafficking 
pathways of these compartments remain unclear. It is generally accepted that 
GLUT4 is localized in tubulovesicular and vesicular structures that are biochemically 
distinct from the vesicles of the recycling endosomal network. Furthermore, the 
GLUT4 compartment is enriched in the SNARE (soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor), vesicle-associated membrane protein 2 (VAMP2) 
but not in the related VAMP3/cellubrevin isoform, which is present in recycling 
endosomes (Pessin et al., 1999). This specific compartmentalization of GLUT4 
provides a mechanism by which insulin can stimulate robust translocation of GLUT4 
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to the plasma membrane while only mildly stimulating the translocation of other 
recycling proteins. Although the mechanism of intracellular tethering of the GLUT4 
vesicle in resting cells is unknown, sequestration of GLUT4 depends on C-terminal 
sequences in the protein (Haney et al., 1995; Marsh et al., 1995). The GLUT4 
compartment also contains the insulin-responsive aminopeptidase (IRAP) (Keller et 
al., 1995). Overproduction of the N-terminus of GLUT4, results in GLUT4 localization 
to the plasma membrane (Waters et al., 1997). These results suggest that both the 
C-terminus of GLUT4 and the N-terminus of IRAP contribute to the cytoplasmic 
sequestration of GLUT4 vesicles.  
 
 
Figure 2. A model for diverse signaling pathways in insulin action. Two signaling 
pathways are required for the translocation of the glucose transporter GLUT4 by 
insulin in fat and muscle cells. Tyrosine phosphorylation (Y-P) of the insulin receptor 
substrate (IRS) proteins after insulin stimulation leads to an interaction with and 
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subsequent activation of the Src-homology 2 (SH2)-domain-containing protein 
phosphatidylinositol 3-kinase (PI3-K), producing the polyphosphoinositide 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which in turn interacts with and 
localizes protein kinases such as phosphoinositide-dependent kinase 1 (PDK1) 
(Adopted from Satiel and Pessin, 2002). 
 
2.1.4 Effects of insulin on male reproductive function 
The importance of insulin has been demonstrated in male rat reproduction by using 
streptozotocin, to deplete the β-cells of the pancreas, and thereby inducing IDDM 
(Murray et al., 1983). The deficiency of insulin in these rats led to a decrease in 
Leydig cell number as well as an impairment in Leydig cell function. This 
consequently translated to a decrease in androgen biosynthesis and serum 
testosterone levels.  
 
The impaired Leydig cell function and subsequent decrease in testosterone in IDDM 
could be explained by the absence of the direct stimulatory effects of insulin on 
Leydig cells, as well as to an insulin-dependent decrease in follicle stimulating 
hormone (FSH) and luteinizing hormone (LH) levels (Wang et al., 1998).  
 
It was also reported that insulin plays a central role in the regulation of the 
hypothalamic-pituitary-testicular axis by the reduction in secretion of LH and FSH in 
diabetic men as well as in knockout mice lacking the insulin receptor in the 
hypothalamus (Baccetti et al., 2002).  Both the diabetic men and the knockout mice 
had notably impaired spermatogenesis, increased germ cell depletion and Sertoli cell 
vacuolization (Brüning et al., 2000; Baccetti et al., 2002). Furthermore, men affected 
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with IDDM have sperm with severe structural defects, significantly lower motility 
(Bacetti et al., 2002) and lower ability to penetrate zona free hamster eggs 
(Shrivastav et al., 1989). Figure 3 shows that insulin is required to stimulate the 
hypothalamus to release gonadotrophin releasing hormone (GnRH) which stimulates 
the release of LH and FSH from the anterior pituitary gland.  It has been reported that 
higher insulin concentrations, as found in NIDDM, lead to hypogonadism (Barrett-
Connor et al., 1990) as well as decreased serum testosterone levels (Dhindsa et al., 
2004). Furthermore, Pitteloud and co-workers (2005) also reported that insulin 
resistance lead to a decrease in testosterone secretion at testicular level (Leydig cell) 
that was not due to changes in hypothalamic or pituitary function. These findings 
point to a direct action of insulin at gonadal level (see Figure 3). 
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Figure 3. The interaction of insulin, leptin and the endocrine control of 
spermatogenesis. Diabetes mellitus and obesity have an influence on circulating 
insulin and leptin levels respectively. Both insulin and leptin affect the secretion of 
gonadotrophin releasing hormone (GnRH) from the hypothalamus which 
subsequently orchestrate the secretion of luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) from the anterior pituitary gland. These hormones in turn 
affect gonadal function and spermatogenesis. Both insulin and leptin can exert 
direct effects on the testes as well.  
 
Morphological abnormalities have been reported in IDDM human testicular biopsies. 
These abnormalities included increasing tubule-wall thickness, germ cell depletion 
and Sertoli cell vacuolization (Cameron et al., 1985). Morphological and functional 
spermatozoal abnormalities that have been observed in diabetic animal models 
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appear to be reversible with the administration of insulin (Howland and Zebrowski, 
1976; Seethalakshmi et al., 1987). A significantly lower sperm count, and epididymal 
sperm motility was reported in diabetic rats in comparison to controls (Seethalakshmi 
et al., 1987). In vitro insulin administration to these retrieved epididymal spermatozoa 
restored their motility to that of normal levels, suggesting a direct effect on 
spermatozoa due to defective carbohydrate metabolism. Studies have reported that 
insulin as well as insulin-like growth factor I (IGF-I) and IGF-II promote the 
differentiation of spermatozoa into primary spermatocytes by binding to the IGF-I 
receptor (Nakayama et al., 1999). There is also evidence that both the sperm 
membrane and the acrosome represent cytological targets for insulin (Silvestroni et 
al., 1992).  
 
2.1.5 Insulin and human spermatozoa 
In adult mammals, insulin is thought to be produced only in the β-cells in the 
pancreas (Throsby et al., 1998). Insulin has been shown to play a central role in the 
regulation of gonadal function; however, its significance in male fertility is not 
completely understood and properly elucidated (Aquila et al., 2005).  
 
Recently studies have demonstrated that insulin is expressed in and secreted by 
human ejaculated spermatozoa. Both, transcriptions for insulin as well as the actual 
protein were detected in ejaculated human sperm (Aquila et al., 2005). It was found 
that capacitated spermatozoa secreted more insulin than noncapacitated 
spermatozoa (Aquila et al., 2005) thereby suggesting a possible role for insulin in 
sperm capacitation.   
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2.1.6 GLUT8 as a glucose transporter in human spermatozoa 
Glucose uptake and metabolism are essential for proliferation and survival of cells 
and is usually carried out through glucose transporters. It is largely known that the 
fertility of germ cells is directly associated with the glucose metabolism of these cells 
and that spermatogenesis is disturbed in IDDM, thereby causing infertility (Bacetti et 
al., 2002; Shrivastav et al., 1989).  
 
It has been assumed previously that the major sugar transporter of the sperm cell is 
the GLUT5 (Burant et al., 1992). GLUT5 is a specific fructose transporter (Kane et 
al., 1997) and does not transport glucose to a significant extent. Because GLUT5 
was not detected in rat testis, it was suggested that other sugar transporters, 
presumably the GLUT3, catalyze the fuel supply of the rat sperm cell (Burant and 
Davidson, 1994a).  
 
In recent years, a novel 447-amino-acid glucose transporter protein, GLUT8 was 
discovered (Ibberson et al., 2000; Doege et al., 2000; Carayannopoulos et al., 2000). 
GLUT8 is expressed to some extent in insulin-sensitive tissues, e.g., brain, adrenal 
gland, spleen, adipose tissue, muscle, heart, and liver (Ibberson et al., 2000; Doege 
et al., 2000; Reagan et al., 2001). GLUT8 mRNA expression is greatest in the 
testicular tissue and its expression was linked to circulating gonadotrophin levels 
(Doege et al., 2000; Scheepers et al., 2001).  
 
GLUT8 was found to be specifically located in the head of mouse and human 
spermatozoa and that it is predominantly located within the head of mature sperm 
cells in the region of the acrosome (Schürmann et al., 2002). Coincidentally, insulin 
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has also been reported to be predominant in these areas of human spermatozoa 
(Silvestroni et al., 1992).  The intracellular localization of GLUT8 is similar to that of 
insulin-sensitive GLUT4, and it has indeed been described that insulin could produce 
a translocation of GLUT8 to the plasma membrane of blastocysts (Carayannopoulos 
et al., 2000). In addition, Lisinski et al. (2001) showed that GLUT8 translocates 
between internal membranes and the plasma membrane in rat adipocytes and 
COS-7 cells.  
 
2.2 Leptin 
2.2.1 Introduction 
Leptin is a 16-kDa protein that is produced mainly by adipose tissue and is encoded 
by the ob gene (Zhang et al., 1994), but is also produced by the placenta (Masuzaki 
et al., 1997), stomach (Bado et al., 1998) and skeletal muscles (Wang et al., 1998). 
The tertiary structure of leptin resembles that of cytokines and lactogenic hormones 
(Zabeau et al., 2003). Leptin is best known as a regulator of food intake and energy 
expenditure via hypothalamic-mediated effects (Schwartz et al., 1999). Recent 
studies have demonstrated that leptin has many additional effects, often as a 
consequence of direct peripheral actions. These include angiogenesis, 
hematopoiesis, lipid and carbohydrate metabolism and effects on the reproductive, 
cardiovascular and immune systems (Wauters et al., 2000; Caprio et al., 2001) as 
demonstrated in Figure 4. Thus, changes in plasma leptin concentrations have 
important and wide-ranging physiological implications.  
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Figure 4. Schematic representation of the actions of leptin. Leptin acts either directly 
or by activating specific centers in the central nervous system to decrease food 
intake, increase energy expenditure, influence glucose and fat metabolism, and alter 
neuroendocrine function (Modified from Mantzoros CS, 1999).  
 
 
2.2.2 Regulation of serum leptin 
Leptin levels increase exponentially with increasing fat mass (Sahu, 2004; Lonnqvist 
et al., 1995; Considine et al., 1996). Its levels reflect not only the amount of fat 
stored, but also energy imbalance. Prolonged fasting substantially decreases leptin 
levels, whereas over feeding lead to increases in leptin levels (Tritos and Mantzoros, 
1997; Flier, 1997). Diet composition, such as the intake of micronutrients such as 
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zinc, and hormonal factors also regulate leptin levels (Jenkins et al., 1997). 
Prolonged insulin infusions or supraphysiological insulin levels markedly increase 
circulating leptin levels (Caro et al., 1996; Ryan and Elahi, 1996). Glucocorticoids 
have been shown to increase leptin production in vitro (Bjorbæck and Kahn, 2004; 
Wabitsch et al., 1996), while exogenously administered glucocorticoids produce a 
sustained increase in circulating leptin levels in humans (Miell at al., 1996; Larsson 
and Ahren, 1996). Several cytokines such as tumor necrosis factor-α (TNF-α), 
interleukin-1 (IL-1) and IL-6, also alter leptin mRNA expression and circulating levels 
(Zumbach et al., 1997; Grunfeld et al., 1996)  as illustrated in Figure 5. 
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Figure 5. Schematic representation of feedback loops involving leptin. Leptin 
circulates in the serum either in free form or bound to leptin-binding proteins, 
activates receptors in the hypothalamus, and alters expression of several 
neuropeptides; these in turn decrease appetite, increase energy expenditure by 
altering sympathetic and parasympathetic tone, and alter neuroendocrine function. 
Increase in leptin levels activate the thyroid, growth hormone, and gonadal axes and 
suppress the pituitary-adrenal axis. Leptin also influences hemopoiesis and immune 
function and improves glucose and fat metabolism. GC = glucocorticoids; IGF = 
insulin-like growth factor; IL = interleukin; TNF-α = tumor necrosis factor-α (Modified 
from Mantzoros CS, 1999). 
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2.2.3 Leptin and the testes 
Studies have shown that the leptin receptor is found in the testes (Hoggard et al., 
1997). The passage of leptin across the blood-testis barrier has also been 
investigated, and showed that leptin enters the testis by a passive, non-saturable 
process (Banks et al., 1999). It was demonstrated that leptin exerts a rapid and dose-
dependent inhibition of LH-stimulated testosterone production in rat cells in culture 
(Caprio et al., 1999). Other studies have shown that leptin inhibits testosterone 
secretion from adult rat testicular slices incubated in vitro, but not from prepubertal 
testes (Tena-Sempere et al., 1999).  
 
Circulating leptin levels have been shown to be elevated in obese individuals 
(Tchernof et al., 1995). In addition, it has been known for some time that the degree 
of androgen reduction is related to the amount of fat mass (Zumoff et al., 1990) and 
recently, it has also been linked to leptin levels (Vettor et al., 1997). The androgen 
response to human chorionic gonadotropin (hCG) stimulation is impaired in obese 
women, and leptin has been shown to be the best hormonal predictor of the obesity-
related reduction in androgen response (Isidori et al., 1999). These observations 
indicate that leptin excess might play an important role in the development of 
reduced androgen output in male obesity.  
 
Immunohistochemical studies have demonstrated that mouse testes germ cells 
express the leptin receptor (OB-R) in a stage and age-dependent manner (El-
Hefnawy et al., 2000). Furthermore, in vitro treatment of isolated seminiferous tubules 
with leptin led to signal transducer and activator of transcription 3 (STAT-3) 
phosphorylation, which indicated that the OB-R is functional and capable of signal 
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transduction in germ cells. These data suggest that leptin might have additional 
testicular effects, possibly exerted on the proliferation and differentiation of germ 
cells, and that lack of its action might be locally involved in the pathogenesis of 
infertility observed in leptin-deficient mice (El-Hefnawy et al., 2000).   
 
2.2.4 Leptin receptors 
Leptin acts via transmembrane receptors which show structural similarity to the class 
I cytokine receptor family (Tartaglia et al., 1995; Lee et al., 1996; Myers, 2004), which 
includes the receptors of IL-2, IL-3, IL-4, IL-6, IL-7, leukemia inhibitory factor (LIF), 
granulocyte colony-stimulating factor, growth hormone, prolactin and erythropoietin 
(Bazan, 1989). The OB-R is produced in several alternatively spliced forms, 
designated OB-Ra, OB-Rb, OB-Rc, OB-Rd, OB-Re, OB-Rf (Lee et al., 1996; Wang et 
al., 1998) that have in common an extracellular domain of over 800 amino acids, a 
transmembrane domain of 34 amino acids and a variable intracellular domain, 
characteristic of each of the isoforms. The isoforms can be classified into three 
classes: short, long and secreted (Tartaglia et al., 1995; Myers, 2004). The short 
forms of the receptor, i.e. OB-Ra, OB-Rc, OB-Rd and OB-Rf as illustrated in Figure 6, 
consist of 30-40 cytoplasmic residues. However, only the long full-length isoform, 
OB-Rb, was considered to be the functional receptor, based on the finding that it has 
an extended domain approximately 300 cytoplasmic residues, containing various 
motifs required for the interaction with other proteins and subsequent signalling 
pathway activation (Tartaglia et al., 1995). It is due to the lack of the full-length OB-R 
that the diabetic (db/db) mouse and the obese Zucker (fa/fa) rat become obese 
(Chua et al., 1996). The phenotype of these mice and rats suggest that the long form 
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of leptin receptor plays an important role in regulation of food intake, energy 
expenditure and endocrine function.  
 
 
 
Figure 6. Leptin receptor isoforms. CR =cytokine receptor domain, F-III = fibronectin 
type III domain, Box 1, 2, 3=consensus intracellular motifs (Adopted from Hegyi et al., 
2004).  
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2.2.5 Main leptin signaling pathways  
2.2.5.1 JAK/STAT signal transduction cascade 
The JAK/STAT signaling pathway comprises a family of four non-receptor tyrosine 
kinases (JAKs) and seven 85-95kDA transcription factors (STATs) that are 
phosphorylated on specific serine and tyrosine residues. The JAK/STAT signaling 
cascade is activated by interferons, interleukins and some other cytokines which 
have no intrinsic kinase activity in their receptors (Ihle and Kerr, 1995). The OB-R 
contains no intrinsic tyrosine kinase domain, and therefore binds cytoplasmic 
kinases, mainly JAK2 (Murakami et al., 1991). The JAK2 proteins are associated with 
membrane-proximal sequences of the receptor intracellular domain, which are 
activated and translocated to the nucleus leads to transcription stimulation. The OB-
R has been implicated in the ligand-receptor binding activation of STAT3, STAT5, 
and STAT6, but not STAT1, STAT2, or STAT4 (Sweeney, 2002).  
 
2.2.5.2 Mitogen-activated protein kinase (MAPK) cascade 
The MAPK signaling cascade can be stimulated by either OB-Ra or OB-Rb, even 
though the OB-Ra stimulation is usually weaker (Banks et al, 2000). Leptin is able to 
trigger the MAPK pathway in two ways. Firstly via tyrosine phosphorylation of JAK2 
receptor-associated activation and secondly it can trigger the signaling cascade 
independently of receptor phosphorylation (Hegyi et al., 2004). An intact catalytic 
domain of SHP-2 is required downstream of both the pathways (Bjørbæck et al., 
2001). Leptin has been reported to increase the phosphorylation of p38 MAPK in 
mononuclear cells and L6 muscle cells. It does this by reducing insulin-stimulated 
p38 MAPK phosphorylation (van den Brink et al., 2000).  
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2.2.5.3 The PI3K pathway 
PI3K activity is one of the key targets regulated by several ligands with insulin 
deserving a special mention. In fact, PI3K is involved in most insulin-dependent 
actions which make this a very relevant point of cross-talk between the insulin and 
leptin signaling pathways (Ducy et al., 2000; Hegyi et al., 2004; Niswender and 
Schwartz, 2003). The PI3K pathway leads to the stimulation of protein kinases such 
as PKB/Akt and protein kinase C (PKC) isoforms (Sweeney, 2002). Studies have 
shown that leptin acts through some of the components of the insulin signaling 
cascade as illustrated in Figures 7 and 8. When insulin binds to its receptor, it leads 
to the recruitment of several IRSs which are tyrosine-phosphorylated by intrinsic 
kinase activity of the receptor. The phosphorylation of the IRSs increases their affinity 
for binding other signaling molecules, leading to further steps of the pathway 
(Figure 8). 
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Figure 7. Stimulation of the PI3K pathway by leptin (L) represents a key cascade to 
exert several different effects of the hormone at multiple sites (Adopted from 
Frühbeck, 2006). 
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Figure 8. Cross-talk between leptin signaling and insulin-induced pathways. Leptin 
receptor (OB-Rb) activation acts through some of the components of the insulin 
signaling cascade recruiting several IRSs (Adopted from Frühbeck, 2006). 
 
2.2.5.4 Other signaling cascades activated by leptin 
Leptin has been implicated cross-talk with many different signal transduction 
pathways through its ubiquitous receptors. A functional relationship has been 
established between leptin and nitric oxide (NO) (Frühbeck et al., 2001). It has been 
shown that leptin increase serum NO concentrations while NO has been shown to 
facilitate leptin-induced lipolysis (Frühbeck and Gómez-Ambrosi, 2001). The effect of 
leptin on other signaling pathways has also been shown to have an influence on the 
Rho family GTPases which are involved in several cellular processes including 
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apoptosis as well as the regulation of the actin-myosin cytoskeleton (Sweeney, 
2002).  
 
2.2.6 Effects of leptin on male reproductive function 
Leptin receptor isoforms have been reported to be present in gonadal tissue, 
suggesting that it could exert a direct endocrine action on the gonads (Cioffi et al., 
1996; Cioffi et al., 1997; Karlsson et al., 1997). Indeed studies have shown that 
treatment with leptin of infertile ob/ob knockout mice restored reproductive ability 
(Mounzih et al., 1997). Injecting ob/ob mice with leptin was reported to cause an 
elevation in FSH levels, while it also stimulated gonadal development Barash et al., 
1996). It was further shown that the chronic administration of antileptin antibody to 
rats inhibited LH release (Carro et al., 1997). 
 
Humans deficient of leptin have shown similar effects as observed in animal models. 
A case study of a male with a homozygous leptin mutation reported that he was still 
pre-pubertal and showed clinical traits typical of hypogonadism and androgen 
deficiency despite being 22 years of age (Strobel et al., 1998). Furthermore, another 
male subject with a leptin receptor deficiency showed no pubertal development at 
either 13 or 19 years of age (Clément et al., 1998). Reports like these emphasize the 
biological importance of leptin at the onset of puberty in males. 
 
The mechanisms through which leptin act are not yet clearly elucidated but probably 
involve the hypothalamus and its subsequent effects on the pituitary and gonadal 
axis. It has been shown that the administration of gonadotrophin releasing hormone 
(GnRH) to the leptin-deficient male induced a normal increase in serum LH and FSH 
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levels, while the administration of gonadotrophins increased testosterone levels 
(Strobel et al., 1998).  As illustrated in Figure 3, it may be that leptin stimulates GnRH 
synthesis or secretion from the hypothalamic neurons or secretion of gonadotrophins 
by the pituitary gland (Yu et al., 1997). 
 
2.2.7 Leptin and human spermatozoa 
Leptin has been implicated to play a role in the regulation of reproduction in both 
experimental animals and humans (Barash et al., 1996). In female reproduction, its 
participation is well established, whereas its role in male reproduction is yet to be 
properly elucidated (Camina et al., 2002; Fietta, 2005). The existence of leptin in 
ejaculated human spermatozoa was demonstrated through its transcripts evaluated 
by reverse transcription-polymerase chain reaction (PCR), its protein content 
evidenced by Western blot analysis and through its localization by immunostaining 
analysis (Aquila et al., 2005).  
 
The significance of leptin in reproduction is somehow controversial. Some studies 
have indicated positive effects while others have reported negative effects for leptin 
in gonadal function (Caprio et al., 2001; Clarke and Henry, 1999). It has been shown 
that seminal plasma leptin levels are significantly lower in normozoospermic patients 
compaired to pathological semen samples and that higher leptin levels negatively 
correlated with sperm function (Glander et al., 2002). On the other hand, it was also 
reported that there is no correlation between leptin levels and sperm motility or 
morphology (Zorn et al., 2007). Capacitated spermatozoa were reported to secrete 
more leptin than noncapacitated spermatozoa suggesting that leptin plays a role in 
the process of capacitation (Aquila et al., 2005). Moreover, leptin receptors have 
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been detected in ejaculated spermatozoa and were localized in the tail region (Jope 
et al., 2003).  
 
2.3 Cytokines 
2.3.1 Introduction 
The role of cytokines in male reproductive function has been widely reported (Diemer 
et al., 2003). Although the immune system is the major source of cytokine production 
there are various other cells in the male urogenital tract which secrete cytokines and 
have an effect on sperm function and fertility (Naz and Kaplan, 1994a). Their 
production occurs in response to foreign antigen, pathogen and chronic inflammation 
(Huleihel et al., 1996). The defense strategies of the immune system against 
bacterial infections include the release of proinflammatory cytokines especially 
interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) as 
primary or secondary signals (Metalliotakis et al., 1998). 
 
2.3.2 Importance of cytokines 
Cytokines participate in signal transmission between cells and perform regulatory 
roles in different biological processes, such as cell activation, proliferation, growth, 
differentiation and mobility (Kretser et al., 1998). They also show modulatory effects 
on inflammatory reactions. Examples of these include cytokines of the IL-1 family, the 
IL-6 family, the superfamily of TNF-α and the interferons, IL-2, proinflammatory 
chemokines (eg, IL-8 and IL-12) and IL-15 (Feldmann and Saklatvala, 2001). The 
course of the inflammatory reaction depends on the levels of cytokines produced, as 
well as the presence of cytokine inhibitors and their specific receptors and /or 
antagonists (Eggert-Kruse et al., 2007). Proinflammatory cytokines usually act locally, 
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since they are produced by cells which have been locally activated by stimuli (Koçak 
et al., 2002).  
 
2.3.3 Cytokines and male fertility 
In the male gonad, cytokines are also produced physiologically and are involved in 
the normal function of the organ (Hales et al., 1999; Soder et al., 2000; Diemer et al., 
2003). Because of this, they appear as the natural component of the seminal plasma 
(Maegawa et al., 2002). Studies have shown that some cytokines act as regulators of 
the physiological levels of ROS in seminal plasma (Buch et al., 1994; Depuydt et al., 
1996). It has been reported that the main source of cytokines in the male gonad is 
the testicular macrophages although some cytokines (IL-1 and IL-6) are also 
produced by the cells of the rete testis which include the Leydig and Sertoli cells 
(Cudicini et al., 1997). The extent to which cytokines affect fertility is dependent upon 
their concentration. For instance, it has been reported that IL-12 levels correlates 
with the density and morphology of sperm cells, which suggests a certain biological 
role for IL-12 in male infertility (Naz and Evans, 1998). Naz and Kaplan, (1994b) 
reported that stimulating with IL-6, capacitation and acrosome reaction of sperm can 
be induced and the proportion of penetrated oocytes is increased. On the other hand, 
increased IL-6 levels have been observed in seminal plasma of infertile males (Naz 
and Kaplan, 1994a). It has been observed that high levels of certain cytokines in 
semen are often linked with a decrease in the quality of sperm parameters 
(Gruschwitz et al., 1996). 
 
Some studies have reported that particular cytokines modulate the expression of 
genes responsible for the redox system in semen (Shimoya et al., 1993; Naz and 
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Kaplan, 1994a). For instance, an increase in ROS production by human sperm was 
observed after the addition of IL-1α, IL-1β or TNF-α, the result of which was an 
increase in sperm membrane lipid peroxidation (Buch et al., 1994). 
 
IL-1β is a well-known proinflammatory cytokine that is especially important for 
testicular physiology. It has been reported to be involved in autocrine and paracrine 
regulation of local control of spermatogenesis and spermiogenesis, and constitutes 
one of the elements of immune privilege in the testes (Huleihel et al., 2000; Soder et 
al., 2000; Fiszer et al., 2003; Rozwadowska et al., 2005). This cytokine is responsible 
for the development and maintenance of the immune and inflammatory responses to 
invading pathogens. Huleihel and Lunenfeld, (2004) reported that an increase in the 
expression of IL-1β in the testes during local infection or inflammation is associated 
with decreased testosterone production by Leydig cells and decreased intensity of 
spermatogenesis, probably mediated through apoptosis.  
 
There is a relationship between the IL-6 levels in seminal plasma and the intensity of 
sperm membrane peroxidation (Camejo et al., 2001). This cytokine is principally 
produced by monocytes/macrophages and its most important functions include the 
stimulation of B-lymphocyte differentiation, the activation of T lymphocytes, and the 
stimulation of acute phase protein release (Furunya et al., 2003). Infertile patients 
have reported high levels of IL-6 (Camejo et al., 2001; Furunya et al., 2003).  
 
TNF-α is one of the major cytokines produced during inflammation. It is 
predominantly secreted by the monocytes and macrophages, mainly after contact 
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with lipopolysaccharides (Buch et al., 1994). The cytotoxic influence of TNF-α is 
augmented by ROS and phospholipase A2 (Perdichizzi et al., 2007).  
 
IL-12 has been detected in seminal plasma samples of both infertile and fertile males 
(Naz and Evans, 1998). The higher IL-12 levels observed in the seminal plasma 
samples of fertile males compared to infertile ones suggests the participation of this 
cytokine in the physiological functioning of the reproductive system (Naz and Evans, 
1998).  
 
IL-18 belongs to the large IL-1 superfamily, and although it is similar in structure to 
IL-1 family members, it differs in terms of mode of action (Munder et al., 1998). It is 
not only produced by the cells of the immune system, such as monocytes and 
macrophages, but can also be released from keratinocytes, most epithelial cells, and 
osteoblasts (Dinarello, 1999). The proinflammatory activity of IL-18 is mostly linked to 
the stimulation of proliferation and the cytotoxicity of natural killer cells and T 
lymphocytes among others, through the induction of interferon gamma (IFN-צ) 
production (Munder et al., 1998). In turn, IFN-צ which is induced by both IL-18 and IL-
12 stimulates macrophages to produce TNF-α, NO, and ROS as part of the defense 
against infectious agents (Dinarello, 1999; Nakanishi et al., 2001). 
 
2.4 Nitric oxide 
2.4.1 Introduction 
NO is a free radical gaseous molecule which has a very short biological half life 
(Santoro et al., 2001). In recent years, NO has become one of the most studied 
substances because of its important role in several biological systems. It has been 
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shown that NO has a role in the modulation of sexual and reproductive function 
(Middendorff et al., 1997). 
 
2.4.2 NO synthesis 
The production of NO is catalysed by a family of NO synthase (NOS) enzymes 
(Thundathil et al., 2003). NOS is responsible for the conversion of L-arginine to NO 
and L-citrulline (O’Bryan et al., 1998). Two NOS types have been identified in human 
spermatozoa: NOS similar to the constitutively expressed brain neuronal NOS 
(nNOS) and endothelial NOS (eNOS) (Donnelly et al., 1997). The ability of human 
spermatozoa to synthesize NO has been demonstrated indirectly by measuring nitrite 
accumulation (Lewis et al., 1996),  as well as L-[3H] citrulline generation (Revelli et 
al., 1999) or directly by means of an NO meter (Donnelly et al., 1997) and 
fluorescence activated cell sorting (FACS) analysis (Lampiao et al., 2006).  
 
2.4.3 Importance of NO 
NO is a potent vasodilator and neurotransmitter and has been implicated in 
numerous physiological, pharmacological and pathological processes (Moncada et 
al., 1991). It has also been shown to be an essential mediator in the female 
(Yallampalli et al., 1993; Rosselli et al., 1994) and the male reproductive tracts 
(Adams et al., 1992). Its deficiency has been suggested as the contributory factor in 
pre-eclampsia (Fickling et al., 1993; Seligman et al., 1994), while its vasodilatory 
activities on cavernosal smooth muscles are responsible for achieving penile erection 
(Burnett et al., 1992).  
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Despite being a free radical itself, NO can also act as a free radical scavenger by 
inactivating and inhibiting the production of superoxide (O2-) (Clancy et al., 1992). O2- 
leads to lipid peroxidation which results in functional impairment of spermatozoa 
(Jeyendran et al., 1984). In vitro studies have shown that exogenous NO yield 
contrasting results on human sperm function depending on the concentrations 
applied (Sengoku et al., 1998). It has been reported that lower concentrations of NO 
are beneficial to human sperm function whereas higher concentrations become 
detrimental (Wu et al., 2004).  
 
Studies have reported a relationship among insulin, leptin, cytokines and NO. Pro-
inflammatory cytokines such as TNF-α and IL-6 have been reported to induce NO 
production in the pancreatic islets (Erbagei et al., 2001; Rabinovitch, 1998). Recent 
evidence shows that cytokines and NO are associated with destruction of pancreatic 
cells and development of DM (Berman et al., 1996; Rabinovitch, 1998). The 
production of leptin has been shown to be regulated by insulin, cytokines and 
chemokines (Nomura et al., 2000; Lauszus et al., 2001).  Some of these substances 
are implicated in sperm physiology therefore, imperative to investigate. 
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Chemicals 
Hams F10, wortmannin, nifedipine, erbstatin, leptin, L-NAME, propidium iodide (PI), 
fluorescein isothiacyanate Pisum sativum agglutinin (FITC-PSA), glucose, tumor 
necrosis factor alpha (TNF-α), interleukin-6 (IL), calcium ionophore A23187 and 
progesterone were obtained from Sigma Chemical Co., (St Louis, MO, USA). Human 
insulin was purchased from Lilly France S.A.S (Federsheim, France). 4,5-
diaminofluorescein-2/diacetate (DAF-2/DA) was from Calbiochem, San Diego, CA, 
USA. GLUT8 goat polyclonal IgG primary antibody and donkey anti-goat IgG-Texas 
Red conjugated secondary antibody were purchased from Santa Cruz Biotechnology, 
California, USA. Donkey serum was from Sigma Aldrich Inc., St Louis, MO, USA. 
DakoCytomation Fluorescent Mounting Medium was bought from Dako North 
America Inc., CA, USA, and Hoechst was purchased from Invitrogen, California, 
USA.  
 
3.2 Semen collection 
Semen samples were obtained from 43 normozoospermic healthy volunteer donors 
studying at the Tygerberg Campus, University of Stellenbosch, aged between 19-23 
years who provided informed consent for a research protocol approved by the 
University of Stellenbosch Ethics Committee. All semen samples were collected by 
masturbation after 2-3 days of sexual abstinence according to the World Health 
Organization criteria (WHO, 1999). Semen samples were collected in sterile wide 
mouthed containers after which the semen was allowed to liquefy for 30 minutes at 
37˚C before processing. 
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3.3 Semen preparation using double wash swim-up technique 
Fresh semen was placed in a 5ml tube and an equal amount of Hams F10 medium 
was added. The tube was centrifuged for 5 minutes at 400xg. The supernatant was 
discarded leaving a pellet at the bottom which was resuspended in fresh Hams F10 
medium and centrifuged again for 5 minutes at 400xg. The supernatant was carefully 
removed by aspiration without disturbing the pellet and 1.2 mL of HTF/Hams F10 
mixed with 3% bovine serum albumin (BSA) medium was layered on top of the pellet. 
The tube was placed on a rack inclined at 45 degrees and incubated (37˚C, 5% CO2, 
60 min). After 1 hour the media containing a homogenous motile sperm population 
was collected (swim-up). 
 
3.4 Semen preparation using two-layer density discontinuous gradient 
system 
Two mililitres of PureSperm®80 was added to a conical centrifuge tube. 
PureSperm®80 is denser than PureSperm®40. This was followed by carefully layering 
of 2 mL PureSperm®40 on top of the PureSperm®80. Using a Pasteur pipette, 1.5 mL 
of semen was layered onto the PureSperm®. The tube was centrifuged at 300 x g for 
20 minutes. After centrifugation the top layer which consisted of seminal plasma and 
debris was aspirated and discarded. The middle layer which contains less motile 
sperm in PureSperm®40 was aspirated and placed into a 5 mL tube which was filled 
to the 5 mL mark with Hams F10 medium. The pellet at the bottom which contains 
more motile cells in PureSperm®80 was collected and resuspended in 5 mL Hams 
F10 medium. The two tubes were centrifuged at 400 x g for 10 minute. The Hams 
F10 medium supernatant was aspirated leaving as little liquid as possible above the 
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pellet. The sperm pellet was resuspended in a suitable volume of Hams F10 medium 
+ 3% BSA medium to obtain the required sperm concentration.  
 
3.5 Motility 
Sperm motility/kinematics were determined with the HTM-IVOS analyzer (Hamilton-
Thorne Research Inc., Beverley, MA, USA) with the following standard set-up 
parameters: 30 frames/60 HZ; minimum contrast, 80; minimum cell size, 2; minimum 
static contrast, 30; low path velocity (VAP) cut-off, 5 µm s-1; static head intensity, 
0.60-1.40; slow cell, nonmotile; magnification, 2.01 and temperature, 37°C. The 
following parameters were evaluated: sperm concentration (million/mL), motile (%) 
and progressive motility (%), average path velocity (VAP, µm/s), straight line velocity 
(VSL, µm/s), curvilinear velocity (VCL, µm), amplitude of lateral head displacement 
(ALH, µm/s), beat cross frequency (BCF, Hz), straightness (STR, %) and linearity 
(LIN, %). Motion characteristics were recorded in samples using randomly selected 
microscopic fields. Sperm motion characteristics are illustrated below (Figure 9).  
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Figure 9. An illustration of different sperm motility parameters measured using CASA 
(Adapted from WHO, 1999)  
 
3.6 Cell viability 
Spermatozoa which had received different treatment interventions were incubated for 
different periods before the administration of PI (1 µM, 15 minutes). Viability was 
assessed using flow cytometry as described in section 3.8. Living cells with an intact 
cell membrane and active metabolism will exclude PI while cells with damaged 
membranes or impaired metabolism allow PI to enter the cell and stain the DNA. An 
increase in PI fluorescence was interpreted as decreased cell viability.  
 
3.7 Acrosome reaction  
Spermatozoa were left to capacitate for 3 hours after which they were induced to 
undergo the acrosome reaction by means of a physiological trigger, progesterone 
Straight line 
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Curvilinear path 
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(1 µg/mL, 30 min), calcium ionophore A23187 (1 µg/mL, 30 min) or left to undergo 
the spontaneous acrosome reaction (30 min). 
 
The extent of the acrosome reaction was assessed by placing samples on spotted 
slides and left to air dry after which they were fixed in cold ethanol (WHO, 1999). 
Fluorescein isothiacyanate Pisum sativum agglutinin (FITC-PSA) (125 µg/ml) was 
layered on the slides and they were incubated for 30 min in a dark humid 
atmosphere. Slides were subsequently rinsed with distilled water in order to eliminate 
excess probe, and then observed under a fluorescence microscope. At least 200 
cells were evaluated per spot. 
 
3.8 Flow cytometry 
NO and sperm cell viability was measured by flow cytometric analysis (FACS: 
fluorescence-activated cell sorter). A Becton Dickinson FACSCaliburTM analyzer (BD, 
San Jose, CA, USA) was used to quantify fluorescence at the single-cell level and 
data was analyzed using CellQuestTM version 3.3 (Becton Dickinson, San Jose, CA, 
USA) software. In each sample, the mean fluorescence intensity of the analyzed cells 
was determined after gating the cell population by forward and side light scatter 
signals as recorded on a dot plot (Figure 10). In total, 100,000 events were acquired, 
but non-sperm particles and debris (located at the bottom left corner of the dot plot) 
were excluded by prior gating, thereby limiting undesired effects on overall 
fluorescence. Final gated populations usually contained 15,000-20,000 sperm cells. 
Fluorescence signals were recorded on a frequency histogram (Figures 11 and 12) 
using logarithmic amplification. Fluorescence data are expressed as mean 
fluorescence (percentage of control, control adjusted to 100%). 
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Figure 10. A representative dot plot of sperm cells showing the spread of the total 
recorded “events”. Gated population (top right): sperm cells and bottom left: non-
sperm particles, debris.  
 
Figure 11. A representative frequency histogram showing baseline fluorescence 
(log) of 4,5-diaminofluorescein-2/diacetate (DAF-2/DA) on x-axis (A); a shift to right 
depicting an increase in fluorescence intensity (B)  
 
 
 
A B 
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Figure 12. A frequency histogram of propidium iodide (PI) fluorescence with two 
peaks. Cells possessing a damaged membrane will permit PI to enter into the cell 
and bind to DNA causing the cells to fluoresce red. The peak to the left is depicting 
viable cells which are able to exclude PI while that to the right is non-viable cells 
which had absorbed PI. 
 
3.9 Protocols 
This section will outline in detail all the protocols that were employed in this study. 
Spermatozoa were separated from semen through a double wash swim-up or a 
double density gradient system as described in sections 3.3 and 3.4 respectively, 
before the cells were counted using CASA. In each experiment the spermatozoa 
were divided into aliquots containing 5 x 106/mL cells. 
 
3.9.1 The glucose concentration curve 
The aliquots were treated with glucose concentrations (0, 2, 5, 8, 12, 20 mM) and 
incubated (37°C, 5% CO2). Sperm motility parameters were measures by means of 
CASA at 1 and 2 hours (Figure 13).  
M1
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Figure 13.  Protocol to determine the effects of glucose on sperm motility 
parameters. 
 
8.9.2 Effects of different glucose concentrations on PI fluorescence 
The different sperm aliquots were treated with increasing concentrations of glucose 
(0, 2, 5, 8, 12, 20 mM) and incubated (37°C, 5% CO2; 180 min) before the addition of 
PI (1 µM, 15 minutes) (Figure 14). The PI fluorescence assessment was done by 
FACS analysis as described in section 3.8.  
 
 
 
Figure 14. Protocol to determine the effects of different glucose concentrations on PI 
fluorescence 
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3.9.3 The insulin concentration curve 
The spermatozoa aliquots were treated with increasing concentrations of insulin (0, 
5, 10, 20, 30 µIU) and incubated (37°C, 5% CO2). Sperm motility parameters were 
measured by means of CASA at 1, 2 and 3 hours as illustrated in Figure 15. 
 
 
Figure 15. Protocol to determine the effects of different insulin concentrations on 
sperm motility parameters.  
 
 
3.9.4 Effects of different insulin concentrations on PI fluorescence 
Spermatozoa were treated with insulin concentrations (0, 5, 10, 20, 30 µIU) and 
incubated (37°C, 5% CO2; 180 min) before the addition of PI (1 µM, 15 minutes) 
(Figure 16). The PI fluorescence assessment was done by FACS analysis as 
described in section 3.8.  
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Figure 16. Protocol to determine the effects of different insulin concentrations on PI 
fluorescence. 
 
3.9.5 The leptin concentration curve 
The aliquots were treated with leptin concentrations (0, 5, 10, 20, 30 nM) and 
incubated (37°C, 5% CO2). Sperm motility parameters were measured by means of 
CASA at 1, 2 and 3 hours as illustrated in (Figure 17). 
 
 
Figure 17. Protocol to determine the effects of different leptin concentrations on 
sperm motility parameters.  
 
3.9.6 Effects of different leptin concentrations on PI fluorescence 
The spermatozoa was treated with increasing concentrations of leptin (0, 5, 10, 20, 
30 nM) and incubated (37°C, 5% CO2; 180 min) before the addition of PI (1 µM, 15 
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minutes) (Figure 18). The PI fluorescence assessment was done by FACS analysis 
as described in section 3.8.  
 
 
 
Figure 18. Protocol to determine the effects of different leptin concentrations on PI 
fluorescence. 
 
 
3.9.7 Unravelling the insulin signalling pathway in human spermatozoa 
As illustrated in Figure 19, insulin’s effects were blocked in three ways: the blockage 
of insulin release by nifedipine (25 µM), the inhibition of its intracellular effector, PI3K 
by wortmannin (10 µM) and the inhibition of insulin receptor tyrosine phosphorylation 
by erbstatin (25 µM) 30 minutes prior to insulin administration. These concentrations 
were previously described by Aquila et al. (2005a). The control group had sperm 
cells in HTF medium with no extra glucose whereas the glucose free group 
comprised of sperm cells in glucose free HTF medium. Sperm motility parameters 
were measured by means of CASA at 1, 2 and 3 hours.  
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Figure 19. Protocol to determine the effects of insulin on sperm motility parameters.  
 
 
3.9.8 Effects of insulin on PI fluorescence 
As illustrated in Figure 20, insulin’s effects were blocked by nifedipine, wortmannin 
and erbstatin 30 minutes prior to insulin administration. After insulin administration, 
the cells were incubated (180 minutes) before the addition of PI (1 µM, 15 minutes). 
The PI fluorescence assessment was done by FACS analysis as described in section 
3.8.  
 
 
Figure 20. Protocol to determine the effects of insulin on PI fluorescence. 
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3.9.9 Effects of insulin on acrosome reaction  
As illustrated in Figure 21, insulin’s effects were blocked by nifedipine, wortmannin 
and erbstatin 30 minutes prior to insulin administration. Progesterone (1 µg/mL, 30 
minutes) and calcium ionophore A23187 (10 µmol/L, 30 minutes) were used as 
inducers of the AR. The rest of the experiment was done as outlined in section 3.7. 
 
 
 
Figure 21. Protocol to determine the effects of insulin on acrosome reaction. 
 
 
3.9.10 Effects of insulin and leptin on sperm motility parameters 
Wortmanin (10 µM) was used to block the effects of insulin and leptin 30 minutes 
prior to insulin and leptin administration (Figure 22). Sperm motility parameters were 
measures by means of CASA at 1, 2 and 3 hours.  
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Figure 22. Protocol to determine the effects of insulin and leptin on sperm motility 
parameters.  
 
3.9.11 Effects of insulin and leptin on PI fluorescence 
Some aliquots were treated with wortmannin (10 µM) 30 minutes prior to insulin and 
leptin administration. After insulin and leptin administration, the cells were incubated 
for 180 minutes before the addition of PI (1 µM, 15 minutes) (Figure 23). The PI 
fluorescence assessment was done by FACS analysis as described in section 3.8.  
 
 
Figure 23. Protocol to determine the effects of insulin and leptin on PI fluorescence.  
 
3.9.12 Effects of insulin and leptin on DAF-2/DA fluorescence 
After wortmannin administration (10 µM; 30 minutes) cells were treated with insulin 
and leptin. Samples which had received different treatments were loaded with DAF-
2/DA (10 µM) and incubated (120 min, 37 ºC) in the dark. Some of the samples were 
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loaded with the NOS inhibitor, L-NAME (0.7 mM), 30 minutes prior to DAF-2/DA 
administration (Figure 24). Care was taken to prevent exposure to light throughout 
the rest of the experimentation as the probe is light sensitive. After incubation with 
DAF-2/DA the cells were analysed by FACS as described in section 3.8.  
 
 
Figure 24. Protocol to determine the effects of insulin and leptin on DAF-2/DA 
fluorescence.  
 
3.9.13 Effects of insulin and leptin on sperm acrosome reaction 
After the administration of wortmannin (10 µM; 30 minutes), insulin and leptin were 
administered. Progesterone and calcium ionophore were used as inducers of the AR 
(Figure 25). The rest of the experiment was done as outlined in section 3.7. 
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Figure 25. Protocol to determine the effects of insulin and leptin on sperm acrosome 
reaction. 
 
3.9.14 Characterizing the spermatozoa separated by the PureSperm® two-layer 
density discontinuous gradient  
Spermatozoa were separated into two fractions by the PureSperm® two-layer density 
discontinuous gradient system as described in section 3.4. Sperm motility parameters 
from the two fractions were assessed by means of CASA. Cell viability of the two 
fractions was assessed by flow cytometry using PI as a probe. Morphology smears 
were made, air-dried and stained using the Diff-quick staining technique. The 
Tygerberg Strict Criteria was used to evaluate morphology using CASA on Sperm 
Class Analyser (SCA) (Figure 26).  
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Figure 26. Protocol to determine the characteristic of the two sperm fractions 
separated by the PureSperm® two-layer density discontinuous gradient system.  
 
3.9.15 Effects of insulin and leptin on motility parameters of 
asthenozoospermic and teratozoospermic spermatozoa 
Spermatozoa were separated into two fractions using the PureSperm® two-layer 
density discontinuous gradient system and subsequently treated with insulin (10 µIU) 
and leptin (10 nM). Motility parameters were measured after three hours of 
incubation (Figure 27).  
 
 
 
Figure 27. Protocol to determine the effects of insulin and leptin on motility 
parameters of asthenozoospermic and teratozoospermic spermatozoa. 
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3.9.16 Effects of TNF-α and IL-6 on motility parameters 
The spermatozoa aliquots were incubated (37˚C, 5% CO2) with increasing 
concentrations of TNF-α and IL-6 (0, 2, 5, 10, 20, 50, 100 ng/mL) for 1, 3, 5 hours in  
1 mL Hams + BSA medium according to concentrations described by Perdichizzi et 
al., (2007). At the end of the incubation, the aliquots’ sperm motility parameters were 
assessed using CASA (Figure 28). 
 
 
Figure 28. Protocol to determine the effects TNF-α and IL-6 on motility parameters. 
 
 
3.9.17 Effects of TNF-α and IL-6 on PI fluorescence 
Increasing concentrations of TNF-α and IL-6 (0, 2, 5, 10, 20, 50, 100 ng/mL were 
administered to spermatozoa and incubated (37˚C, 5% CO2; 5hrs). Subsequently, the 
cells were loaded with PI (1 µM, 15 min) (Figure 29). PI fluorescence was analyzed 
by FACS as described in section 3.8.  
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± TNF-α/IL-6 (0, 2, 5, 10, 20,  50, 100 ng/mL) 
150’  340’  460’  
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Figure 29. Protocol to determine the effects TNF-α and IL-6 on PI fluorescence. 
 
3.9.18 Effects of TNF-α and IL-6 on DAF-2/DA fluorescence 
Cells were treated with TNF-α and IL-6 (0, 5, 20, 100 ng/mL before they were loaded 
with DAF-2/DA (10 µM) and incubated (5hrs, 37 ºC) in the dark. Some of the samples 
were loaded with the NOS inhibitor, L-NAME (0.7 mM), 30 min prior to DAF-2/DA 
administration (Figure 30).  After incubation with DAF-2/DA the cells were analyzed 
by FACS as described in section 3.8. 
 
 
 
Figure 30. Protocol to determine the effects TNF-α and IL-6 on DAF-2/DA 
fluorescence.  
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3.9.19 Effects of TNF-α and IL-6 on spontaneous, calcium ionophore and 
progesterone-induced acrosome reaction 
The spermatozoa aliquots were incubated for 3 hours to capacitate and then 
exposed to increasing concentrations of TNF-α and IL-6 (0, 2, 5, 20, 50, 100 pg/mL) 
for 30 minutes (Figure 31). The concentrations were chosen to cover TNF-α and IL-6 
levels detected in the seminal plasma (Koçak et al., 2002; Eggert-Kruse et al., 2007). 
Each aliquot was split into three fractions: one for analysis of the spontaneous AR, 
the second for exposure to calcium ionophore A23187 and the third for exposure to 
progesterone. The extent of the AR was assessed as described in section 3.7. 
 
 
 
Figure 31. Protocol to determine the effects TNF-α and IL-6 on spontaneous, 
calcium ionophore and progesterone-induced acrosome reaction. 
 
 
3.9.20 Immunofluorescence of GLUT8 in human spermatozoa 
Human spermazoa were washed 3 times in PBS before fixed and permeabilized with 
1:1 methanol/acetone fixative in an eppendorf on ice and incubated at 4˚C for 10 
minutes. The fixative was washed out 3 times by PBS. The sperm sample was 
layered on a slide and airdried for 20 minutes. The slide was rinsed with 1.5 mL PBS 
300’ 90’ 
Swim-up  
30’ 
Washx2  
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350’ 310’ 
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Air dry FITC AR ± TNF-α/IL-6 (0, 2, 5,  
10, 20,  50, 100 ng/mL) 
270’ 
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before addition of 10% donkey serum (100 µl) for 20 minutes at room temperature. 
The serum was carefully drained from the slide before the addition of GLUT8 goat 
polyclonal IgG primary antibody (100 µl; 1:200) and incubated for 90 min at room 
temperature. The slides were then rinsed with PBS carefully before the addition of 
donkey anti-goat IgG-Texas Red conjugated secondary antibody (100 µl; 1:200) and 
incubated for 30 minutes at room temperature in the dark. This was followed by the 
addition of 100 µl Hoechst (1:200) and incubated for 10 minutes as illustrated in 
Figure 32. The slides were washed 3 times with PBS and mounted with 
DakoCytomation Fluorescent Mounting Medium, before storage at -20˚C for up to 
2 weeks. Fluorescence was detected by means of fluorescence microscope.  
 
 
 
 
Figure 32. Protocol for immunostaining of GLUT8 in human spermatozoa.  
 
 
 
3.9.21 Statistical analysis 
 
The results were analyzed on the GraphPad PrismTM 4 statistical program. All data 
are expressed as mean ± SEM. Student’s t-test or One-way analysis of variance 
(ANOVA) (with Bonferroni post hoc test if p < 0.05) was used for statistical analysis. 
DAF-2/DA fluorescence data are expressed as mean fluorescence (percentage of 
control, control adjusted to 100%). Differences were regarded statistically significant 
if p < 0.05.  
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CHAPTER 4: RESULTS 
 
 
 
4.1 The glucose concentration curve after one and two hours of incubation 
Table I shows the effects of different glucose concentrations (2, 5, 8, 12, 16, and 
20 mM) on sperm motility parameters after 1 hour of incubation. The number of 
motile cells significantly increased in all the glucose treated groups when compared 
to the control (p < 0.05 vs. Control). Progressive motility, VAP, ALH and rapid cells 
were all significantly increased in glucose treated groups when compared to the 
control (p < 0.05 vs. Control). On the other hand static cells were significantly 
decreased in all the glucose treated groups when compared to the control (p < 0.05 
vs. Control). No statistically significant differences were observed in VSL, VCL, BCF, 
STR, and LIN (p > 0.05 vs. Control). 
 
Similar results were observed after incubation for 2 hours (Table II). Motile cells were 
significantly increased in all the glucose treated groups when compared to the control 
(p < 0.05 vs. Control). Progressive motility was only significantly increased in the 
 2 mM and 5 mM glucose treated groups when compared to the control (p < 0.05 vs. 
Control). VAP and ALH were significantly increased in all the glucose treated groups 
when compared to the control (p < 0.05 vs. Control). There was a significant 
reduction in static cells in all the glucose treated groups when compared to the 
control (p < 0.05 vs. Control). No significant differences were observed for VSL, VCL, 
BCF, STR, LIN and rapid cells after 2 hours of incubation (p > 0.05 vs. Control). 
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Table I. Effects of glucose on sperm motility parameters after 1 hour of incubation 
 (n = 15) 
 
 
 
 
*p < 0.05 vs. Control 
 
 
Parameter 
 
 
Control 
 
 
2 mM 
 
5 mM 
 
8 mM 
 
12 mM 
 
16 mM 
 
20 mM 
 
Motile 
(%) 
 
40.89±4.92 
 
 
56.33±2.48* 
 
61.44±1.75* 
 
58.89±2.13* 
 
57.73±1.97* 
 
53.33±2.52* 
 
54.33±4.95* 
 
Progr. Mot 
(%) 
 
21.44±2.61 
 
28.33±3.08* 
 
29.11±1.34* 
 
29.00±2.01* 
 
28.33±1.41* 
 
26.44±2.38* 
 
27.00±3.71* 
 
VAP 
(m/s) 
 
49.97±2.27 
 
60.58±2.20* 
 
62.03±2.64* 
 
60.90±3.85* 
 
60.50±3.23* 
 
58.66±2.20* 
 
59.14±2.10* 
 
VSL 
(m/s) 
 
42.44±1.99 
 
50.24±2.57 
 
48.71±1.94 
 
51.01±4.73 
 
50.70±4.04 
 
48.24±2.78 
 
49.93±2.91 
 
VCL 
(m) 
 
74.51±3.03 
 
80.31±3.71 
 
82.94±3.34 
 
84.14±7.31 
 
82.71±4.82 
 
81.29±3.78 
 
80.46±4.18 
 
ALH 
(m/s) 
 
3.67±0.12 
 
4.37±0.10* 
 
4.70±0.09* 
 
4.71±0.15* 
 
4.42±0.08* 
 
4.52±0.14* 
 
4.31±0.16* 
 
BCF 
(Hz) 
 
21.20±2.20 
 
22.59±0.59 
 
24.13±1.04 
 
23.58±0.84 
 
23.09±0.43 
 
22.93±0.43 
 
23.21±0.74 
 
STR 
(%) 
 
83.00±0.81 
 
82.22±0.87 
 
83.44±0.70 
 
82.33±1.21 
 
83.00±0.72 
 
82.33±1.00 
 
81.67±1.64 
 
LIN 
(%) 
 
55.33±1.01 
 
55.00±1.20 
 
56.89±1.18 
 
56.11±2.05 
 
56.22±0.99 
 
54.78±1.28 
 
54.11±1.70 
 
Rapid cells 
(%) 
 
30.78±3.82 
 
40.11±3.37* 
 
40.11±2.87* 
 
40.22±2.77* 
 
40.56±2.01* 
 
37.67±1.62* 
 
39.00±4.48* 
 
Static cells 
(%) 
 
 
37.78±5.70 
 
20.67±1.65* 
 
19.33±2.60* 
 
24.00±2.33* 
 
21.89±3.24* 
 
23.22±3.04* 
 
21.22±3.11* 
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Table II. Effects of glucose on sperm motility parameters after 2 hours of incubation 
(n = 15) 
 
 
 
 
 
 
*p < 0.05 vs. Control 
 
 
 
Parameter 
 
 
Control 
 
 
2 mM 
 
5 mM 
 
8 mM 
 
12 mM 
 
16 mM 
 
20 mM 
 
Motile 
(%) 
 
52.50±1.40 
 
 
60.00±3.68* 
 
63.83±1.62* 
 
63.00±2.88* 
 
60.50±2.46* 
 
60.50±3.13* 
 
59.50±2.37* 
 
Progr. Mot 
(%) 
 
30.67±2.80 
 
39.67±2.39* 
 
39.33±4.01* 
 
37.50±5.54 
 
36.83±2.48 
 
36.50±3.65 
 
36.50±2.68 
 
VAP 
(m/s) 
 
51.23±0.80 
 
64.13±3.63* 
 
68.22±3.21* 
 
66.17±2.59* 
 
63.78±3.30* 
 
62.80±3.71* 
 
64.80±3.51* 
 
VSL 
(m/s) 
 
51.03±2.78 
 
59.15±2.89 
 
61.93±3.23 
 
60.38±2.56 
 
58.43±4.63 
 
57.88±4.02 
 
58.33±3.95 
 
VCL 
(m) 
 
76.88±3.72 
 
82.53±3.82 
 
84.63±2.12 
 
83.90±2.57 
 
81.60±3.45 
 
82.25±1.64 
 
82.92±3.32 
 
ALH 
(m/s) 
 
3.80±0.15 
 
4.85±0.16* 
 
4.81±0.17* 
 
4.98±0.20* 
 
4.81±0.27* 
 
4.73±0.20* 
 
4.70±0.21* 
 
BCF 
(Hz) 
 
20.53±0.48 
 
21.13±1.24 
 
22.10±0.61 
 
22.23±0.90 
 
22.40±0.62 
 
22.68±0.62 
 
23.38±0.40 
 
STR 
(%) 
 
83.17±1.81 
 
83.17±1.79 
 
84.00±1.52 
 
84.50±1.58 
 
82.67±1.35 
 
83.33±1.25 
 
83.50±1.14 
 
LIN 
(%) 
 
59.00±2.17 
 
57.17±2.38 
 
59.67±2.14 
 
59.50±2.34 
 
57.50±1.76 
 
58.17±1.35 
 
57.67±1.45 
 
Rapid cells 
(%) 
 
45.50±1.33 
 
50.67±2.20 
 
51.00±1.52 
 
50.50±4.66 
 
50.83±0.98 
 
51.17±3.20 
 
49.50±2.86 
 
Static cells 
(%) 
 
 
32.17±2.08 
 
20.33±1.14* 
 
21.17±3.18* 
 
20.17±1.62* 
 
22.50±5.57* 
 
20.83±2.05* 
 
20.83±2.65* 
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4.1.1 Effects of different glucose concentrations on PI fluorescence 
As illustrated in Figure 33, there were no statistically significant differences in PI 
fluorescence with increasing glucose concentration.  
 
 
 
Figure 33. The effects of different glucose concentrations on PI fluorescence (n = 15) 
 
 
 
 
 
 
 
 
 
 
 84
4.2 The effects of different insulin concentrations on sperm motility 
parameters after 1, 2, and 3 hours of incubation 
Table III shows the effects of different insulin concentrations on sperm motility 
parameters after one hour of incubation. The number of motile sperm cells was 
significantly increased in the 10 µIU insulin treated group compared to the control  
(p < 0.05 vs. Control). Static cells were also significantly decreased in the 10 µIU 
insulin treated group when compared to the control (p < 0.05 vs. Control). There were 
no significant differences in any of the other motility parameters (p > 0.05 vs. 
Control). 
 
After two hours of incubation (Table IV), the number of motile cells was significantly 
increased in the 10 µIU, 20 µIU and 30 µIU insulin treated groups when compared to 
the control (p < 0.05 vs. Control). Progressive motility was significantly increased in 
the 10 µIU insulin treated group only when compared to the control (p < 0.05 vs. 
Control). VAP was significantly increased in both 5 µIU and 10 µIU insulin treated 
groups when compared to the control (p < 0.05 vs. Control). Similarly, rapid cells 
were also significantly increased in the 5 µIU and 10 µIU insulin treated groups when 
compared to the control (p < 0.05 vs. Control). However, static cells were only 
significantly reduced in the 10 µIU insulin treated group when compared to the 
control (p < 0.05 vs. Control). 
 
Table V shows the effects of different insulin concentrations on sperm motility 
parameters after three hours of incubation. Motile cells and progressive motility were 
significantly increased in all the insulin treated groups when compared to the control 
(p < 0.05 vs. Control). On the other hand, VAP, VSL, VCL, ALH and rapid cells were 
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significantly increased only in the 5 µIU and 10 µIU insulin treated groups when 
compared to the control (p < 0.05 vs. Control). Static cells were significantly reduced 
in the 5 µIU and 10 µIU insulin treated groups when compared to the control  
(p < 0.05 vs. Control). No significant differences were observed for BCF, STR and 
LIN (p > 0.05 vs. Control). 
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Table III. The effects of different insulin concentrations on sperm motility parameters 
after one hour of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                   *p < 0.05 vs. Control 
 
Parameter 
 
 
Control 
 
 
5 µIU 
 
10 IU 
 
20 IU 
 
30 IU 
 
Motile 
(%) 
 
66.80±2.64 
 
 
69.70±2.50 
 
77.30±2.62* 
 
75.90±2.12 
 
75.20±3.47 
 
Progr. Mot 
(%) 
 
44.10±3.08 
 
50.70±2.21 
 
52.50±1.62 
 
52.10±2.97 
 
51.80±2.77 
 
VAP 
(m/s) 
  
60.32±3.24 
 
67.88±0.86 
 
69.11±2.51 
 
70.31±1.22 
 
65.62±3.66 
 
VSL 
(m/s) 
 
52.40±2.96 
 
59.65±0.98 
 
63.11±1.98 
 
63.03±1.27 
 
57.22±3.45 
 
VCL 
(m) 
 
81.63±5.17 
 
91.02±2.75 
 
91.27±4.44 
 
91.88±1.79 
 
87.59±4.28 
 
ALH 
(m/s) 
 
3.47±0.22 
 
3.59±0.14 
 
3.68±0.18 
 
3.69±0.16 
 
3.84±0.21 
 
BCF 
(Hz) 
 
15.97±1.08 
 
17.02±0.87 
 
16.82±0.88 
 
17.71±0.90 
 
17.58±0.73 
 
STR 
(%) 
 
84.10±1.08 
 
86.60±1.12 
 
85.30±0.83 
 
87.40±1.08 
 
84.80±1.23 
 
LIN 
(%) 
 
62.20±1.42 
 
66.70±2.08 
 
65.30±1.25 
 
67.40±2.02 
 
63.00±1.64 
 
Rapid cells 
(%) 
 
55.80±2.70 
 
69.90±2.97 
 
71.00±2.64 
 
63.00±3.78 
 
64.70±4.95 
 
Static cells 
(%) 
 
 
29.10±2.44 
 
20.20±3.37 
 
16.90±2.30* 
 
23.20±2.95 
 
20.80±3.00 
 87
Table IV. The effects of different insulin concentrations on sperm motility parameters 
after two hours of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                *p < 0.05 vs. Control 
 
Parameter 
 
 
Control 
 
 
5 µIU 
 
10 IU 
 
20 IU 
 
30 IU 
 
Motile 
(%) 
 
64.50±3.63 
 
 
72.80±1.68 
 
81.60±1.41* 
 
77.60±1.12* 
 
76.30±1.68* 
 
Progr. Mot 
(%) 
 
40.50±3.87 
 
52.00±1.27 
 
57.10±2.31* 
 
51.40±3.36 
 
53.50±1.80 
 
VAP 
(m/s) 
 
  57.27±3.88 
 
72.11±3.32* 
 
73.57±3.16* 
 
67.59±1.77 
 
68.75±3.30 
 
VSL 
(m/s) 
 
50.80±2.47 
 
62.08±2.05 
 
65.39±2.36 
 
59.71±1.80 
 
58.57±2.50 
 
VCL 
(m) 
 
80.91±5.34 
 
95.94±4.37 
 
96.62±5.58 
 
88.94±5.17 
 
87.89±5.17 
 
ALH 
(m/s) 
 
3.72±0.26 
 
3.95±0.22 
 
3.82±0.21 
 
3.85±0.28 
 
3.79±0.26 
 
BCF 
(Hz) 
 
16.50±0.86 
 
17.33±0.95 
 
17.25±1.00 
 
16.95±0.98 
 
17.47±0.89 
 
STR 
(%) 
 
83.00±1.20 
 
85.50±0.88 
 
84.60±1.01 
 
85.40±0.68 
 
84.20±1.17 
 
LIN 
(%) 
 
59.60±1.77 
 
64.10±1.74 
 
65.10±1.39 
 
63.00±1.71 
 
62.00±1.80 
 
Rapid cells 
(%) 
 
54.70±4.62 
 
69.50±2.77* 
 
75.30±2.80* 
 
60.20±3.99 
 
60.00±4.09 
 
Static cells 
(%) 
 
 
25.00±2.93 
 
18.10±2.33 
 
12.30±1.36* 
 
23.60±3.46 
 
23.50±2.68 
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Table V. The effects of different insulin concentrations on sperm motility parameters 
after three hours of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                *p < 0.05 vs. Control 
 
Parameter 
 
 
Control 
 
 
5 µIU 
 
10 IU 
 
20 IU 
 
30 IU 
 
Motile 
(%) 
 
60.40±2.00 
 
 
75.50±2.75* 
 
83.80±1.22* 
 
78.70±1.71* 
 
75.90±2.44* 
 
Progr. Mot 
(%) 
 
34.70±4.82 
 
50.80±3.01* 
 
58.00±0.85* 
 
53.20±0.98* 
 
50.20±3.70* 
 
VAP 
(m/s) 
 
  55.15±4.84 
 
73.14±2.49* 
 
74.22±3.29* 
 
69.41±2.67 
 
64.53±3.85 
 
VSL 
(m/s) 
 
45.70±3.27 
 
64.49±1.88* 
 
65.64±2.10* 
 
60.46±2.92 
 
57.26±3.36 
 
VCL 
(m) 
 
78.01±5.79 
 
98.36±4.71* 
 
98.92±5.12* 
 
91.35±5.40 
 
84.41±6.43 
 
ALH 
(m/s) 
 
3.47±0.20 
 
4.01±0.23* 
 
4.04±0.18* 
 
3.79±0.28 
 
3.70±0.22 
 
BCF 
(Hz) 
 
18.14±1.38 
 
17.33±0.90 
 
16.48±0.75 
 
18.13±0.84 
 
18.23±0.91 
 
STR 
(%) 
 
81.10±1.81 
 
84.60±0.90 
 
84.60±0.63 
 
85.50±1.03 
 
83.60±1.31 
 
LIN 
(%) 
 
58.20±2.42 
 
63.70±1.83 
 
63.20±1.06 
 
66.30±3.22 
 
60.10±1.60 
 
Rapid cells 
(%) 
 
49.80±5.51 
 
67.60±3.28* 
 
71.70±2.63* 
 
54.80±3.29 
 
54.60±3.87 
 
Static cells 
(%) 
 
 
28.50±4.21 
 
16.40±1.47* 
 
13.40±1.39* 
 
21.80±4.98 
 
25.50±3.04 
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4.2.1 Effects of different insulin concentrations on PI fluorescence 
Insulin significantly decreased PI fluorescence at all the concentrations when 
compared to the control (Figure 34). The decrease in PI fluorescence was interpreted 
as an increase in viability. 
 
 
 
Figure 34. The effects of different insulin concentrations on PI fluorescence (n = 18) 
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4.3 The effects of different leptin concentrations on sperm motility 
parameters after 1, 2, and 3 hours of incubation. 
Table VI shows the effects of different leptin concentrations on sperm motility 
parameters. The number of motile cells was significantly increased in the 10 nM 
leptin treated group when compared to the control (p < 0.05 vs. Control). On the 
other hand the author observed a significant decrease in the number of motile cells in 
the 30 nM leptin treated group when compared to the 10 nM leptin treated group 
(p < 0.05), but was not statistically different when compared to the control (p > 0.05). 
No significant differences were observed in the other motility parameters (p > 0.05 
vs. Control). 
 
After two hours of incubation (Table VII), there was a significant increase in motile 
cells in the 10 nM leptin treated group when compared to the control (p < 0.05 vs. 
Control). However, the 20 nM and 30nmol leptin treated groups had significantly less 
motile cells when compared to the 10 nM treated group (p < 0.05), but were not 
statistically different when compared to the control (p > 0.05). Progressive motility 
and VAP were significantly increased in the 10 nM leptin treated group when 
compared to the control (p < 0.05 vs. Control). No significant differences were 
observed in the other parameters (p > 0.05 vs. Control). 
 
Motile cells and progressive motility were significantly increased in the 5 nM and  
10 nM leptin treated groups when compared to the control (p < 0.05 vs. Control) after 
three hours of incubation (Table VIII). VAP and VSL were significantly increased in 
the 10 nM leptin treated group when compared to the control (p < 0.05 vs. Control). 
VCL was significantly increased in the 10 nM, 20 nM and 30 nM leptin treated groups 
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when compared to the control (p < 0.05 vs. Control). Static cells were significantly 
decreased in the 10 nM leptin treated group when compared to the control (p < 0.05 
vs. Control). 
 
Table VI. The effects of different leptin concentrations on sperm motility parameters 
after one hour of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                *p < 0.05 vs. Control; #p < 0.05 vs. 10 nmol leptin. 
 
 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
5 nmol 
 
10 nmol 
 
20 nmol 
 
30 nmol 
 
Motile 
(%) 
 
66.80±2.64 
 
 
67.60±2.38 
 
77.80±2.41* 
 
68.70±4.16 
 
63.90±2.52# 
 
Progr. Mot 
(%) 
 
44.10±3.08 
 
47.50±2.00 
 
49.30±1.27 
 
47.50±2.92 
 
46.90±3.19 
 
VAP 
(m/s) 
 
  60.32±3.24 
 
62.75±2.76 
 
62.88±3.23 
 
66.04±1.46 
 
61.32±3.76 
 
VSL 
(m/s) 
 
52.40±2.96 
 
55.20±1.61 
 
58.58±2.08 
 
58.72±1.36 
 
55.03±1.69 
 
VCL 
(m) 
 
81.63±5.17 
 
82.61±3.45 
 
89.18±3.04 
 
87.53±2.29 
 
83.25±2.51 
 
ALH 
(m/s) 
 
3.47±0.22 
 
3.42±0.14 
 
3.33±0.18 
 
3.61±0.16 
 
3.50±0.14 
 
BCF 
(Hz) 
 
15.97±1.08 
 
17.31±0.79 
 
16.30±0.63 
 
17.78±1.01 
 
18.91±1.27 
 
STR 
(%) 
 
84.10±1.08 
 
85.60±1.01 
 
82.40±0.96 
 
86.70±0.85 
 
83.90±1.21 
 
LIN 
(%) 
 
62.20±1.42 
 
63.30±1.44 
 
59.90±1.37 
 
66.10±1.59 
 
62.10±2.12 
 
Rapid cells 
(%) 
 
58.80±2.70 
 
56.80±2.56 
 
61.20±1.63 
 
61.30±3.32 
 
658.10±3.76 
 
Static cells 
(%) 
 
 
29.10±2.44 
 
28.00±2.24 
 
26.10±2.49 
 
24.80±2.92 
 
23.80±2.85 
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Table VII. The effects of different leptin concentrations on sperm motility parameters 
after two hours of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
                      *p < 0.05 vs. Control; #p < 0.05 vs. 10 nmol leptin. 
 
 
Parameter 
 
 
Control 
 
 
5 nmol 
 
10 nmol 
 
20 nmol 
 
30 nmol 
 
Motile 
(%) 
 
64.50±3.63 
 
 
71.70±2.86 
 
79.60±1.55* 
 
67.20±2.54# 
 
68.20±3.57# 
 
Progr. Mot 
(%) 
 
40.50±3.87 
 
47.30±3.33 
 
53.10±1.75* 
 
50.63±3.86 
 
49.10±3.93 
 
VAP 
(m/s) 
 
  57.27±3.88 
 
60.19±3.38 
 
71.89±3.35* 
 
63.36±2.72 
 
62.56±2.66 
 
VSL 
(m/s) 
 
50.80±2.47 
 
52.98±2.83 
 
60.11±2.00 
 
55.91±2.55 
 
56.10±2.49 
 
VCL 
(m) 
 
80.91±5.34 
 
82.26±3.78 
 
88.59±3.32 
 
85.04±3.89 
 
85.87±2.99 
 
ALH 
(m/s) 
 
3.72±0.26 
 
3.35±0.22 
 
3.51±0.26 
 
3.68±0.16 
 
3.82±0.15 
 
BCF 
(Hz) 
 
16.50±0.86 
 
17.20±0.97 
 
16.73±1.12 
 
18.08±0.62 
 
18.09±0.72 
 
STR 
(%) 
 
83.00±1.20 
 
85.20±1.20 
 
82.80±0.55 
 
85.95±0.75 
 
85.90±1.21 
 
LIN 
(%) 
 
59.60±1.77 
 
62.00±1.78 
 
61.60±1.67 
 
64.20±1.57 
 
63.70±1.89 
 
Rapid cells 
(%) 
 
54.70±4.62 
 
62.20±1.44 
 
61.70±2.64 
 
57.90±3.53 
 
61.30±4.06 
 
Static cells 
(%) 
 
 
25.00±2.93 
 
22.40±2.83 
 
21.50±2.64 
 
25.00±2.84 
 
25.30±3.01 
 93
Table VIII. The effects of different leptin concentrations on sperm motility parameters 
after three hours of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                *p < 0.05 vs. Control 
 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
5 nmol 
 
10 nmol 
 
20 nmol 
 
30 nmol 
 
Motile 
(%) 
 
60.40±2.00 
 
 
75.90±2.49* 
 
77.30±1.77* 
 
64.00±2.40 
 
65.90±2.43 
 
Progr. Mot 
(%) 
 
34.70±4.82 
 
51.10±3.37* 
 
54.10±2.26* 
 
48.30±1.90 
 
48.80±1.86 
 
VAP 
(m/s) 
 
  55.15±4.84 
 
59.93±2.87 
 
65.54±4.54* 
 
64.96±1.75 
 
63.32±2.47 
 
VSL 
(m/s) 
 
45.70±3.27 
 
52.15±2.92 
 
58.87±2.21* 
 
57.15±1.86 
 
54.25±2.35 
 
VCL 
(m) 
 
78.01±5.79 
 
82.46±3.47 
 
90.78±3.28* 
 
87.86±2.50* 
 
88.21±3.38* 
 
ALH 
(m/s) 
 
3.47±0.20 
 
3.53±0.19 
 
3.57±0.27 
 
3.81±0.10 
 
3.58±0.16 
 
BCF 
(Hz) 
 
18.14±1.38 
 
17.79±0.89 
 
17.47±0.59 
 
17.60±1.02 
 
18.05±1.13 
 
STR 
(%) 
 
81.10±1.81 
 
82.60±0.81 
 
81.20±0.48 
 
85.70±0.73 
 
81.80±1.63 
 
LIN 
(%) 
 
58.20±2.42 
 
58.20±1.56 
 
58.20±1.11 
 
63.80±1.34 
 
60.30±1.16 
 
Rapid cells 
(%) 
 
49.80±5.51 
 
51.20±2.56 
 
61.00±2.82 
 
58.80±2.19 
 
56.00±4.39 
 
Static cells 
(%) 
 
 
28.50±4.21 
 
21.70±2.72 
 
18.30±14.05 
 
24.90±2.46 
 
27.40±4.75 
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4.3.1 Effects of different leptin concentrations on PI fluorescence 
Figure 35 shows that there was no statistical difference in PI fluorescence with the 
administration of 5 nmol and 10 nmol leptin when compared to the control (p > 0.05). 
However, the 30 nmol leptin treated group had significantly more PI fluorescence 
when compared to the 10 nmol treated group (24.95 ± 2.09 vs. 16.70 ± 1.16;  
p < 0.05). 
 
 
 
Figure 35. The effects of different leptin concentration on PI fluorescence (n = 18) 
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4.4 Teasing out the insulin signalling pathway in human spermatozoa after 
1, 2, and 3 hours of incubation. 
The concentration of 10 µIU of insulin was chosen from the dose response curve to 
be administered to the cells. After one hour of incubation (Table IX), the insulin 
treated group had significantly higher percentage of motile cells and progressive 
motility when compared to the erbstatin + insulin treated group (p < 0.05). The 
erbstatin + insulin group also had significantly lower progressive motility when 
compared to the control (p < 0.05). Percent motile cells were significantly decreased 
in the erbstatin and erbstatin + insulin group when compared to the insulin treated 
group (p < 0.05).  
 
Table X shows the effects of insulin on sperm motility parameters after two hours of 
incubation. The erbstatin, nifedipine and wortmannin concentrations used in this 
study were those as described by Aquila et al. (2005). Motile cells were significantly 
decreased in the glucose free, erbstatin (25 µM) and erbstatin + insulin groups when 
compared to the control and the insulin treated group (p < 0.05). Nifedipine (25 µM) 
and wortmannin (10 µM) also significantly decreased motile cells when compared to 
the insulin treated group (p < 0.05). The glucose free, erbstatin, erbstatin + insulin 
and wortmannin groups had significantly lower progressive motility when compared 
to the control (p < 0.05). However, the addition of insulin significantly increased 
progressive motility as well as rapid cells when compared to the control, nifedipine, 
erbstatin, erbstatin + insulin and wortmannin treated groups (p < 0.05).  VAP, VSL, 
VCL and ALH were significantly decreased in the glucose free group when compared 
to the control (p < 0.05). Static cells were significantly decreased in the insulin group 
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when compared to the nifedipine, nifedipine + insulin, erbstatin and erbstatin + insulin 
groups (p < 0.05). Erbstatin and erbstatin + insulin treated groups also had 
significantly higher percentages of static cells when compared to the control (p < 
0.05). 
 
After three hours of incubation (Table XI) the glucose free group had significantly 
lower motile cells, progressive motility, VAP, VSL, VCL, ALH and rapid cells when 
compared to the control (p < 0.05). Static cells were also significantly increased in the 
glucose free group when compared to the control (p < 0.05). The addition of insulin 
significantly increased rapid cells when compared to the control, nifedipine, erbstatin 
and erbstatin + insulin treated groups (p < 0.05). Motile cells and progressive motility 
were significantly decreased in the nifedipine, erbstatin and erbstatin + insulin treated 
groups when compared to the control and the insulin treated group (p < 0.05). VAP, 
VSL, VCL and rapid cells were significantly decreased in the erbstatin + insulin group 
when compared to both the control and the insulin treated group (p < 0.05). 
Nifedipine and erbstatin also significantly decreased rapid cells when compared to 
the insulin treated group. Static cells were significantly increased in the nifedipine 
treated group when compared to the control and the insulin treated group (p < 0.05) 
respectively.   
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Table IX. Unravelling the insulin signalling pathway after one hour of incubation (n = 20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p < 0.05 vs. Control; #p < 0.05 vs. Insulin 
 
 
Parameter 
 
 
Control 
 
Glucose-free 
 
Insulin (10 µIU) 
 
Nifedipine 
 (25 µM) 
 
Nifedipine+ 
    Insulin 
 
Erbstatin 
(25 µM) 
 
Erbstatin + 
    Insulin 
 
Wortmannin 
(10  µM) 
 
Wortmannin + 
Insulin 
 
Motile 
(%) 
 
73.90±2.96 
 
66.80±2.64 
 
 
77.30±2.62 
 
66.70±3.72 
 
71.50±4.35 
 
63.20±2.49 
 
56.80±1.78# 
 
67.50±3.32 
 
64.40±3.57 
 
Progr. Mot 
(%) 
 
54.90±2.62 
 
44.10±3.08 
 
52.50±1.62 
 
49.60±3.37 
 
49.20±3.93 
 
44.10±2.61 
 
31.90±1.47*# 
 
48.70±3.03 
 
43.30±3.87 
 
VAP 
(m/s) 
 
68.54±1.05 
 
60.32±3.24 
 
69.11±2.51 
 
70.31±1.22 
 
65.62±3.66 
 
57.69±1.86 
 
56.53±1.44 
 
66.04±1.46 
 
61.32±2.31 
 
VSL 
(m/s) 
 
59.60±0.60 
 
52.40±2.96 
 
 
63.11±1.98 
 
62.51±1.21 
 
57.02±3.53 
 
50.80±1.87 
 
47.67±1.38 
 
58.72±1.36 
 
53.64±2.08 
 
VCL 
(m) 
 
91.02±2.75 
 
81.63±5.17 
 
91.27±4.44 
 
92.58±2.16 
 
89.33±4.58 
 
79.73±2.67 
 
77.78±2.28 
 
87.53±2.29 
 
83.25±2.51 
 
ALH 
(m/s) 
 
3.59±0.14 
 
3.47±0.22 
 
3.68±0.18 
 
3.69±0.16 
 
3.84±0.21 
 
3.42±0.14 
 
3.33±0.18 
 
3.61±0.16 
 
3.50±0.14 
 
BCF 
(Hz) 
 
17.02±0.87 
 
15.97±1.08 
 
16.82±0.88 
 
17.71±0.90 
 
17.58±0.73 
 
17.31±0.79 
 
16.30±0.63 
 
17.78±0.01 
 
18.91±1.27 
 
STR 
(%) 
 
86.60±1.12 
 
84.10±1.08 
 
85.30±0.83 
 
87.40±1.08 
 
84.80±1.23 
 
85.60±1.01 
 
82.40±0.96 
 
86.70±0.85 
 
83.90±1.21 
 
LIN 
(%) 
 
66.70±2.08 
 
62.20±1.42 
 
65.30±1.25 
 
67.40±2.02 
 
63.00±1.64 
 
63.30±1.44 
 
54.90±1.37 
 
66.10±1.59 
 
62.10±2.12 
 
Rapid cells 
(%) 
 
69.90±2.97 
 
    55.80±2.70 
 
71.00±2.64 
 
63.00±3.78 
 
64.70±2.95 
 
56.80±2.56 
 
50.10±1.65 
 
61.30±3.32 
 
58.10±3.76 
 
Static cells 
(%) 
 
 
20.20±3.37 
 
29.10±2.44 
 
16.90±2.30 
 
23.20±2.95 
 
20.80±3.00 
 
28.00±2.24# 
 
36.10±2.49# 
 
24.80±2.92 
 
23.80±2.85 
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Table X. Unravelling the insulin signalling pathway after two hours of incubation (n = 20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p < 0.05 vs. Control; #p < 0.05 vs. Insulin 
 
 
Parameter 
 
 
Control 
 
Glucose-free 
 
 
Insulin (10 µIU) 
 
Nifedipine 
(25 µM) 
 
Nifedipine+ 
    Insulin 
 
Erbstatin 
(25 µM) 
 
Erbstatin + 
    Insulin 
 
Wortmannin 
(10 µM) 
 
Wortmannin + 
Insulin 
 
Motile 
(%) 
 
76.10±2.15 
 
64.50±3.63* 
 
 
81.60±1.41 
 
64.70±3.55# 
 
68.30±3.47 
 
54.20±3.45*# 
 
59.90±2.57*# 
 
62.20±3.28# 
 
68.50±3.42 
 
Progr. Mot 
(%) 
 
54.00±1.78 
 
40.50±3.87* 
 
67.10±2.31* 
 
41.90±3.55# 
 
46.60±3.25 
 
35.30±3.30*# 
 
38.60±2.85*# 
 
44.90±3.91# 
 
49.10±3.93 
 
VAP 
(m/s) 
 
72.11±3.32 
 
  57.27±3.88* 
 
73.57±3.16 
 
64.55±3.43 
 
63.86±4.09 
 
60.19±3.38 
 
59.80±3.41 
 
63.36±2.72 
 
62.56±2.66 
 
VSL 
(m/s) 
 
63.06±2.64 
 
50.80±2.47* 
 
65.39±2.36 
 
56.51±3.07 
 
55.58±4.09 
 
52.47±3.03 
 
50.87±2.77 
 
55.91±2.55 
 
56.10±2.49 
 
VCL 
(m) 
 
95.94±4.37 
 
80.91±5.34* 
 
96.62±5.58 
 
88.94±5.17 
 
87.89±5.17 
 
82.26±3.78 
 
81.54±4.11 
 
85.04±3.89 
 
85.87±2.99 
 
ALH 
(m/s) 
 
4.17±0.23 
 
3.72±0.26* 
 
3.82±0.21 
 
3.85±0.28 
 
3.79±0.26 
 
3.50±0.22 
 
3.51±0.26 
 
3.68±0.16 
 
3.82±0.15 
 
BCF 
(Hz) 
 
17.33±0.95 
 
16.50±0.86 
 
17.25±1.00 
 
16.95±0.98 
 
17.47±0.89 
 
17.20±0.97 
 
16.73±1.12 
 
18.08±0.62 
 
18.09±0.72 
 
STR 
(%) 
 
85.50±0.88 
 
83.00±1.20 
 
84.60±1.01 
 
85.40±0.68 
 
84.20±1.17 
 
85.20±1.20 
 
82.80±0.55 
 
85.90±0.75 
 
85.90±1.21 
 
LIN 
(%) 
 
64.10±1.74 
 
59.60±1.77 
 
65.10±1.39 
 
63.00±1.71 
 
62.00±1.80 
 
62.00±1.78 
 
61.60±1.67 
 
64.20±1.57 
 
63.70±1.89 
 
Rapid cells 
(%) 
 
69.50±2.77 
 
54.70±4.62 
 
75.30±2.80* 
 
56.90±4.09# 
 
60.00±4.09 
 
47.80±3.95# 
 
53.70±2.90# 
 
57.90±3.53 
 
61.30±4.06 
 
Static cells 
(%) 
 
 
18.10±2.33 
 
25.00±2.93 
 
12.30±1.36 
 
23.60±3.46# 
 
23.50±2.68# 
 
32.40±2.83*# 
 
31.50±2.64*# 
 
25.00±2.84 
 
25.30±3.01 
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Table XI. Unravelling the insulin signalling pathway after three hours of incubation (n = 20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p < 0.05 vs. Control; #p < 0.05 vs. Insulin 
 
 
Parameter 
 
 
Control 
 
 
Glucose-free 
 
Insulin (10 µIU) 
 
Nifedipine 
(25 µM) 
 
Nifedipine+ 
    Insulin 
 
Erbstatin 
(25 µM) 
 
Erbstatin + 
    Insulin 
 
Wortmannin 
(10 µM) 
 
Wortmannin + 
Insulin 
 
Motile 
(%) 
 
75.70±2.58 
 
60.40±2.00* 
 
 
79.60±2.56 
 
58.40±4.14*# 
 
63.90±2.46 
 
55.30±2.98*# 
 
50.00±2.73*# 
 
64.00±2.40 
 
62.00±4.41 
 
Progr. Mot 
(%) 
 
52.80±3.02 
 
34.70±4.82* 
 
61.50±3.42 
 
39.90±3.79*# 
 
40.20±3.46# 
 
33.00±2.13*# 
 
27.00±2.14*# 
 
45.20±2.18# 
 
39.10±3.85*# 
 
VAP 
(m/s) 
 
73.14±2.49 
 
55.15±4.84* 
 
79.24±4.47 
 
67.08±3.95 
 
60.14±5.01 
 
59.93±2.87 
 
53.88±3.88*# 
 
64.96±1.75 
 
63.32±2.47 
 
VSL 
(m/s) 
 
64.83±2.49 
 
45.70±3.27* 
 
71.12±3.66 
 
59.31±3.60 
 
51.61±4.47 
 
52.15±2.92 
 
45.93±3.56*# 
 
57.15±1.86 
 
54.25±2.35 
 
VCL 
(m) 
 
98.36±4.71 
 
78.01±5.79* 
 
94.55±6.84 
 
91.35±5.40 
 
84.41±6.43 
 
82.46±3.47 
 
75.12±4.98*# 
 
87.86±2.50 
 
88.21±3.38 
 
ALH 
(m/s) 
 
4.56±0.21 
 
3.47±0.20* 
 
4.64±0.25 
 
3.79±0.28 
 
3.70±0.22 
 
3.53±0.19 
 
3.57±0.27 
 
3.81±0.10 
 
3.58±0.16 
 
BCF 
(Hz) 
 
17.33±0.90 
 
18.14±1.38 
 
16.48±0.75 
 
18.13±0.84 
 
18.23±0.91 
 
17.79±0.89 
 
17.47±0.59 
 
17.60±1.02 
 
18.05±1.13 
 
STR 
(%) 
 
84.60±0.90 
 
81.10±1.81 
 
84.60±0.63 
 
85.50±1.03 
 
83.60±0.31 
 
82.60±0.81 
 
81.20±0.48 
 
85.70±0.73 
 
81.80±1.63 
 
LIN 
(%) 
 
63.70±1.83 
 
58.20±2.42 
 
63.20±1.06 
 
66.30±3.22 
 
60.10±1.60 
 
58.20±1.56 
 
58.20±1.11 
 
63.80±1.34 
 
60.30±1.16 
 
Rapid cells 
(%) 
 
70.00±3.21 
 
49.80±5.15* 
 
78.00±4.50* 
 
52.40±4.31# 
 
52.60±3.73 
 
48.30±3.23# 
 
41.10±3.33*# 
 
57.20±2.70 
 
56.00±4.39 
 
Static cells 
(%) 
 
 
16.40±1.47 
 
28.50±4.21* 
 
13.40±1.39 
 
30.80±4.98*# 
 
25.90±3.04 
 
31.70±2.72 
 
38.30±4.05 
 
24.90±2.46 
 
27.40±4.75 
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4.4.1 Effects of insulin on PI fluorescence 
Figure 36 shows that PI fluorescence was significantly increased in the glucose free 
group when compared to the control (26.41 ± 1.58% vs. 19.98 ± 0.80%; p < 0.05). 
Addition of insulin significantly decreased the PI fluorescence when compared to the 
control (16.40 ± 0.94% vs. 19.98 ± 0.80%; p < 0.05), but the blockage of endogenous 
insulin secretion by nifedipine significantly increased PI fluorescence when compared 
to the control (25.99 ± 1.91 vs. 19.98 ± 0.80%; p < 0.05). No statistically significant 
differences were observed with the other groups (p > 0.05). 
 
 
Figure 36. Effects of insulin on PI fluorescence. *, p < 0.05 vs. Control (n = 20) 
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4.4.2 Effects of insulin on acrosome reaction 
 
In Figure 37 it can be seen in the control group that progesterone stimulation led to 
significantly more spermatozoa undergoing the AR when compared to cells left to 
spontaneously acrosome react. This phenomenon was observed in all of the 
treatment groups (glucose free, insulin, nifedipine, erbstatin, and wortmannin). The 
lack of glucose significantly reduced the percentage of cells undergoing AR when 
compared to the control (12.42 ± 0.80% vs. 22.92 ± 1.54 %; p < 0.05) for 
spermatozoa which were left to undergo the spontaneously acrosome reaction. 
Insulin significantly increased spontaneously acrosome reacted cells compared to the 
control (44.67 ± 2.20% vs. 22.92 ± 1.54 %; p < 0.05). On the other hand, the 
inhibition of insulin release by nifedipine as well as the inhibition of the IRS tyrosine 
phosphorylation by erbstatin significantly decreased spontaneously acrosome 
reacted spermatozoa compared to the control (15.33 ± 0.92%; 17.67 ± 0.69% vs. 
22.92 ± 1.54 %; p < 0.05) respectively. Wortmannin had no effect on spontaneous 
acrosome reaction when compared to the control.  
 
When spermatozoa were stimulated with progesterone to acrosome react in this 
study was observed a similar trend. The glucose-free group had a significantly lower 
percentage of acrosome reacted spermatozoa compared to the progesterone control 
(19.42 ± 0.63% vs. 31.17 ± 1.06%; p < 0.05). The addition of insulin significantly 
increased the progesterone stimulated acrosome reaction compared to the control 
(53.42 ± 1.56 % vs. 31.17 ± 1.06%; p < 0.05). Inhibition of insulin release by 
nifedipine as well as inhibition of IRS tyrosine phosphorylation by erbstatin 
significantly decreased the percentage of progesterone stimulated acrosome reacted 
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spermatozoa compared to the control (23.17 ± 1.27%; 20.92 ± 0.93% vs. 31.17 ± 
1.06%; p < 0.05) respectively. The PI3K inhibitor, wortmannin, had no effect on 
progesterone stimulated acrosome reaction compared to the control. The addition of 
insulin to the nifedipine treated group significantly increased AR compared to the 
spontaneous nifedipine treated group (28.58 ± 0.98 vs. 15.33 ± 0.92; p < 0.05).  
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Figure 37. Effects of insulin, nifedipine, erbstatin and wortmannin on acrosome 
reaction. Cells were stimulated with progesterone to induce the acrosome reaction or 
left to spontaneously acrosome react. *, p < 0.05 vs. Control (spontaneous); ●, p < 
0.05 vs. Control (progesterone); @, p < 0.05 vs. Progesterone in the same group; #, p 
< 0.05 (n = 20). 
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4.5 The additive effects of insulin and leptin on sperm motility parameters 
after different incubation periods. 
After one hour of incubation (Table XII) there was a significant increase in motile cells 
in the leptin and insulin + leptin treated groups when compared to control (p < 0.05). 
Progressive motility and VCL were also significantly increased in the leptin and 
insulin + leptin treated groups when compared to the control (p < 0.05). On the other 
hand, VAP, ALH and rapid cells were significantly increased in the insulin + leptin 
treated group only when compared to the control (p < 0.05). Percentage of motile 
cells were significantly increased in the leptin and insulin + leptin group when 
compared to the control (p < 0.05). 
 
Table XIII shows the effects of insulin and leptin on motility parameters after two 
hours of incubation. Motile cells, progressive motility, VCL, and rapid cells were 
significantly increased in the insulin, leptin and insulin + leptin treated groups when 
compared to the control (p < 0.05). ALH was significantly increased in the leptin and 
insulin + leptin treated groups when compared to the control (p < 0.05). The 
percentage of static cells was significantly decreased in the insulin, leptin and insulin 
+ leptin treated groups compared to the control (p < 0.05). 
 
Motile cells, progressive motility, VCL, ALH, and rapid cells were all significantly 
increased in the insulin, leptin and insulin + leptin treated groups compared to the 
control (p < 0.05) after three hours of incubation (Table XIV). Percentage of motile 
cells was significantly increased in the insulin, leptin and insulin + leptin treated 
groups when compared to the control (p < 0.05). 
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Table XII. Effects of insulin and leptin on sperm motility parameters after one hour of 
incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              *p < 0.05 vs. Control 
 
Parameter 
 
 
Control 
 
 
Insulin 
 (10 µIU) 
 
Leptin 
(10 nmol) 
 
Insulin+ 
    Leptin 
 
Wortmannin 
(10 µM) 
 
Insulin+Leptin+ 
Wortmannin 
 
Motile 
(%) 
 
64.80±2.74 
 
 
72.80±2.05 
 
75.30±0.57* 
 
76.10±2.53* 
 
63.70±2.63 
 
66.90±2.09 
 
Progr. Mot 
(%) 
 
42.30±2.84 
 
44.80±3.09 
 
51.60±1.98* 
 
52.30±3.08* 
 
43.90±2.83 
 
43.70±2.06 
 
VAP 
(m/s) 
 
55.71±3.08 
 
54.18±3.07 
 
60.18±2.40 
 
64.21±2.84* 
 
61.55±2.33 
 
60.77±1.61 
 
VSL 
(m/s) 
 
46.72±3.04 
 
45.42±3.20 
 
52.07±2.67 
 
55.42±3.09 
 
55.38±2.60 
 
56.18±3.87 
 
VCL 
(m) 
 
78.51±3.90 
 
86.49±3.48 
 
93.15±2.92* 
 
97.40±3.33* 
 
83.44±2.17 
 
83.71±3.82 
 
ALH 
(m/s) 
 
3.36±0.13 
 
3.36±0.13 
 
3.79±0.15 
 
4.00±0.15* 
 
3.89±0.11 
 
3.90±0.17 
 
BCF 
(Hz) 
 
18.15±0.65 
 
16.93±0.95 
 
19.74±0.64 
 
19.00±0.50 
 
19.02±0.62 
 
19.88±0.41 
 
STR 
(%) 
 
83.30±1.00 
 
82.70±1.38 
 
84.80±1.05 
 
84.20±0.96 
 
84.60±0.83 
 
84.20±0.57 
 
LIN 
(%) 
 
60.20±1.65 
 
58.50±2.00 
 
60.90±1.24 
 
61.40±1.41 
 
59.50±1.16 
 
61.30±0.95 
 
Rapid cells 
(%) 
 
61.10±2.87 
 
66.90±2.88 
 
68.80±1.31 
 
70.70±2.61* 
 
54.30±3.18 
 
57.00±3.09 
 
Static cells 
(%) 
 
 
29.30±2.57 
 
19.30±1.40 
 
17.20±1.11* 
 
16.10±1.89* 
 
22.50±1.19 
 
23.30±1.83 
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Table XIII. Effects of insulin and leptin on sperm motility parameters after two hours 
of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              *p < 0.05 vs. Control 
 
 
Parameter 
 
 
Control 
 
 
Insulin 
(10 µIU) 
 
Leptin 
(10 nmol) 
 
Insulin+ 
    Leptin 
 
Wortmannin 
(10 µM) 
 
Insulin+Leptin+ 
Wortmannin 
 
Motile 
(%) 
 
54.30±2.43 
 
 
69.00±2.22* 
 
72.20±2.02* 
 
73.80±2.81* 
 
59.00±1.92 
 
58.10±3.00 
 
Progr. Mot 
(%) 
 
32.90±3.83 
 
47.30±3.81* 
 
53.20±3.00* 
 
54.80±3.13* 
 
39.80±3.53 
 
39.00±3.61 
 
VAP 
(m/s) 
 
60.66±4.17 
 
63.66±2.76 
 
65.36±2.29 
 
67.23±1.97 
 
60.72±2.44 
 
58.94±2.33 
 
VSL 
(m/s) 
 
53.64±4.04 
 
56.39±3.03 
 
57.76±2.19 
 
59.11±1.55 
 
53.68±2.06 
 
51.89±2.10 
 
VCL 
(m) 
 
84.97±5.39 
 
99.78±2.07* 
 
105.2±1.87* 
 
106.6±1.59* 
 
82.99±3.27 
 
82.50±3.51 
 
ALH 
(m/s) 
 
4.20±0.16 
 
4.76±0.24 
 
5.20±0.24* 
 
5.40±0.26* 
 
3.92±0.13 
 
3.97±0.17 
 
BCF 
(Hz) 
 
19.35±1.10 
 
20.48±0.53 
 
20.50±0.53 
 
19.53±0.51 
 
18.84±0.52 
 
20.11±0.52 
 
STR 
(%) 
 
84.40±0.77 
 
85.40±0.92 
 
84.90±0.79 
 
85.40±0.84 
 
85.10±1.01 
 
84.40±0.71 
 
LIN 
(%) 
 
60.60±1.64 
 
61.70±1.85 
 
62.90±0.94 
 
62.80±1.03 
 
61.50±1.05 
 
61.90±1.00 
 
Rapid cells 
(%) 
 
45.20±4.13 
 
61.30±3.14* 
 
66.00±2.38* 
 
67.20±2.84* 
 
50.80±2.79 
 
50.90±3.61 
 
Static cells 
(%) 
 
 
33.30±1.93 
 
19.40±1.44* 
 
19.20±1.77* 
 
16.80±1.59* 
 
26.00±1.57 
 
31.30±2.44 
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Table XIV. Effects of insulin and leptin on sperm motility parameters after three hours 
of incubation (n = 18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              *p < 0.05 vs. Control 
 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
Insulin 
(10 µIU) 
 
Leptin 
(10 nmol) 
 
Insulin+ 
    Leptin 
 
Wortmannin 
(10 µM) 
 
Insulin+Leptin+ 
Wortmannin 
 
Motile 
(%) 
 
54.70±2.85 
 
 
69.40±1.33* 
 
70.30±2.43* 
 
73.00±1.51* 
 
55.10±2.40 
 
52.50±2.15 
 
Progr. Mot 
(%) 
 
35.90±4.32 
 
45.50±2.77* 
 
49.20±3.00* 
 
49.80±3.29* 
 
32.70±2.52 
 
30.40±1.85 
 
VAP 
(m/s) 
 
61.22±3.43 
 
65.21±2.00 
 
64.05±2.74 
 
61.05±3.08 
 
55.54±3.60 
 
56.81±3.83 
 
VSL 
(m/s) 
 
53.76±3.80 
 
56.60±1.89 
 
56.54±2.27 
 
53.19±3.01 
 
45.30±1.80 
 
48.97±3.65 
 
VCL 
(m) 
 
85.89±3.34 
 
106.0±1.66* 
 
106.9±2.04* 
 
110.5±1.91* 
 
80.18±3.18 
 
80.20±4.42 
 
ALH 
(m/s) 
 
4.17±0.13 
 
6.12±0.29* 
 
6.47±0.20* 
 
7.16±0.26* 
 
4.66±0.34 
 
4.47±0.26 
 
BCF 
(Hz) 
 
19.92±0.47 
 
19.76±0.33 
 
18.90±0.72 
 
20.67±0.33 
 
19.86±0.31 
 
20.60±0.41 
 
STR 
(%) 
 
85.30±1.30 
 
84.80±0.67 
 
85.70±0.80 
 
86.10±0.97 
 
83.80±0.71 
 
82.90±0.64 
 
LIN 
(%) 
 
61.00±2.44 
 
59.90±1.17 
 
62.70±1.49 
 
61.50±1.55 
 
57.60±1.19 
 
58.20±1.35 
 
Rapid cells 
(%) 
 
47.00±4.01 
 
61.60±1.95* 
 
61.80±2.09* 
 
62.70±1.92* 
 
47.40±2.79 
 
41.90±2.21 
 
Static cells 
(%) 
 
 
30.50±2.77 
 
20.60±0.96* 
 
19.70±1.47* 
 
16.50±1.34* 
 
24.70±0.74 
 
30.30±1.95 
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4.5.1 Effects of insulin and leptin on propidium iodide (PI) fluorescence 
 
In this study no statistically significant results were observed in viability for cells 
treated with insulin, leptin, and insulin + leptin when compared to the control (Figure 
38).  
 
 
 
Figure 38. Effects of insulin and leptin on PI fluorescence. PI was used as a probe 
for non-viable cells. Spermatozoa were treated with insulin, leptin, insulin + leptin 
(Ins/Lep), insulin + leptin + wortmannin (Ins/Lep/Wort), or wortmannin (Wort). Data is 
expressed as the percentage of PI fluorescence (n = 18) 
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4.5.2 Effects of insulin and leptin on sperm acrosome reaction 
 
In all of the groups the progesterone-stimulated samples had significantly more 
acrosome-reacted cells compared to samples left to undergo the spontaneous 
acrosome-reaction (p < 0.05) (Figure 39). The addition of insulin, leptin, and 
insulin + leptin significantly increased the percentage of spontaneous acrosome-
reacted cells compared to the control (35.33 ± 1.73 %, 36.56 ± 1.93 %, and 
41.78 ± 1.31 % vs. 14.56 ± 0.64 %, respectively; p < 0.05). Similarly, insulin, leptin, 
and insulin + leptin significantly increased acrosome reaction in cells stimulated with 
progesterone when compared to the control (42.11 ± 2.05 %, 42.89 ± 1.26 %, and 
49.11 ± 1.18 % vs 20.00 ± 1.35 %, respectively; p < 0.05). The inhibition of PI3K with 
wortmannin did not affect the percentage of acrosome-reacted cells compared to the 
control in either spontaneous or progesterone-stimulated groups. Wortmannin, 
however, attenuated the stimulatory effects of insulin/leptin on acrosome reaction 
when used as a cotreatment. 
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Figure 39. Effects of insulin and leptin on sperm acrosome reaction. Spermatozoa 
were treated with insulin, leptin, insulin + leptin (Ins/Lep), 
insulin + leptin + wortmannin (Ins/Lep/Wort), or wortmannin (Wort). Cells were 
simulated to acrosome react with progesterone or left to undergo spontaneous 
acrosome reaction. *P < 0.05 vs spontaneous control; **P < 0.05 vs spontaneous; 
***P < 0.05 vs progesterone control (n = 18) 
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4.5.3 Effects of insulin and leptin on 4,5-diaminofluorescein-2/diacetate (DAF-
2/DA) fluorescence 
 
Figure 40 shows the effects of insulin and leptin on DAF-2/DA fluorescence. The 
NOS inhibitor, L-NAME (0.7 mM), significantly reduced DAF-2/DA fluorescence 
compared to the control (81.01 ± 1.48 % vs 100 %; p < 0.05). Wortmannin (10 µM), a 
PI3K inhibitor, also significantly reduced DAF-2/DA fluorescence compared to the 
control (91.58 ± 2.35 % vs 100 %; p < 0.05). Insulin, leptin, and insulin + leptin 
groups significantly increased DAF-2/DA fluorescence compared to the control 
(113.10 ± 1.25 %, 115.30 ± 3.24 %, and 120.80 ± 2.70 % vs 100 %, respectively; 
p < 0.05). The addition of insulin + leptin to the L-NAME and wortmannin treated 
groups did not reverse the situation after 150 min of incubation.  
 
 
 
 
 111
 
 
Figure 40. Effects of insulin and leptin on DAF-2/DA fluorescence. Spermatozoa 
were treated with N-nitro-L-arginine methyl ester L-NAME), wortmannin, insulin, 
leptin, insulin + leptin (Ins/Lep), insulin + leptin + L-NAME (Ins/Lep/L-N), 
insulin + leptin + wortmannin (Ins/Lep/Wort). Values are expressed as mean DAF-
2/DA fluorescence percentage of the control (control adjusted to 100 %) of 10 
samples. *P < 0.05 vs control  
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4.6 Characterizing the spermatozoa separated by the PureSperm® two-layer 
density discontinuous gradient system.  
 
4.6.1 Motility parameters 
As shown in Table XV, there was a significantly higher percentage of motile cells, 
progressive motility, VAP, VSL, VCL, ALH and rapid cells in the mature group when 
compared to the immature groups (p < 0.05). No significant differences were 
observed in BCF, STR and LIN between the two groups (p > 0.05). However, static 
cells were significantly decreased in the mature sperm group when compared to the 
immature sperm group (p < 0.05) separated by PureSperm® two-layer density 
discontinuous gradient system.  
 
4.6.2 Sperm head morphology 
Figure 41 shows that the immature group had significantly high sperm head 
morphology abnormalities when compared to the mature group (10.48 ± 2.85% vs. 
23.83 ±6.01%; p < 0.05).  
 
4.6.3 Cell viability 
There was a significant increase in PI fluorescence in the immature group when 
compared to the mature group (31.29 ± 2.13 vs. 15.14 ± 1.53; p < 0.05) as 
demonstrated by Figure 42.  
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Table XV. Motility parameters of bottom and top fractions of spermatozoa separated 
by the PureSperm® two-layer density discontinuous gradient (n = 20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                *p < 0.05  
 
 
Parameter 
 
 
Mature 
 
 
Immature 
 
Motile 
(%) 
 
58.33±4.81* 
 
 
17.17±1.85 
 
Progr. Mot 
(%) 
 
26.17±5.04* 
 
6.83±0.87 
 
VAP 
(m/s) 
 
        51.62±5.64* 
 
36.83±2.48 
 
VSL 
(m/s) 
 
38.32±3.93* 
 
27.75±1.60 
 
VCL 
(m) 
 
66.83±5.62* 
 
53.78±1.79 
 
ALH 
(m/s) 
 
3.61±0.23* 
 
2.56±0.31 
 
BCF 
(Hz) 
 
20.28±1.08 
 
18.28±0.87 
 
STR 
(%) 
 
79.00±1.06 
 
76.83±3.00 
 
LIN 
(%) 
 
51.00±1.31 
 
53.67±2.77 
 
Rapid cells 
(%) 
 
46.83±6.68* 
 
12.33±1.40 
 
Static cells 
(%) 
 
 
28.00±3.45* 
 
71.33±4.40 
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Figure 41. Sperm head morphology of bottom and top fractions of spermatozoa 
separated by the PureSperm® two-layer density discontinuous gradient (n = 15) 
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Figure 42. PI fluorescence of bottom and top fractions of spermatozoa separated by 
the PureSperm® two-layer density discontinuous gradient (n = 15) 
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4.6.4 Effects of insulin and leptin on motility parameters of mature and 
immature spermatozoa separated by the PureSperm® two-layer density 
discontinuous gradient  
As shown in Table XVI, insulin, leptin and insulin + leptin significantly increased 
motile cells as well as progressive motility in both mature and immature groups 
compared to their untreated controls (p < 0.05) after three hours of incubation. VAP 
was significantly increased in both mature and immature groups with the addition of 
insulin + leptin.  VSL was significantly increased in the mature group treated with 
insulin + leptin. ALH was significantly increased in the leptin treated mature cells 
compared to untreated mature cells (p < 0.05). The number of rapid cells was 
significantly increased when cells were treated with insulin, leptin and insulin + leptin 
in the mature group whereas in the immature group rapid cells were significantly 
increased with the treatment of insulin + leptin.  No statistical significances were 
observed with VCL, BCF, STR and LIN in both mature and immature groups.  Static 
cells were significantly decreased with the addition of insulin, leptin and insulin + 
leptin in both mature and immature groups when compared to the untreated group 
(p < 0.05).  
 
Table XVII shows that the percentage increase in motile cells, progressive motility as 
well as rapid cells above their respective own controls was much higher in immature 
cells treated with insulin, leptin and insulin + leptin when compared to the 
corresponding treated mature cells.  
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Table XVI. Effects of insulin and leptin on motility parameters of mature and immature spermatozoa separated by PureSperm® two-
layer density discontinuous gradient after three hours of incubation (n = 20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mature 
 
Immature 
 
Parameter 
 
 
Control 
 
 
Insulin (10 µIU) 
 
Leptin 
 (10 nmol) 
 
Insulin+Leptin 
 
     Control 
 
Insulin (10 µIU) 
 
Leptin 
(10 nmol) 
 
Insulin+Leptin 
 
Motile 
(%) 
 
58.33±4.81 
 
 
66.00±3.32* 
 
67.00±2.51* 
 
70.83±1.95* 
 
17.17±1.85 
 
27.33±2.76# 
 
25.50±2.36# 
 
35.83±2.30# 
 
Progr. Mot 
(%) 
 
26.17±5.04 
 
36.33±4.16* 
 
36.33±5.34* 
 
42.00±2.65* 
 
6.83±0.87 
 
11.67±1.22# 
 
11.00±1.52# 
 
16.67±1.70# 
 
VAP 
(m/s) 
 
51.62±5.64 
 
58.85±3.25 
 
62.60±3.58 
 
66.80±3.12* 
 
36.83±2.48 
 
42.42±2.75 
 
43.92±3.59 
 
50.03±4.68# 
 
VSL 
(m/s) 
 
38.32±3.93 
 
 
48.40±1.79 
 
50.77±0.90 
 
55.12±1.26* 
 
27.75±1.60 
 
30.10±2.62 
 
30.83±2.81 
 
33.82±2.27 
 
VCL 
(m) 
 
66.83±5.62 
 
69.90±3.90 
 
73.32±4.84 
 
74.87±3.22 
 
53.78±1.79 
 
53.82±2.67 
 
56.68±3.13 
 
56.55±3.25 
 
ALH 
(m/s) 
 
3.61±0.23 
 
3.933±0.16 
 
4.16±0.11* 
 
3.93±0.18 
 
2.56±0.31 
 
3.20±0.18 
 
2.85±0.03 
 
3.25±0.21 
 
BCF 
(Hz) 
 
20.28±0.97 
 
20.98±0.75 
 
20.45±1.21 
 
20.87±0.70 
 
21.28±1.03 
 
20.80±1.24 
 
19.00±0.47 
 
19.10±0.93 
 
STR 
(%) 
 
79.00±1.06 
 
78.00±1.21 
 
78.00±1.46 
 
78.67±2.36 
 
76.83±3.00 
 
81.33±1.40 
 
77.83±1.97 
 
80.67±0.95 
 
LIN 
(%) 
 
51.00±1.31 
 
56.50±1.23 
 
54.83±1.70 
 
56.67±0.88 
 
53.67±2.77 
 
49.67±0.71 
 
50.00±2.81 
 
53.33±2.80 
 
Rapid cells 
(%) 
 
46.83±6.68 
 
55.83±4.71* 
 
60.00±3.44* 
 
62.83±3.32* 
 
12.33±1.40 
 
19.67±2.47 
 
18.50±2.04 
 
26.83±2.10# 
 
Static cells 
(%) 
 
 
28.00±3.45 
 
19.33±1.33* 
 
18.33±1.17* 
 
15.83±0.83* 
 
71.33±4.40 
 
63.33±4.31# 
 
61.33±3.58# 
 
49.33±2.66# 
*p < 0.05 vs. Mature Control; #p < 0.05 vs. Immature Control 
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Table XVII. Percentage increase in motility parameters of mature and immature sperm after insulin and leptin treatment after three 
hour of incubation (n = 20) 
 
Mature 
 
Immature 
 
Parameter 
 
 
Control 
 
 
Insulin (10 µIU) 
 
Leptin 
(10 nmol) 
 
Insulin+Leptin 
 
     Control 
 
Insulin (10 µIU) 
 
Leptin 
(10 nmol) 
 
Insulin+Leptin 
 
Motile 
(%) 
 
58.33±4.81 
 
 
13.15% 
 
14.86% 
 
21.43% 
 
17.17±1.85 
 
59.17% 
 
48.51% 
 
108.68% 
 
Progr. Mot 
(%) 
 
26.17±5.04 
 
38.82% 
 
38.82% 
 
60.49% 
 
6.83±0.87 
 
70.86% 
 
61.05% 
 
144.07% 
 
VAP 
(m/s) 
 
51.62±5.64 
 
14.01% 
 
21.27% 
 
29.41% 
 
36.83±2.48 
 
15.18% 
 
19.25% 
 
35.84% 
 
VSL 
(m/s) 
 
38.32±3.93 
 
 
26.30% 
 
32.49% 
 
43.84% 
 
27.75±1.60 
 
8.47% 
 
11.10% 
 
21.87% 
 
VCL 
(m) 
 
66.83±5.62 
 
4.59% 
 
9.71% 
 
12.03% 
 
53.78±1.79 
 
0.07% 
 
5.39% 
 
5.15% 
 
ALH 
(m/s) 
 
3.61±0.23 
 
8.95% 
 
15.24% 
 
8.86% 
 
2.56±0.31 
 
25.00 
 
11.33% 
 
26.56% 
 
BCF 
(Hz) 
 
20.28±0.97 
 
3.45% 
 
0.84% 
 
2.91% 
 
21.28±1.03 
 
-2.26% 
 
-10.71% 
 
-10.24% 
 
STR 
(%) 
 
79.00±1.06 
 
-1.27% 
 
-1.27% 
 
-0.42% 
 
76.83±3.00 
 
5.82% 
 
1.30% 
 
5.00% 
 
LIN 
(%) 
 
51.00±1.31 
 
10.78% 
 
7.51% 
 
11.12% 
 
53.67±2.77 
 
-7.45% 
 
-6.84% 
 
-0.63% 
 
Rapid cells 
(%) 
 
46.83±6.68 
 
19.22% 
 
28.12% 
 
34.17% 
 
12.33±1.40 
 
59.53% 
 
50.04% 
 
117.60% 
 
Static cells 
(%) 
 
 
28.00±3.45 
 
-31.00% 
 
-34.50% 
 
-43.50% 
 
71.33±4.40 
 
-11.20% 
 
-14.00% 
 
-30.80% 
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4.7 Effects of TNF-α on motility parameters after 1, 3, and 5 hours of 
incubation 
Table XVIII shows the effects of TNF-α on motility parameters after 1 hour of 
incubation. No significant differences were observed in the TNF-α treated groups for 
motile cells, progressive motility, BCF, STR and LIN after one hour of incubation 
when compared to the control (p > 0.05). In the 20, 50 and 100 ng/mL TNF-α treated 
groups, VAP was significantly decreased when compared to the control (p < 0.05). 
On the other hand, VSL and ALH were significantly decreased in the 50 and  
100 ng/mL TNF-α treated groups when compared to the control (p < 0.05). VCL was 
significantly decreased in the 100 ng/mL TNF-α treated group when compared to the 
control (p < 0.05) whereas, static cells were significantly increased in the 10, 20, 50 
and 100 ng/mL TNF-α treated groups when compared to the control (p < 0.05). 
 
After three hours of incubation (table XIX), the number of motile cells were 
significantly decreased in the 100 ng/mL TNF-α treated group when compared to the 
control (p < 0.05). Progressive motility was significantly decreased in the 20, 50, and 
100 ng/mL TNF-α treated groups when compared to the control (p < 0.05). VAP, 
VSL, VCL, ALH and rapid cells were significantly decreased in the 50 and 100 ng/mL 
TNF-α treated groups when compared to the control (p < 0.05). On the other hand, 
the number of static cells was significantly increased in the 5, 10, 20, 50, and  
100 ng/mL TNF-α treated groups when compared to the control (p < 0.05).  
 
Table XX shows that five hours of incubation led to a significant decrease in the 
number of motile cells in the 50 and 100 ng/mL TNF-α treated groups when 
compared to the control (p < 0.05). Progressive motility and VSL were significantly 
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decreased in the 10, 20, 50, 100 ng/mL TNF-α treated groups when compared to the 
control (p < 0.05). VAP and ALH were significantly decreased in the 50 and  
100 ng/mL TNF-α treated groups when compared to the control (p < 0.05) while VCL 
was significantly decreased in the 100 ng/mL TNF-α treated group when compared to 
the control (p < 0.05). The percentage of static cells was significantly increased in the 
10, 20, 50, and 100 ng/mL TNF-α treated groups when compared to the control  
(p < 0.05). 
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Table XVIII. Effects of TNF-α on motility parameters after one hour of incubation 
(n = 15) 
 
 
*p < 0.05 vs. Control 
 
 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
2 ng 
 
5 ng 
 
10 ng 
 
20 ng 
 
50 ng 
 
100 ng 
 
Motile 
(%) 
 
77.80±2.52 
 
 
74.30±2.48 
 
71.40±2.13 
 
69.10±1.50 
 
69.90±2.32 
 
68.40±1.99 
 
68.30±2.03 
 
Progr. Mot 
(%) 
 
49.10±4.83 
 
46.60±5.07 
 
41.10±4.02 
 
41.40±4.52 
 
34.30±3.65 
 
35.20±4.87 
 
33.30±5.01 
 
VAP 
(m/s) 
 
66.19±1.72 
 
63.38±3.18 
 
56.48±0.85 
 
57.26±1.17 
 
53.98±1.93* 
 
46.92±2.42* 
 
46.01±3.17* 
 
VSL 
(m/s) 
 
57.21±2.66 
 
53.87±3.55 
 
50.37±2.13 
 
48.04±1.50 
 
48.03±1.68 
 
40.03±1.65* 
 
39.89±2.61* 
 
VCL 
(m) 
 
87.51±3.33 
 
85.66±2.89 
 
85.45±1.57 
 
84.72±1.61 
 
83.43±1.38 
 
76.44±3.22 
 
69.97±3.32* 
 
ALH 
(m/s) 
 
4.42±0.20 
 
4.27±0.24 
 
4.02±0.19 
 
3.88±0.15 
 
3.53±0.19 
 
3.17±0.21* 
 
3.28±0.19* 
 
BCF 
(Hz) 
 
19.45±0.97 
 
17.49±0.56 
 
17.60±0.39 
 
18.27±0.39 
 
17.81±0.47 
 
18.33±0.57 
 
17.43±0.46 
 
STR 
(%) 
 
79.80±1.90 
 
79.70±1.90 
 
78.30±1.55 
 
77.10±1.60 
 
78.00±2.12 
 
74.80±2.32 
 
73.00±2.60 
 
LIN 
(%) 
 
55.30±1.40 
 
56.40±1.54 
 
54.70±0.93 
 
54.40±1.55 
 
57.20±1.40 
 
47.90±5.33 
 
52.00±1.84 
 
Rapid cells 
(%) 
 
73.90±3.52 
 
66.30±3.58 
 
59.30±3.83 
 
58.20±3.18 
 
58.30±4.57 
 
57.70±3.76 
 
56.60±4.53 
 
Static cells 
(%) 
 
 
16.50±2.20 
 
20.70±1.75 
 
22.70±2.00 
 
25.80±2.02* 
 
26.60±2.21* 
 
28.30±1.93* 
 
30.00±2.28* 
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Table XIX. Effects of TNF-α on motility parameters after three hours of incubation 
(n = 15) 
 
 
 
*p < 0.05 vs. Control 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
2 ng 
 
5 ng 
 
10 ng 
 
20 ng 
 
50 ng 
 
100 ng 
 
Motile 
(%) 
 
77.80±2.52 
 
 
74.30±2.48 
 
71.40±2.13 
 
69.10±1.50 
 
69.90±2.32 
 
68.40±1.99 
 
68.30±2.03* 
 
Progr. Mot 
(%) 
 
48.20±3.69 
 
44.80±2.94 
 
39.10±4.90 
 
38.70±3.63 
 
31.90±3.06* 
 
31.10±3.29* 
 
28.70±3.25* 
 
VAP 
(m/s) 
 
63.48±1.60 
 
61.69±1.48 
 
57.35±1.72 
 
50.29±5.63 
 
53.31±1.65 
 
43.63±5.03* 
 
45.12±3.70* 
 
VSL 
(m/s) 
 
54.30±1.54 
 
54.31±1.47 
 
49.78±1.84 
 
47.01±0.97 
 
46.41±1.35 
 
39.00±2.56* 
 
37.76±2.65* 
 
VCL 
(m) 
 
84.49±1.49 
 
87.97±0.51 
 
83.93±1.64 
 
79.96±1.15 
 
80.39±2.55 
 
71.38±3.90* 
 
68.18±4.91* 
 
ALH 
(m/s) 
 
4.50±0.12 
 
4.28±0.20 
 
4.08±0.17 
 
3.90±0.13 
 
3.65±0.18 
 
3.28±0.24* 
 
3.30±0.22* 
 
BCF 
(Hz) 
 
20.27±0.59 
 
17.67±0.40 
 
18.30±0.48 
 
18.37±0.47 
 
17.75±0.34 
 
18.14±0.36 
 
16.87±0.34 
 
STR 
(%) 
 
81.50±1.58 
 
80.20±1.75 
 
79.30±1.70 
 
78.90±1.65 
 
77.30±2.28 
 
75.20±2.70 
 
73.10±2.61 
 
LIN 
(%) 
 
56.70±1.30 
 
58.00±1.16 
 
55.70±1.77 
 
56.60±1.17 
 
55.30±1.07 
 
52.70±1.83 
 
50.80±1.58 
 
Rapid cells 
(%) 
 
66.00±3.41 
 
61.00±3.14 
 
53.60±4.94 
 
52.50±3.37 
 
51.10±3.00 
 
50.00±3.64* 
 
50.30±2.82* 
 
Static cells 
(%) 
 
 
17.50±1.71 
 
25.00±1.71 
 
26.00±2.19* 
 
27.80±1.63* 
 
30.10±1.82* 
 
30.00±1.27* 
 
32.90±1.62* 
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Table XX. Effects of TNF-α on motility parameters after five hours of incubation 
(n = 15) 
 
 
*p < 0.05 vs. Control 
 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
2 ng 
 
5 ng 
 
10 ng 
 
20 ng 
 
50 ng 
 
100 ng 
 
Motile 
(%) 
 
68.90±3.42 
 
 
64.20±4.08 
 
59.40±4.45 
 
59.20±2.51 
 
58.70±1.92 
 
57.00±1.80* 
 
56.20±1.77* 
 
Progr. Mot 
(%) 
 
43.40±4.11 
 
36.50±2.09 
 
32.90±1.62 
 
27.90±1.76* 
 
26.20±1.81* 
 
24.80±2.33* 
 
22.20±2.45* 
 
VAP 
(m/s) 
 
61.11±2.49 
 
57.28±1.56 
 
56.71±0.99 
 
54.40±1.67 
 
53.98±2.16 
 
44.31±2.73* 
 
42.75±3.14* 
 
VSL 
(m/s) 
 
53.79±2.62 
 
50.95±1.89 
 
48.69±0.74 
 
45.18±1.24* 
 
43.81±1.42* 
 
36.10±2.21* 
 
33.91±1.50* 
 
VCL 
(m) 
 
81.87±1.64 
 
81.28±1.94 
 
79.01±3.13 
 
77.72±2.11 
 
79.67±2.44 
 
71.90±3.48 
 
68.73±4.30* 
 
ALH 
(m/s) 
 
4.35±0.26 
 
4.35±0.18 
 
3.86±0.18 
 
3.89±0.21 
 
3.37±0.31 
 
3.26±0.21* 
 
3.25±0.22* 
 
BCF 
(Hz) 
 
20.74±0.48 
 
17.66±0.48 
 
18.45±0.75 
 
18.24±0.76 
 
17.44±0.25 
 
17.71±0.43 
 
17.38±0.47 
 
STR 
(%) 
 
83.00±1.23 
 
79.80±1.38 
 
78.90±1.80 
 
77.00±2.28 
 
76.70±2.87 
 
73.70±3.35 
 
71.60±3.60 
 
LIN 
(%) 
 
59.00±1.03 
 
56.80±1.33 
 
54.80±1.34 
 
54.20±1.25 
 
56.90±1.80 
 
56.60±1.64 
 
51.10±2.09 
 
Rapid cells 
(%) 
 
60.50±4.38 
 
52.70±2.74 
 
51.10±2.12 
 
50.40±2.06 
 
49.80±2.83 
 
49.10±2.56 
 
49.40±3.26 
 
Static cells 
(%) 
 
 
21.70±1.17 
 
26.40±1.147 
 
26.30±2.88 
 
30.50±1.48* 
 
33.40±0.84* 
 
37.20±1.46* 
 
38.30±1.30* 
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4.7.1 Effects of IL-6 on motility parameters after 1, 3, and 5 hours of incubation 
After one hour of incubation (table XXI), VAP was significantly decreased in the 20, 
50 and 100 ng/mL IL-6 treated groups when compared to the control (p < 0.05). VSL 
and ALH were significantly decreased in the 50 and 100 ng/mL IL-6 treated groups 
whereas, VCL was significantly decreased in the 100 ng/mL IL-6 treated group when 
compared to the control (p < 0.05) respectively. However, the number of static cells 
was significantly increased in the 50 and 100 ng/mL IL-6 treated groups when 
compared to the control (p < 0.05). No differences were observed with the other 
motility parameters (p > 0.05). 
 
After three hours of incubation as shown in table XXII, progressive motility and VCL 
were significantly decreased in the 100 ng/mL IL-6 treated group when compared to 
the control (p < 0.05). VAP, VSL and ALH were significantly decreased in the 50 and 
100 ng/mL IL-6 treated groups compared to the control (p < 0.05). On the other hand 
the number of static cells was significantly increased in the 20, 50 and 100 ng/mL  
IL-6 treated groups when compared to the control (p < 0.05).  
 
Table XXIII shows the effects of IL-6 on motility parameters after five hours of 
incubation. Progressive motility, VAP and VSL were significantly decreased in the 50 
and 100 ng/mL IL-6 treated groups when compared to the control (p < 0.05). ALH 
was decreased only in the 100 ng/mL IL-6 treated group whereas the number of 
static cells was significantly increased in the 10, 20, 50 and 100 ng/mL IL-6 treated 
groups (p < 0.05). 
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Table XXI. Effects of IL-6 on motility parameters after one hour of incubation (n = 15) 
 
 
*p < 0.05 vs. Control 
 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
2 ng 
 
5 ng 
 
10 ng 
 
20 ng 
 
50 ng 
 
100 ng 
 
Motile 
(%) 
 
77.80±2.52 
 
 
76.50±2.84 
 
73.80±2.31 
 
71.40±2.26 
 
70.80±3.46 
 
69.20±2.89 
 
68.80±2.88 
 
Progr. Mot 
(%) 
 
49.10±4.83 
 
50.20±4.49 
 
42.50±5.43 
 
43.90±4.35 
 
38.60±6.39 
 
36.30±5.52 
 
34.40±5.04 
 
VAP 
(m/s) 
 
66.19±1.72 
 
67.00±2.26 
 
58.20±0.84 
 
57.46±1.47 
 
54.11±1.26* 
 
47.40±2.69* 
 
46.30±2.84* 
 
VSL 
(m/s) 
 
57.21±2.66 
 
58.80±1.71 
 
55.46±1.28 
 
51.29±1.13 
 
50.48±1.01 
 
41.65±1.88* 
 
40.84±2.33* 
 
VCL 
(m) 
 
87.51±3.33 
 
92.10±2.32 
 
86.51±2.11 
 
83.01±2.45 
 
86.17±2.89 
 
76.50±3.47 
 
72.31±3.60* 
 
ALH 
(m/s) 
 
4.42±0.20 
 
4.54±0.16 
 
4.17±0.17 
 
4.03±0.18 
 
3.66±0.21 
 
3.23±0.21* 
 
3.15±0.24* 
 
BCF 
(Hz) 
 
19.45±0.97 
 
18.45±0.54 
 
19.51±0.46 
 
19.85±0.60 
 
18.53±0.68 
 
18.85±0.93 
 
17.56±0.85 
 
STR 
(%) 
 
79.80±1.90 
 
81.00±1.57 
 
80.60±1.70 
 
79.50±1.64 
 
78.80±2.68 
 
66.48±3.23 
 
74.00±2.76 
 
LIN 
(%) 
 
55.30±1.40 
 
57.90±1.01 
 
57.10±1.42 
 
55.10±1.26 
 
58.20±1.30 
 
53.50±1.79 
 
52.00±1.54 
 
Rapid cells 
(%) 
 
73.90±3.52 
 
70.00±3.70 
 
59.50±4.94 
 
59.10±3.83 
 
55.90±5.56 
 
58.90±3.81 
 
56.90±4.13 
 
Static cells 
(%) 
 
 
16.50±2.20 
 
19.20±1.56 
 
23.00±3.33 
 
24.60±2.20 
 
25.60±2.54 
 
28.40±2.80* 
 
29.60±2.97* 
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Table XXII. Effects of IL-6 on motility parameters after three hours of incubation 
(n = 15) 
 
 
*p < 0.05 vs. Control 
 
 
Parameter 
 
 
Control 
 
 
2 ng 
 
5 ng 
 
10 ng 
 
20 ng 
 
50 ng 
 
100 ng 
 
Motile 
(%) 
 
77.80±2.52 
 
 
72.20±2.82 
 
68.90±2.13 
 
65.40±1.86 
 
65.10±2.16 
 
64.90±2.67 
 
64.60±2.33 
 
Progr. Mot 
(%) 
 
48.20±3.69 
 
48.10±3.80 
 
41.30±3.58 
 
40.20±3.73 
 
32.40±3.40 
 
34.20±4.80 
 
29.80±3.20* 
 
VAP 
(m/s) 
 
63.48±1.60 
 
63.86±1.46 
 
59.32±1.06 
 
57.01±0.93 
 
55.77±2.03 
 
48.60±2.58* 
 
45.63±3.60* 
 
VSL 
(m/s) 
 
54.30±1.54 
 
57.00±1.44 
 
52.08±0.71 
 
49.16±1.30 
 
49.25±1.52 
 
40.60±2.77* 
 
39.38±2.51* 
 
VCL 
(m) 
 
84.49±1.49 
 
88.83±0.93 
 
85.20±1.40 
 
85.75±0.75 
 
83.89±2.61 
 
73.00±3.68 
 
70.59±4.72* 
 
ALH 
(m/s) 
 
4.50±0.12 
 
4.41±0.20 
 
4.20±0.16 
 
3.95±0.15 
 
3.74±0.20 
 
3.24±0.23* 
 
3.20±0.29* 
 
BCF 
(Hz) 
 
20.27±0.59 
 
18.98±0.44 
 
19.37±0.55 
 
20.11±0.51 
 
18.11±0.66 
 
19.04±0.94 
 
17.97±0.90 
 
STR 
(%) 
 
81.50±1.58 
 
82.60±1.52 
 
80.90±1.46 
 
80.00±1.81 
 
78.60±2.26 
 
76.70±2.57 
 
74.80±2.84 
 
LIN 
(%) 
 
56.70±1.30 
 
59.10±1.22 
 
56.20±0.96 
 
57.20±1.71 
 
57.20±1.03 
 
54.20±1.91 
 
53.20±1.93 
 
Rapid cells 
(%) 
 
66.00±3.41 
 
64.30±3.16 
 
56.40±4.11 
 
55.70±2.64 
 
55.30±3.24 
 
54.90±23.69 
 
53.70±3.50 
 
Static cells 
(%) 
 
 
17.50±1.71 
 
22.30±1.47 
 
24.00±2.88 
 
26.30±2.15 
 
27.80±2.29* 
 
29.80±2.12* 
 
30.90±3.05* 
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Table XXIII. Effects of IL-6 on motility parameters after five hours of incubation 
(n = 15) 
 
 
 
*p < 0.05 vs. Control 
 
 
 
 
 
 
 
Parameter 
 
 
Control 
 
 
2 ng 
 
5 ng 
 
10 ng 
 
20 ng 
 
50 ng 
 
100 ng 
 
Motile 
(%) 
 
68.90±3.42 
 
 
65.70±4.43 
 
61.10±3.27 
 
61.10±3.49 
 
60.40±4.00 
 
60.40±2.57 
 
57.30±3.16 
 
Progr. Mot 
(%) 
 
43.40±4.11 
 
40.90±3.55 
 
36.40±3.84 
 
36.80±4.71 
 
34.90±5.28 
 
25.10±2.59* 
 
24.20±3.38* 
 
VAP 
(m/s) 
 
61.11±2.49 
 
60.83±1.83 
 
57.37±1.50 
 
55.70±1.36 
 
53.41±1.55 
 
45.64±3.07* 
 
44.24±3.56* 
 
VSL 
(m/s) 
 
53.79±2.62 
 
54.94±2.06 
 
48.48±1.30 
 
46.03±1.21 
 
45.40±1.28 
 
38.28±2.30* 
 
37.74±2.44* 
 
VCL 
(m) 
 
81.87±1.64 
 
86.56±2.13 
 
79.44±3.42 
 
78.86±1.35 
 
80.30±2.09 
 
71.14±2.67 
 
69.58±4.55 
 
ALH 
(m/s) 
 
4.35±0.26 
 
4.44±0.19 
 
3.85±0.18 
 
3.86±0.20 
 
3.43±0.31 
 
3.19±0.35 
 
2.97±0.34* 
 
BCF 
(Hz) 
 
20.74±0.48 
 
18.21±0.39 
 
19.38±0.85 
 
18.90±0.58 
 
18.38±0.93 
 
19.06±1.23 
 
16.89±0.95 
 
STR 
(%) 
 
83.00±1.23 
 
81.10±1.26 
 
79.30±1.50 
 
78.30±2.16 
 
78.70±2.92 
 
74.80±3.47 
 
72.60±3.66 
 
LIN 
(%) 
 
59.00±1.03 
 
56.60±0.89 
 
54.80±1.02 
 
54.20±1.05 
 
55.60±1.29 
 
51.90±1.36 
 
53.60±3.69 
 
Rapid cells 
(%) 
 
60.50±4.38 
 
59.20±4.00 
 
52.80±4.21 
 
52.70±4.40 
 
52.90±4.03 
 
52.60±3.47 
 
51.40±3.04 
 
Static cells 
(%) 
 
 
21.70±1.17 
 
25.90±2.47 
 
26.20±2.13 
 
30.00±1.22* 
 
31.20±1.14* 
 
34.30±2.15* 
 
35.20±1.74* 
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4.7.2 Effects of TNF-α and IL-6 on PI fluorescence 
Sperm cell viability was assessed by PI fluorescence. The increase in PI 
fluorescence was interpreted as an increase in non-viable cells. No significant 
differences in PI fluorescence (P > 0.05) were observed for both TNF-α and IL-6 
dose response curve (Figure 43). However, there was a trend of increase in PI 
fluorescence with increase in TNF-α and IL-6 concentrations.  
 
Figure 43. Effects of TNF-α and IL-6 on PI fluorescence. Cells were incubated with 
increasing concentrations of TNF-α and IL-6 and incubated for 5 hours. PI was used 
as a viability probe (n = 15) 
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4.7.3 Effects of TNF-α and IL-6 on DAF-2/DA fluorescence 
Three concentrations of TNF-α and IL-6 (5, 20 and 100 ng/mL) were chosen for the 
NO experiments. A significant increase in mean DAF-2/DA fluorescence was 
observed in cells treated with 5, 20, 100 ng TNF-α compared to the untreated cells 
(109.00 ± 2.29%; 119.20 ± 2.76%; 129.20 ± 4.25% vs. 100%; P < 0.05) respectively, 
while the addition of L-NAME (0.7 mM) significantly reduced fluorescence in all the 
groups (Figure 44). IL-6 significantly increased mean DAF-2/DA fluorescence at 20 
and 100 ng (115.40 ± 2.29%; 123.10 ± 2.55% vs. 100%; P < 0.05) while the addition 
of L-NAME significantly reduced fluorescence in all the groups (P < 0.05) (Figure 45). 
The reduction of fluorescence by L-NAME confirmed negative control and probe 
specificity of DAF-2/DA. 
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Figure 44. Effects of TNF-α on DAF-2/DA fluorescence. Cells were incubated with 5, 
20 and 100 ng/mL TNF-α in the presence or absence of L-NAME (0.7 mM) and 
incubated for 5 ours with DAF-2/DA. Values are expressed as mean DAF-2/DA 
fluorescence percentage of control (control adjusted to 100%) of 10 samples. 
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Figure 45. Effects of IL-6 on DAF-2/DA fluorescence. Cells were incubated with 5, 20 
and 100 ng/mL IL-6 in the presence or absence of L-NAME (0.7 mM) and incubated 
for 5 hours with DAF-2/DA. Values are expressed as mean DAF-2/DA fluorescence 
percentage of control (control adjusted to 100%) of 10 samples.  
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4.7.4 Effects of TNF-α and IL-6 on spontaneous, calcium ionophore and 
progesterone-stimulated acrosome reaction 
Figure 46 shows the effect of TNF-α on calcium and progesterone-induced AR as 
well as spontaneous AR. Lower concentrations of TNF-α IL-6 were used in the AR 
studies when compared to the motility studies to avoid killing the cells; furthermore, 
these concentrations were within the range measured in the seminal plasma of men 
with accessory gland infection (Koçak et al., 2002). TNF-α significantly reduced the 
ability of human spermatozoa to undergo spontaneous AR at the concentrations of 
20 pg/mL, 50 pg/mL and 100 pg/mL when compared to the spontaneous control 
(5.80 ± o.29%; 4.75 ± 0.26%; 3.90 ± 0.17% vs. 13.75 ± 0.54%; p < 0.05). The 
calcium ionophore-induced AR was significantly reduced by TNF-α at the 
concentrations of 5 pg/mL, 20 pg/mL, 50 pg/mL and 100 pg/mL when compared to 
the calcium ionophore-induced control (31.70 ± 1.87%; 24.20 ± 1.25%; 20.40 ± 
0.84%; 17.35 ± 0.73% vs. 46.30 ± 2.08%; p < 0.05). TNF-α also significantly reduced 
the progesterone-induced AR at the concentrations of 20 pg/mL, 50 pg/mL and 100 
pg/mL when compared to the progesterone-induced control (14.30 ± 1.14%; 12.50 ± 
0.73%; 9.60 ± 0.76% vs. 29.10 ± 1.91%; p < 0.05). In all the groups, calcium and 
progesterone significantly increased the number of acrosome reacted cells compared 
to the spontaneously acrosome reacted cells in the same group.  
 
IL-6 significantly reduced spontaneous AR at the concentration of 100 pg/mL when 
compared to the spontaneous control (5.30 ± 0.19% vs. 13.75 ± 0.54%; p < 0.05) 
(Figure 47). On the other hand, IL-6 significantly reduced the calcium ionophore-
induced AR at the concentrations of 20 pg/mL, 50 pg/mL and 100 pg/mL when 
compared to the calcium-induced control (27.30 ± 1.93%; 23.80 ± 1.09%; 17.85 ± 
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0.85% vs. 46.30 ± 2.08%; p < 0.05). The progesterone-induced AR was significantly 
reduced by IL-6 at the concentrations of 50 pg/mL and 100 pg/mL when compared to 
the progesterone-induced control (13.70 ± 0.98%; 11.85 ± 0.92% vs. 29.10 ± 1.91%; 
p < 0.05).  
 
 
 
Figure 46. The effects of TNF-α on AR. Human spermatozoa were treated with 0, 2, 
5, 20, 50 and 100 pg/mL TNF-α before stimulated to undergo AR with calcium 
ionophore A23187 (10 µmol/L), progesterone (1 µmol/mL) or left to undergo the 
spontaneous AR (n = 15) 
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Figure 47. The effects of IL-6 on AR. Human spermatozoa were treated with 0, 2, 5, 
20, 50 and 100 pg/mL IL-6 before stimulated to undergo AR with calcium ionophore 
A23187 (10 µmol/L), progesterone (1 µmol/mL) or left to undergo the spontaneous 
AR (n = 15)  
 
 
 
 
 
 134
 
4.7.5 Effects of insulin, leptin, TNF-α and IL-6 on DCFH-DA fluorescence  
Figure 48 shows that TNF-α significantly increased DCFH-DA fluorescence at the 
concentrations of 20 and 100 ng/mL when compared to the control (130.30 ± 6.01%; 
136.80 ± 6.95% vs. 100%; p < 0.05). On the other hand, IL-6 significantly increased 
DCFH-DA fluorescence at 100 ng/mL when compared to the control (128.00 ± 6.41% 
vs. 100%; p < 0.05). No significant differences were observed in the insulin and leptin 
treated groups when compared to the control (p > 0.05). 
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Figure 48. Effects of insulin, leptin, TNF-α and IL-6 on DCFH-DA fluorescence (n = 
15) 
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4.8 Immunofluorescence of GLUT8 in human spermatozoa 
Figure 49 shows the GLUT8 immunoreactivity with and without insulin stimulation in 
human spermatozoa. The blue colour represents the Hoechst staining whereas the 
red colour represents the GLUT8 Texas-Red conjugated secondary antibody 
immunoflurescence. There was no immunoflurescence detection in the negative 
control cells observed under light and fluorescent microscope. The cells which were 
stimulated with insulin produced an increased immunoreactivity when compared with 
the unstimulated cells. More GLUT8 immunoreactivity in the insulin stimulated cells 
was observed to be localized in the plasma membrane whereas that in the 
unstimulated cells was localized more in the intracellular of the midpiece region. 
GLUT8 immunoreactivity was also observed in the acrosome and midpiece regions 
of the insulin stimulated spermatozoa. 
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Figure 49. GLUT8 Texas-red conjugated immunofluorescence in human 
spermatozoa as visualized by light and fluorescence microscopy. Negative control 
observed under light microscope (A1), Negative control with Hoechst staining 
observed under fluorescent microscope (A2); Unstimulated spermatozoa observed 
under light microscope (B1); Unstimulated spermatozoa observed under fluorescent 
microscope showing the localization of GLUT8 in the midpiece region (B2); Insulin 
stimulated spermatozoa observed under light microscope (C1); Insulin stimulated 
spermatozoa observed under fluorescent microscope showing increase in GLUT8 
localization in the midpiece region and its translocation to the acrosome region (C2). 
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CHAPTER 5: DISCUSSION 
 
5.1 The glucose concentration curve 
Energy substrates such as glucose and lactate are present in most culture media 
used for in vitro fertilization (IVF). These substrates have been shown to be essential 
for sperm function (Mitchell et al., 1976; Fraser and Quinn, 1981) or oocyte function 
(Tsunoda and Chang, 1975). This study has confirmed the importance of glucose in 
human sperm function as evidenced by increases in total sperm motility, progressive 
motility and various other motility parameters as well as enhancing cell viability with 
the administration of different glucose concentrations after a two hours incubation 
period. Glucose concentration of 5.6 mM was choosen as appropriate to be 
administered to human spermatozoa because it gave better results compared to the 
control as well as it was a concentration previously used by Williams and Ford, 
(2001). Our results are in agreement with the findings of (Williams and Ford, 2001; 
Mahadevan et al., 1997) in which they reported that glucose was able to improve 
motility parameters, sperm capacitation as well as fertilization rate.    
 
5.2 The insulin dose response curve 
The insulin dose response curve was performed to establish a suitable concentration 
of insulin to be administered to the human spermatozoa in vitro since it has been 
reported that human ejaculated spermatozoa are capable of secreting their own 
insulin (Aquila et al., 2005a). This study has established that administration of 10 µIU 
of insulin to human spermatozoa yielded the best beneficial effects as indicated by 
increased motility parameters as well as cell viability. The concentration used in this 
study is within the range of physiologically secreted insulin by human ejaculated 
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spermatozoa as reported by Aquila et al (2005a) who demonstrated that capacitated 
spermatozoa were capable of secreting up to 18 µIU of insulin. As far as we are 
aware, this is the first study to report specific exogenous concentrations of insulin 
which are beneficial to human spermatozoa function.  
 
5.3 The leptin dose response curve 
To establish the suitable leptin concentration to be administered in vitro to human 
spermatozoa, a dose response curve was performed. It appears leptin is beneficial at 
lower concentrations of up to 10nmol/mL and its beneficial effects are abolished at 
higher concentrations. Leptin concentrations of up to 4ng/mL have been measured in 
capacitated human ejaculated spermatozoa. Lackey et al. (2002) reported leptin 
concentration levels of approximately 1 ng/mL in human seminal plasma, whereas in 
female follicular fluid, leptin levels of approximately 16 ng/mL have been reported 
(Dorn et al., 2003). Human spermatozoa have been reported to secrete their own 
leptin (Aquila et al., 2005b). This study reports for the first time that leptin has in vitro 
beneficial effects to human spermatozoa at lower concentrations and that the 
beneficial effects are abolished at higher concentrations. This study has established 
that leptin concentrations of more than 20 nmol abolish the beneficial effects of leptin 
to human spermatozoa. Based on this finding, 10 nmol of leptin was chosen as 
appropriate to administer to human spermatozoa because it yielded the best results 
as indicated by increased motility parameters and cell viability. 
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5.4 Investigating the insulin signalling pathway and its effects on motility 
parameters, viability and acrosome reaction 
The motility results as illustrated in tables IX, X and XI have demonstrated that 
glucose was required to support optimum total and progressive motility as evidenced 
by a significant reduction in both total motility and progressive motility in the glucose-
free group. The importance of glucose was further demonstrated by a decrease in 
cell viability in the glucose free media (Figure 36). The data are in agreement with the 
findings of Williams and Ford (2001) in which they reported that glucose and other 
glycolysable sugars improved sperm motility.  
 
The decrease in motility and cell viability when endogenous insulin release was 
blocked by nifedipine, IRS tyrosine phosphorylation was inhibited by erbstatin and 
when downstream insulin intracellular effector, PI3K, was inhibited by wortmannin, 
confirm the importance of insulin in human sperm function. We speculate that 
endogenous insulin was required for the mobilization of energy reserves in the 
human spermatozoa by enhancing glucose up-take which subsequently led to 
improved sperm function.  
 
The acrosome reaction results (Figure 37) demonstrate that insulin increased the 
ability of sperm to acrosome react. These results were further confirmed by the 
significant reduction in acrosome reacted spermatozoa when insulin release was 
blocked by nifedipine and the IRS tyrosine phosphorylation was inhibited by 
erbstatin. This finding confirms the speculation that insulin is involved in the triggering 
of the process of sperm capacitation (Aquila et al., 2005a) which is a pre-requisite 
step for the sperm to undergo acrosome reaction (Jaiswal et al., 1998). On the other 
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hand the inhibition of PI3K with wortmannin had no effect on the acrosome reaction 
status of the cells when compared to the control (Figure 37).  
 
5.5 The insulin and leptin signalling pathway and its effects on sperm 
motility parameters, acrosome reaction and nitric oxide generation 
The existence of insulin and leptin in human ejaculated spermatozoa was 
demonstrated through their transcripts evaluated by RT-PCR, their protein content 
evidenced by Western blotting and through their localization by immunostaining 
analysis (Aquila et al., 2005a, and b). The significance of leptin in influencing 
reproduction was evidenced by leptin-deficient female mice (ob mice) which are 
infertile (Jones and Harrison, 1957). However, treatment with leptin restores fertility in 
ob male mice suggesting its role in reproduction (Chehab et al., 1996). The role of 
leptin in male reproduction and human spermatozoa function is not clearly 
elucidated. So far, some studies indicate positive effects while others indicate 
negative effects of leptin on gonadal function (Caprio et al., 2001; Clarke and Henry, 
1999). Glander et al. (2002) reported that seminal plasma leptin levels were 
significantly lower in patients with normal spermiogram parameters, compared with 
pathological semen samples, and showed a negative correlation with motility of 
human spermatozoa, suggesting that higher leptin concentration has negative effects 
on sperm function. In our leptin dose response curve, we also observed that high 
leptin concentrations of more than 20 nmol abolished the beneficial effects observed 
when lower concentrations were administered (Tables VI and VII). On the other 
hand, Zorn et al. (2007) found no correlation between leptin levels and sperm motility 
and morphology. 
 
 141
The importance of insulin in spermatozoa physiology is demonstrated by men who 
lack  insulin due to insulin dependent diabetes. These men have sperm with severe 
structural defects, significantly lower motility (Baccetti et al., 2002) and lower ability to 
penetrate hamster eggs (Shrivastav et al., 1989). Our data has demonstrated that 
insulin and leptin may possibly play a role in enhancing human sperm motility 
parameters as evidenced by increased total motility, progressive motility as well as 
the sperm hyperactivation characteristics (VCL and ALH) (Tables XII, XIII and XIV).  
 
Insulin and leptin secretion was reported to be significantly increased in capacitated 
sperm when compared to non-capacitated sperm, suggesting the involvement of 
these hormones in the process of capacitation. Capacitated sperm released up to 
around 18 µIU of insulin and 4 ng/mL of leptin (Aquila et al., 2005a, b). Lackey et al., 
(2002) reported leptin concentration levels of around 1 ng/mL in the human seminal 
plasma, whereas in the female follicular fluid leptin levels of around 16 ng/mL have 
been reported (Dorn et al., 2003). 
 
Studies have shown that capacitated sperm display an increase in metabolic rate, 
overall energy expenditure, intracellular ion concentrations, plasma membrane 
fluidity, intracellular pH and reactive oxygen species, presumably to affect the 
changes in sperm signaling and function during capacitation (Aitken et al., 2007; 
Visconti et al., 1998). Sperm capacitation is a pre-requisite step for sperm to undergo 
the acrosome reaction (Liu et al., 2008; Jaiswal et al., 1998). This possibly explains 
why insulin and leptin increased the percentage of spontaneous and progesterone 
acrosome reacted cells in our study (Figure 39). It is not clear that this increase is 
due to the agonists’ effect on capacitation or AR itself. Further studies are 
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recommended. However, the blockage of PI3K with wortmannin had no effect on the 
acrosome reaction status of the cells when compared to the control. This finding is 
consistent with results observed by Fisher et al. (1998), in which wortmannin was 
found not to inhibit the acrosome reaction induced by A23187 or progesterone. Du 
Plessis et al. (2004) also reported that LY294002 (another PI3K inhibitor) also did not 
inhibit the acrosome reaction induced by A23187, progesterone and solubilized zona 
pellucida. We speculate that the cellular pathways involved in acrosome reaction 
induced by this agonist do not involve PI3K, or alternatively that PI3K is somehow by-
passed. It has been reported that the signaling of insulin is a complex process which 
involves multiple signaling pathways that diverge at or near the activation of its 
tyrosine kinase receptor (Saltiel and Pessin, 2002).  
 
Studies have reported that insulin and leptin enhance NO production in other cell 
types (White et al., 2006; Kim, 2007). Our study has for the first time shown that both 
insulin and leptin enhance NO production in human spermatozoa and that this 
increase is possibly via the PI3K signaling pathway as evidenced by reduction of NO 
production when the PI3K inhibitor, wortmannin, was administered (Figure 40). 
However, it is still preliminary at this stage to make significant conclusions about the 
mechanism of action of insulin and leptin on NO production since wortmannin has 
also been shown to inhibit PI4K (Etkovitz et al., 2007). The attenuation of NO 
production when the NOS inhibitor, L-NAME, was administered confirms that the NO 
was derived from NOS (Figure 40). As illustrated in Figure 52 both insulin and leptin 
stimulation converges at the level of PI3K during the intracellular signaling pathway. 
PI3K activation leads to protein kinase B (PKB/Akt) phosphorylation, which possibly 
in turn causes GLUT8’s translocation and insertion into the cell membrane. This 
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allows for increased glucose uptake, thereby fueling glucose metabolism necessary 
for increased motility and the acrosome reaction. Simultaneously the PI3K and 
PKB/Akt pathway activated by insulin and leptin can also diverge and stimulate the 
endothelial nitric oxide synthase (eNOS) enzyme of spermatozoa in order to increase 
NO generation. It has been shown that NO can also increase sperm motility and 
acrosome reaction (Wu et al., 2004). Therefore, we hypothesize that insulin and 
leptin can possibly act via two methods (GLUT8 translocation; NO production) to 
influence human sperm motility and the acrosome reaction.                               
 
5.6 Characterizing the spermatozoa separated by the PureSperm® two-layer 
density discontinuous gradient  
Semen samples of normozoospermic subjects contain spermatozoa of higher as well 
as lower motility which can be separated by density gradient centrifugation (Ollero et 
al., 2000; Buffone et al., 2004). This study has confirmed that the PureSperm® two-
layer density discontinuous gradient is able to separate spermatozoa into two distinct 
populations. One population contained mature spermatozoa with high motility 
parameters (Table XV), better normal head morphology (Figure 41) and high cell 
viability (Figure 42) whereas, the other contained sperm with poor motility 
parameters, poor morphology and lower cell viability. The mature fraction was 
retrieved from the pellet at the bottom of the PureSperm® two-layer density 
discontinuous gradient whereas the immature fraction was retrieved from the middle 
layer of the PureSperm® two-layer density discontinuous gradient. Our finding was 
similar to that of Buffone et al. (2005) in which they reported that spermatozoa from 
the poor quality fraction are functionally and structurally similar to pathological 
spermatozoa from asthenozoospermic and varicocele samples. 
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5.6.1 Effects of insulin and leptin on motility parameters of mature and 
immature spermatozoa separated by PureSperm® two-layer density 
discontinuous gradient  
In order to investigate whether insulin and leptin could improve motility parameters of 
sperm samples from asthenozoospermic patients, we separated spermatozoa using 
the PureSperm® two-layer density discontinuous gradient. This study reports for the 
first time that insulin and leptin were able to improve the motility of immature human 
spermatozoa separated by the PureSperm® two-layer density discontinuous gradient 
(Table XVI). The insulin effect on immature spermatozoa observed in the study is in 
agreement with the findings of Seethalakshmi et al., (1987); Howland and Zebrowski, 
(1976) where in vitro insulin administration to the retrieved epididymal spermatozoa 
from a diabetic rat model restored their motility to that of normal levels. Future studies 
will indicate whether administration of insulin and leptin to asthenozoospermic 
spermatozoa during in vitro fertilization in ART settings could improve the fertilizing 
capacity of the spermatozoa.  
 
5.7 Effects of TNF-α and IL-6 on sperm motility parameters, viability and 
acrosome reaction 
Cytokines appear to be natural components of seminal plasma (Maegawa et al., 
2002) since they are produced physiologically by germ cells, Leydig cells and Sertoli 
cells in the testis and are involved in the normal function of the testis (Hales et al.,  
1999; Soder et al., 2000; Diemer et al., 2003). Physiological concentrations of 
selected cytokines in semen determined as the mean of several values taken from 
several authors (Huleihel et al., 1999; Matalliotakis et al., 2002; Kamejo, 2003; Kopa 
et al., 2005) were as follows: IL-6 (25.0 pg/mL), IL-8 (50.0 pg/mL), IL-10 (7.8 pg/mL), 
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IFN-צּ (127.1 pg/mL) and TNF-α (1.6 pg/mL). It has been shown that sperm-derived 
hyalauronidase stimulate IL-6 production in the cumulus cells surrounding the oocyte 
complex and thereby enhances fertilization (Shimada et al., 2008). The participation 
of cytokines in the regulation of fertility is dependent upon their concentration 
(Gruschwitz et al., 1996). TNF-α and IL-6 concentration levels have been reported to 
significantly increase in the seminal plasma of men with inflammatory genital 
diseases (Koçak et al., 2002) and in the peritoneal fluid of females with 
endometriosis (Eisermann et al., 1988).  
 
Various pro-inflammatory cytokines are present in seminal plasma but their effect on 
sperm motility, viability and acrosome reaction (AR) is still unclear. Studies have 
demonstrated increased levels of IL-6 in seminal plasma of infertile men which was 
inversely correlated with total sperm number and motility (Naz and Kaplan, 1994). 
However, other in vivo studies did not show a reduction in sperm motility by TNF-α 
and IL-6 (Comhaire et al., 1994; Hussenet et al., 1993). Our in vitro study has 
demonstrated that both TNF-α and IL-6 negatively affected progressive motility in a 
dose and time dependent manner. Our TNF-α results are in agreement with the 
findings of Eisermann et al., (1989) and Perdichizzi et al., (2007) in which sperm 
motility was significantly reduced in a dose- and time-dependent manner. The sperm 
viability results show that increasing concentrations of TNF-α and IL-6 led to increase 
in non-viable cells even though the increase was not significant. 
 
Studies have reported that infertile patients with varicocele exhibited elevated levels 
of cytokines such as IL-6, IL-8 and TNF-α (Sakamoto et al., 2008; Nallella et al., 
2004). In experimental varicocele in rats, Sahin et al., (2006) reported elevated levels 
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of IL-1α and IL-1β.  On the other hand, Aksoy et al., (2000) observed elevated levels 
of NO in seminal plasma of varicocele patients and concluded that the elevated NO 
levels influenced sperm production, motility and morphology in patients with 
varicocele. Oxidative stress due to NO and ROS in infertile patients with varicocele 
has been positively correlated with sperm DNA fragmentation (Sakamoto et al., 
2008). Sperm DNA damage has been reported to be a possible cause of reduced 
fertilization rates and poor outcomes of assisted reproduction (Ozmen et al., 2007; 
Tarozzi et al., 2007). This study has demonstrated that both TNF-α and IL-6 
increased NO production in human spermatozoa which was reversed by L-NAME 
(Figures 44 and 45). The reduction of NO production by L-NAME validated that the 
NO was derived from NOS. We speculate that apart from other sources, the elevated 
NO levels observed in varicocele patients may be due to elevated levels of cytokines 
such as IL-6.  It is known that NO can reduce adenosine triphosphate levels required 
for sperm motility by inhibiting glycolysis and the electron-transport chain (Dimmeler 
et al., 1992) while Weinberg et al., (1995) reported that NO was capable of inhibiting 
sperm motility in vitro. We therefore propose that elevated levels of TNF-α and IL-6 
possibly affect human spermatozoa function via the elevation of NO production. 
 
The presence of cytokines at high concentrations in seminal plasma or around the 
egg may result in defective AR either by inducing premature acrosome loss or 
insufficient acrosome response. TNF-α and IL-6 concentration levels of up to 61.3 
pg/ml and 152.7 pg/ml respectively, have been reported in seminal plasma of men 
with accessory gland infection (Koçak et al., 2002). In the follicular fluid of females 
with endometriosis, TNF-α and IL-6 concentration levels of up to 41.8 pg/ml and  
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30.8 pg/ml respectively have been reported (Wunder et al., 2006).  This study has 
demonstrated that both TNF-α and IL-6 can inhibit sperm from undergoing the AR 
(Figures 46 and 47). At the moment, the mechanism through which the inhibition is 
achieved is not known. Possibly this inhibiting effect could be attributed to the 
influence of the cytokines on the activities of Na+-K+-ATPase proton pumps, 
superoxide dismutase (SOD) and NO concentration (Bian et al., 2007). Our TNF-α 
results are in agreement with the findings of Dimitrov and Petrovská, (1996), and 
Bian et al., (2007) where TNF-α was reported to decrease both spontaneous and 
ionophore-induced AR. On the other hand, our finding that IL-6 has an inhibitory 
effect on AR, is contradictory to previous findings by Naz and Kaplan, (1994), and Zi 
and Song, (2006) but in agreement with Carver-Ward et al., (1997). These 
contradictions may be due to different concentrations of cytokines, methods of sperm 
selection as well as other methodological differences used by the different groups.  
 
Our study has demonstrated that TNF-α and IL-6 elevate NO production in human 
spermatozoa and that they have an effect on human sperm function especially 
progressive motility.  The detrimental effects of TNF-α and IL-6 are not different even 
though TNF-α seems to negatively affect sperm function more than IL-6. We have 
further demonstrated that this suppression of sperm function may be through the 
elevation of NO production.  
 
The finding that TNF-α and IL-6 also inhibit physiologically induced AR by 
progesterone is a novel finding since previous studies only used non-physiological 
inducer, calcium ionophore. This inhibitory effect seems to be dose dependent. In 
conclusion, the increase in concentration of these hormones in the male and female 
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reproductive tracts may be a source of fertilization failure as they may lead to 
decreased motility, viability and insufficient acrosome response to the stimulants.  
 
5.8 Effects of insulin, leptin, TNF-α and IL-6 on ROS generation 
In our earlier studies it was observed that insulin, leptin, TNF-α and IL-6 increased 
NO generation. Paradoxically, the increase of NO due to insulin and leptin was 
accompanied by increased sperm motility and acrosome reaction whereas NO 
increased due to TNF-α and IL-6 administration was accompanied by decreased 
sperm function. This study has shown that apart from NO stimulation, TNF-α and IL-6 
also stimulates ROS production (Figure 48) whereas insulin and leptin did not 
stimulate ROS production. We speculate that the ROS generated by TNF-α and IL-6 
was responsible for the detrimental effects on spermatozoa leading to decreased 
motility and acrosome reaction sensitivity. ROS are very reactive with cellular 
structures, undermining or eliminating their biological functions and properties 
(Agarwal et al., 2003). Our finding that TNF-α and IL-6 increased ROS production is 
in agreement with the findings of Buch et al., (1994); Nallela et al., (2004) and 
Nandipati et al., (2005). It might also be that the NO produced due to TNF-α and IL-6 
stimulation reacted with superoxide (O2-.), a member of the ROS family, to form 
peroxynitrite (ONOO-) which is a more harmful free radical than O2-. (Reiter et al., 
2000). Peroxynitrite formed from O2-. and NO can mediate oxidation, nitration, toxicity 
and alterations in signaling pathways (Radi, 2004). This could explain the reduction 
in sperm motility and acrosome reaction with the addition of TNF-α and IL-6. As 
illustrated in Figure 50 insulin and leptin induce NO production via PKB/Akt 
stimulation of eNOS whereas TNF-α and IL-6 stimulate NO production via inducible 
NOS (iNOS) stimulation. At the same time TNF-α and IL-6 also induced ROS 
 149
generation via the NADPH oxidase activity. We therefore, speculate that the 
detrimental effects observed when TNF-α and IL-6 were administered to 
spermatozoa were because of their induction of excessive ROS and NO generation.  
The NO may also have reacted with some members of the ROS family such as O2-. 
to form more detrimental radicals such as ONOO-.  
 
 
 
Figure 50. A schematic interaction between insulin, leptin, TNF-α and IL-6 in human 
spermatozoa. Insulin and leptin induce NO generation via the PI3K and PKB/Akt 
pathway which stimulates the endothelial nitric oxide synthase (eNOS), whereas 
TNF-α and IL-6 stimulate NO via the stimulation of inducible NOS (iNOS). 
Simultaneously, TNF-α and IL-6 via NADPH oxidase activity stimulates ROS 
production which is harmful to human sperm function at high concentration levels.  
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5.9 Expression and localization of GLUT8 in human spermatozoa 
Studies have shown that glucose in necessary for sperm function, and it has to be 
metabolized by spermatozoa to ensure that tyrosine phosphorylation occurs during 
capacitation, zona pellucida penetration and sperm-oocyte fusion (Urner and Sakkas, 
2003). The process of sperm capacitation requires a significant amount of energy 
and glucose seems to be a major energy source needed to maintain in vitro 
capacitation in mice and human spermatozoa since this sugar has been shown to 
induce much higher penetration rates and capacitation-like changes than do other 
monosaccharides such as fructose or mannose (Travis et al., 2004). GLUT4 is the 
most important and studied insulin-regulated transporter but it has not been detected 
in the testis or spermatozoa (Burant and Davidson, 1994b; Angulo et al., 1998; 
Schürmann et al., 2002), therefore making GLUT8 the best candidate for insulin-
stimulated glucose up-take in human spermatozoa. Gόmez et al., (2006) reported 
that GLUT8 expression in mouse testis first appears when round spermatids are 
formed, persists during spermiogenesis, and is present in spermatozoa isolated from 
the epididymis. However, it is not present in spermatogonia or spermatocytes. Our 
study has found that GLUT8 is constitutively expressed in the mid-piece region of 
mature human spermatozoa (Figure 49). As far as we are aware, this is the first study 
to report an increase in expression of GLUT8 in the midpiece region when 
spermatozoa are stimulated with insulin as well as its translocation to the acrosomal 
region. It is not yet clear why GLUT8 translocates to the acrosomal region. Previously 
it has been reported that GLUT8 translocates from subcellular compartments to the 
cell membrane in insulin-treated blastocysts (Carayannopoulos et al., 2000; Pinto et 
al., 2002). We therefore speculate that insulin through PI3K activation, leads to 
PKB/Akt phosphorylation, which in turn activates GLUT8’s translocation and insertion 
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into the cell membrane. This allows increased glucose uptake, thereby fueling 
glucose metabolism necessary for increased motility and the acrosome reaction as 
illustrated in Figure 51. 
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Figure 51. Hypothetical model of the functional interaction between insulin and leptin in human ejaculated spermatozoa. Insulin 
receptor activation and leptin receptor stimulation converge on PI3K via IRS1/2 and JAK/STAT respectively. Activation of the PI3K 
and PKB/Akt pathway can lead to GLUT8 translocation and insertion in the cell membrane and/or induce NO production. 
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Conclusions  
The discovery that a human ejaculated spermatozoon secretes its own insulin and 
leptin opened a very interested field in reproductive biology. Decreased insulin levels 
have been shown to exert adverse effects on reproductive endocrine function, 
gonadal function but nothing was known about its effects on ejaculated spermatozoa 
function. On the other hand, decreased leptin levels negatively affect the male’s 
reproductive capacity by delaying puberty, whereas higher leptin levels have been 
reported to be negatively correlated with human sperm function. The unanswered 
questions about the role insulin and leptin play in human sperm function made it 
imperative to investigate their physiological effects as well as unravelling their 
signalling pathways.  
 
In this study we have established suitable in vitro concentrations of insulin and leptin 
that can be administered to human spermatozoa. Our findings have also 
demonstrated that insulin and leptin play a beneficial role in enhancing human sperm 
motility parameters, viability and acrosome reaction. The study further demonstrated 
that insulin and leptin improved sperm function of asthernozospermic and 
teratozoospermic spermatozoa separated by the PureSperm® two-layer density 
discontinuous gradient. The study has also demonstrated for the first time the 
localization of GLUT8 in the midpiece region of human spermatozoa and that its 
expression in enhanced with insulin stimulation. Furthermore, insulin stimulation led 
to the translocation of the GLUT8 to the acrosome region. It is not yet clear why 
GLUT8 translocates to the acrosome region upon insulin stimulation. Further studies 
are required to elucidate this phenomenon.  
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This study has demonstrated that insulin and leptin stimulation of human 
spermatozoa converges at the level of PI3K during the intracellular signaling 
pathway. PI3K activation leads to protein kinase B (PKB/Akt) phosphorylation, which 
subsequently leads to GLUT8’s translocation and insertion into the cell membrane. 
The GLUT8 leads to an increase in glucose uptake, thereby fueling glucose 
metabolism necessary for increased motility and the acrosome reaction. On the other 
hand, the PI3K and PKB/Akt pathway stimulated by insulin and leptin can 
simultaneously diverge and stimulate the eNOS enzyme of spermatozoa in order to 
increase NO generation. We therefore, report that insulin and leptin can possibly act 
via two methods (GLUT8 translocation; NO production) to influence human sperm 
motility and acrosome reaction. 
 
This study has confirmed the detrimental effects of TNF-α and IL-6 on human sperm 
motility and acrosome reaction. Our findings have demonstrated that these effects 
are mediated via an excessive increase in NO and ROS induced by these cytokines. 
Apart from other sources, the elevated NO and ROS levels observed in deseased 
states that cause infertility such as varicocele in men and endometriosis in women, 
may be due to elevated levels of cytokines such as TNF-α and IL-6. 
 
Based on the findings of this study, we recommend that insulin and leptin could be 
used to improve human sperm function in vitro especially for asthenozoospemic 
spermatozoa. We also repport that TNF-α and IL-6 are detrimental to human sperm 
function at higher concentrations. Future studies will indicate whether lack of insulin 
or leptin receptors on human spermatozoa could explain the causes of idiopathic 
male infertility.  
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Abstract 
In recent years, there has been an increase in obesity, diabetes mellitus and male 
factor infertility. Obesity, which leads to a condition called the metabolic syndrome, is 
characterized by elevated leptin levels, whereas diabetes mellitus is characterized by 
decreased insulin levels or insulin insensitivity. There is a large body of evidence 
suggesting that insulin and leptin play a role in the physiology of human reproduction. 
Insulin and leptin deficiencies have been shown to negatively affect reproductive 
function in both humans and animal models. These hormones are thought to affect 
male reproduction at multiple levels due to their effects on endocrine control of 
spermatogenesis, spermatogenesis itself, as well as on mature ejaculated 
spermatozoa.  
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Introduction 
A growing body of research has been focusing on obesity, which is a cardinal feature 
of a condition known as the metabolic syndrome, and its pathophysiology. The 
metabolic syndrome is characterized by a group of abnormalities including 
overweight, dyslipidemia, hypertension, and impaired glucose metabolism.  In 
reproductive biology, the metabolic syndrome has garnered more attention because 
of the connection that exists between diabetes mellitus (DM), hyperleptinemia and 
infertility. Infertility is a common phenomenon amongst modern societies and it is 
estimated that about 15% of couples attempting to conceive are not able to do so 
within the time frame of one year. The male contribution to this occurrence is believed 
to be between 20-50% [1].  
 
DM is characterized by poor glucose control leading to hyperglycemia. There are two 
types of DM: Type I DM, also known as insulin-dependent diabetes mellitus (IDDM), 
is a condition in which there is an absolute or relative lack of insulin due to 
autoimmune destruction of the insulin secreting β-cells in the islets of Langerhans in 
the pancreas; Type II DM, also known as non-insulin dependent diabetes mellitus 
(NIDDM), is characterized by cellular insulin insensitivity despite sufficient insulin 
levels [2]. Both Type I and II DM are well recognized as a cause of sexual 
dysfunction, which in turn also contributes to infertility [3]. DM is thought to affect the 
male reproductive function at multiple levels due to its effects on the endocrine 
control of the spermatogenesis process, spermatogenesis itself, as well as impairing 
penile erection and ejaculation [4]. Many studies involving diabetic animal models 
have demonstrated that there is an impairment of sperm quality [5, 6] which leads to 
a reduction in fecundity [6, 7, 8, 9]. Furthermore, it has been reported that men 
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affected with IDDM have sperm with severe structural defects, significantly lower 
motility [10] and lower ability to penetrate zona free hamster eggs [11].  In recent 
years, there has been an increase in NIDDM due to an increase in obesity [3]. 
Therefore, increase in prevalence of DM will pose a significant problem to human 
fertility.  
 
Obese individuals are also reported to have higher circulating leptin levels as well as 
higher prevalence of infertility [12, 13]. Leptin is a 16-kDa protein that is produced 
mainly by adipose tissue and is encoded by the ob gene [14]. Apart from the adipose 
tissue it is also produced by the placenta [15], stomach [16] and skeletal muscles 
[17]. The tertiary structure of leptin resembles that of cytokines and lactogenic 
hormones [18]. Leptin is best known as a regulator of food intake and energy 
expenditure via hypothalamic-mediated effects [19]. An increasing amount of data is 
suggesting that apart from the aforementioned, leptin also acts as a metabolic and 
neuroendocrine hormone. It is involved in glucose metabolism as well as in normal 
sexual maturation and reproduction [20]. Thus, changes in plasma leptin 
concentrations can have important and wide-ranging physiological implications. This 
review will aim at highlighting the roles of both insulin and leptin in male reproduction 
as well as focus on their possible effects at various reproductive levels contributing 
towards male infertility. 
 
Endocrine effects of insulin on male reproduction 
The importance of insulin has been demonstrated in male rat reproduction by using 
streptozotocin, to deplete the β-cells of the pancreas, and thereby inducing IDDM [7]. 
The deficiency of insulin in these rats led to a decrease in Leydig cell number as well 
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as an impairment in Leydig cell function. This consequently translated to a decrease 
in androgen biosynthesis and serum testosterone levels.  
 
The impaired Leydig cell function and subsequent decrease in testosterone in IDDM 
could be explained by the absence of the direct stimulatory effects of insulin on 
Leydig cells, as well as to an insulin-dependent decrease in follicle stimulating 
hormone (FSH) and luteinizing hormone (LH) levels [17].  
 
It was also reported [10] that insulin plays a central role in the regulation of the 
hypothalamic-pituitary-testicular axis by the reduction in secretion of LH and FSH in 
diabetic men as well as in knockout mice lacking the insulin receptor in the 
hypothalamus. Both the diabetic men and the knockout mice had notably impaired 
spermatogenesis, increased germ cell depletion and Sertoli cell vacuolization [10, 
21]. Figure 1 shows that insulin is required to stimulate the hypothalamus to release 
gonadotrophin releasing hormone (GnRH) which instructs the release of LH and FSH 
from the pituitary gland.  It has been reported that higher insulin concentrations, as 
found in NIDDM, lead to hypogonadism [22] as well as decreased serum testosterone 
levels [23]. Furthermore, Pitteloud and associates [24] also reported than insulin 
resistance lead to a decrease in testosterone secretion at testicular level (Leydig cell) 
that was not due to changes in hypothalamic or pituitary function. These findings 
points to a direct action of insulin at gonadal level (see Fig 1). 
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Figure 1. A schematic interaction of insulin, leptin and the endocrine control of 
spermatogenesis. Diabetes mellitus and obesity have an influence on circulating 
insulin and leptin levels respectively. Both insulin and leptin affect the secretion of 
gonadotrophin releasing hormone (GnRH) from the hypothalamus which 
subsequently orchestrate the secretion of luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) from the pituitary gland that affect gonadal function and 
spermatogenesis. Both insulin and leptin can exert direct effects on the testes as 
well.  
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Endocrine effects of leptin on male reproduction 
Three leptin receptor isoforms have been reported to be present in gonadal tissue, 
suggesting that it could exert a direct endocrine action on the gonads [25, 26, 27]. 
Indeed studies have shown that treatment with leptin of infertile ob/ob knockout mice 
restored reproductive ability [28]. Injecting these ob/ob mice with leptin was reported 
to have caused an elevation in FSH levels, while it also stimulated gonadal 
development [29]. It was further shown that the chronic administration of antileptin 
antibody to rats inhibited LH release [30]. 
 
Humans deficient of leptin have shown similar effects as observed in animal models. 
A case study regarding a male with a homozygous leptin mutation reported that he 
was still pre-pubertal and showed clinical traits typical of hypogonadism and 
androgen deficiency despite being 22 years of age [31]. Furthermore, another male 
subject with a leptin receptor deficiency showed no pubertal development at either 13 
or 19 years of age [32]. Reports like these emphasize the importance of leptin on the 
onset of puberty in humans. 
 
The mechanisms through which leptin acts are not yet clearly elucidated but might 
probably involve the hypothalamus and its subsequent effects on the pituitary and 
gonadal axis. It has been shown that the administration of gonadotrophin releasing 
hormone (GnRH) to the leptin-deficient man induced a normal increase in serum LH 
and FSH levels, while the administration of gonadotrophins increased testosterone 
levels [31].  As illustrated in Figure 1, it may be that leptin stimulates GnRH synthesis 
or secretion from the hypothalamic neurons or secretion of gonadotrophins by the 
pituitary gland [33]. 
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Effects of insulin on spermatogenesis  
Morphological abnormalities have been reported in IDDM human testicular biopsies. 
These abnormalities included increasing tubule-wall thickness, germ cell depletion 
and Sertoli cell vacuolization [34]. Morphological and functional spermatozoal 
abnormalities that have been observed in diabetic animal models appear to be 
reversible with the administration of insulin [35, 36]. A significantly lower sperm count, 
and epididymal sperm motility was reported in diabetic rats in comparison to controls 
[36]. In vitro insulin administration to these retrieved epididymal spermatozoa 
restored their motility to that of normal levels, suggesting a direct effect on 
spermatozoa due to defective carbohydrate metabolism. Studies have reported that 
insulin as well as insulin-like growth factor I (IGF-I) and IGF-II promote the 
differentiation of spermatozoa into primary spermatocytes by binding to the IGF-I 
receptor [37]. There is also evidence that both the sperm membrane and the 
acrosome represent cytological targets for insulin [38].  
 
Effects of leptin on spermatogenesis  
The importance of leptin during the process of spermatogenesis was demonstrated 
by the observation that a leptin deficiency in mice was associated with impaired 
spermatogenesis, increased germ cell apoptosis and up-regulated expression of 
proapoptotic genes within the testes [39]. This resulted into the reduction in germ cell 
numbers and the absence of mature spermatozoa in the seminiferous tubules. This 
furthermore stresses the importance of physiological leptin levels in the normal 
production of male gametes. 
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Insulin and ejaculated spermatozoa 
Insulin has been shown to play a central role in the regulation of gonadal function; 
however, its significance in male fertility is not completely understood and properly 
elucidated [40]. In adult mammals insulin was thought to be produced only by the β-
cells in the pancreas [41]. 
 
Recently studies have demonstrated that insulin is expressed in and secreted by 
human ejaculated spermatozoa. Both insulin mRNA as well as the actual protein 
were detected in ejaculated human sperm [41]. It was found that capacitated 
spermatozoa secreted more insulin than noncapacitated spermatozoa [41], thereby 
suggesting a possible role for insulin in sperm capacitation.  Our group has 
furthermore shown the importance of insulin on ejaculated human spermatozoa in 
vitro [42]. Insulin administration to the medium (10µIU) was found to not only 
significantly increase total and progressive motility, but also significantly enhanced 
hyperactivation characteristics (VCL and ALH). In vitro insulin administration also led 
to an increase in spontaneous acrosome reaction, as well as further enhancing the 
sensitivity to the progesterone induced acrosome reaction. It is not clear if this 
increase was due to the agonists’ effect on capacitation or the acrosome reaction 
itself. It was also demonstrated by our group that insulin increased nitric oxide (NO) 
production in human spermatozoa and that this increase was possibly via the 
phosphoinositide 3-kinase (PI3K) signaling pathway as evidenced by the reduction in 
NO production when the PI3K inhibitor, wortmannin, was administered. Insulin may 
play a role in enhancing the fertilization capacity of human spermatozoa by 
increasing motility, NO production and acrosome reaction sensitivity [42].  
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Leptin and ejaculated spermatozoa 
Despite the fact that leptin has been implicated to play a role in the regulation of 
reproduction in both humans and animal models and that its specific role in the 
female reproductive system has been well established, its exact role(s) in the male 
reproductive system remains to be clarified [43, 44]. The expression of leptin in 
ejaculated human spermatozoa was demonstrated through identifying its transcripts 
by means of reverse transcription-polymerase chain reaction, while its protein 
presence was evidenced by Western blot analysis and its localization by 
immunostaining techniques [45].  
 
It seems that the significance of leptin in male reproduction will remain ambiguous for 
at least a while as results from studies are quite controversial and contradictory. 
Some studies have indicated positive effects [46] whereas others have reported 
negative effects of leptin on gonadal function [47]. It has been shown that seminal 
plasma leptin levels are significantly lower in normozoospermic patients compared to 
pathological semen samples and that higher leptin levels negatively correlated with 
sperm function [48]. Conversely, it was also reported that no correlation exists 
between leptin levels and sperm motility or morphology [49]. Capacitated 
spermatozoa were reported to secrete more leptin than noncapacitated spermatozoa 
suggesting that leptin plays a role in the process of capacitation [45]. Moreover, leptin 
receptors have been detected by immunohistochemistry in ejaculated spermatozoa 
and were localized on the tail area [50]. Similar to what we observed with insulin, our 
group has demonstrated that in vitro leptin administration increased various motility 
parameters and NO production as well as increasing the sensitivity of the 
spontaneous and progesterone induced acrosome reaction [42].  
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BOX 1: The effects of different Insulin and Leptin 
concentrations on male reproductive function 
 HIGHER 
CONCENTRATIONS 
ABSENCE or LOWER 
CONCENTRATIONS 
INSULIN Hypogonadism (Dhindsa et 
al., 2004) 
 
Low testosterone 
concentrations (Barret-
Connor et al., 1990) 
 
Decreased testosterone 
levels independent of 
hypothalamus-pituitary –
axis (Leydig cells) 
(Pitteloud et al., 2005) 
Decreased Leydig cell 
number; impaired Leydig 
cell function (Murray et al., 
1983) 
 
Reduction in LH and FSH; 
impaired spermatogenesis; 
increased germ cell 
depletion; Sertoli cell 
vacuolization (Brüning et 
al., 2000; Bacetti et al., 
2002) 
 
Sperm morphological 
abnormalities (Cameron et 
al., 1985) 
 
Reduced sperm motility 
(Lampiao et al., 2008) 
LEPTIN Inverse correlation with 
percentage motile 
spermatozoa and straight 
line velocity (Glander et al., 
2002) 
Decreased FSH and LH 
secretion (Carro et al., 
1997) 
 
Delayed puberty; 
hypogonadism; androgen 
deficiency (Strobel et al., 
1998) 
 
Increased germ cell 
apoptosis; impaired 
spermatogenesis (Bhat et 
al., 2006) 
 
Box 1. A summary of the effects of different insulin and leptin concentrations on 
male reproductive function. 
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GLUT8 as a glucose transporter in human spermatozoa 
Glucose uptake and metabolism are essential for proliferation and survival of cells 
and is usually carried out through glucose transporters (GLUTs). In mammals there 
are fourteen known members of GLUT proteins [51]. Insulin regulation of glucose 
transport in target tissues is known to involve the specialized GLUT4 isoforms, which 
is localized only in insulin responsive tissues [51].  
 
It is well known that glucose metabolism is essential for germ cell fertility and that 
when it is disturbed as in DM, spermatogenesis is impaired causing infertility [10, 11]. 
Previously it has been assumed that GLUT5 was the major sugar transporter of the 
sperm cell [52]. However, it has come to light that GLUT5 is a very specific fructose 
transporter [53] and does not transport glucose to a significant extent. Because 
GLUT5 was not detected in rat testis, it was suggested that other sugar transporters, 
presumably GLUT3, catalyze the fuel supply of the rat sperm cell [54]. In recent 
years, a novel 447-amino-acid glucose transporter protein, GLUT8 was described 
[55, 56, 57]. GLUT8 is expressed to some extent in insulin-sensitive tissues, e.g., 
brain, adrenal gland, spleen, adipose tissue, muscle, heart, and liver [55, 56, 58]. It 
was discovered that GLUT8 mRNA expression is highest in testicular tissue and that 
it was linked to circulating gonadotrophin levels [56, 59].  
 
GLUT8 was found to be specifically located in the head of mouse and human 
spermatozoa and that it is predominantly located within the region of the acrosome of 
mature sperm [60]. Coincidentally, immunohistochemical studies have shown that 
insulin is also predominantly located in these areas of human spermatozoa [38].  The 
intracellular localization of GLUT8 is similar to that of the insulin-sensitive glucose 
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transporter GLUT4, and it has indeed been described that insulin could produce a 
translocation of GLUT8 to the plasma membrane of the blastocyst [57]. In addition, it 
was shown that GLUT8 recycles in a dynamic-dependent manner between internal 
membranes and the plasma membrane in rat adipocytes and COS-7 cells [61]. As 
illustrated in Figure 2, both insulin and leptin stimulation converges at the level of 
PI3K during the intracellular signaling pathway. PI3K activation leads to protein 
kinase B (PKB/Akt) phosphorylation, which in turn causes GLUT8’s translocation and 
insertion into the cell membrane. This allows increased glucose up-take, thereby 
fueling glucose metabolism necessary for increased motility and the acrosome 
reaction. Simultaneously the PI3K and PKB/Akt pathway activated by insulin and 
leptin can also diverge and stimulate the endothelial nitric oxide synthase (eNOS) 
enzyme of spermatozoa in order to increase NO generation. It has been shown that 
NO can also increase sperm motility and acrosome reaction [62]. Therefore, we 
hypothesize that insulin and leptin can possibly act via two methods (GLUT8 
translocation; NO production) to influence human sperm motility and acrosome 
reaction.  
 
In conclusion, there is an association between insulin levels, leptin levels and male 
infertility. Decreased insulin levels have been shown to exert adverse effects on 
reproductive endocrine function, gonadal function as well as ejaculated spermatozoa 
function (see Box 1). On the other hand, decreased leptin levels negatively affect the 
male’s reproductive capacity by delaying puberty, whereas higher leptin levels have 
been reported to be negatively correlated with human sperm function (see Box 1). It 
appears that the insulin and leptin concentration levels are a double edged sword 
and a proper balance need to be struck for normal reproductive function.  The 
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impairment of insulin and leptin due to pathologies such as DM, obesity and 
metabolic syndrome explain why infertility is connected to these conditions. Despite 
the fact that the relationship between obesity, metabolic syndrome, DM and male 
infertility has been established, the exact mechanisms by which they act have not 
been elucidated to the fullest. This brief review has focused only on two hormones 
i.e. insulin and leptin, that can possibly be implicated under these conditions as the 
important role players. Further studies are needed to not only tease out the exact 
roles each play, but also to help find possible in vivo and in vitro solutions and 
treatment regimes for male infertility patients.   
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Figure 2. Hypothetical model of the functional interaction between insulin and leptin 
in human ejaculated spermatozoa. Insulin receptor activation and leptin receptor 
stimulation converge on PI3K via IRS1/2 and JAK/STAT respectively. Activation of 
the PI3K and PKB/Akt pathway can lead to GLUT8 translocation and insertion in the 
cell membrane and/or induce NO production.  
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Abstract 
Aim: To investigate the in vitro effects of insulin and leptin on human sperm motility, 
viability, acrosome reaction, and nitric oxide production. Methods: Washed human 
spermatozoa from normozoospermic donors were treated with insulin (10 µIU) and 
leptin (10 nmol). Insulin and leptin effects were blocked by inhibition of their 
intracellular effector, phosphotidylinositol 3-kinase, by wortmannin (10 µmol) 30 min 
prior to insulin and leptin being given. Computer-assisted semen analysis was used 
to assess motility after 1, 2, and 3 h of incubation. Viability was assessed by 
fluorescence-activated cell sorting using propidium iodide as a fluorescent probe. 
Acrosome-reacted cells were observed under a fluorescent microscope using 
fluorescein-isothiocyanate–Pisum sativum agglutinin as a probe. Nitric oxide was 
measured after treating the sperm with 4,5-diaminofluorescein-2/diacetate and 
analyzed by fluorescence-activated cell sorting. Results: Insulin and leptin 
significantly increased total motility, progressive motility, and acrosome reaction, as 
well as nitric oxide production. Conclusion: This study has shown the in vitro 
beneficial effects of insulin and leptin on human sperm function. These hormones 
could play a role in enhancing the fertilization capacity of human spermatozoa.  
 
Keywords: insulin; leptin; spermatozoa; nitric oxide; motility; acrosome reaction 
 
 
 
 
 
 
 206
Introduction 
 
The discovery that human ejaculated spermatozoa secrete insulin [1] and leptin [2] 
has opened a new field of study in reproductive biology. Leptin, a hormone secreted 
mainly by adipose tissue [3] is known as a regulator of food intake and energy 
expenditure [4]. It also fulfils many other functions, such as the regulation of 
neuroendocrine systems, hematopoieses, angiogenesis, puberty, and reproduction 
[5–8]. Studies have shown the presence of leptin receptors on human spermatozoa 
as well as soluble leptin receptors in seminal plasma [9].  
Insulin is mainly produced by the β cells of the pancreas and is important for the 
promotion of growth, differentiation, and metabolism in somatic cells [10]. It has also 
been shown to play a role in the regulation of gonadal function [11].  
In other cell types, leptin and insulin play a central role in regulation of energy 
homeostasis, acting on the phosphotidylinositol 3-kinase (PI3K)/protein kinase B 
pathway that mediates their metabolic effects [12]. Similarly, in uncapacitated sperm, 
both insulin and leptin increased PI3K activity as well as AktS473 and GSK-3S9 
phosphorylation [1, 2], thereby possibly modulating the availability of the 
spermatozoa’s energetic substrates during capacitation. However, the significance of 
these hormones in male fertility is not properly elucidated.  
Recent studies have confirmed the role of nitric oxide (NO) in modulating sexual and 
reproductive function [13]. The production of NO is catalysed by a family of NO 
synthase (NOS) enzymes [14]. NOS is responsible for the conversion of L-arginine to 
NO and L-citrulline [15] and has been shown to be expressed in spermatozoa [16]. 
The ability of human spermatozoa to synthesize NO has been shown indirectly by 
 207
measuring nitrite accumulation [16], as well as L-[3H]citrulline generation [17] or 
directly by means of an isolated NO meter with sensor [18] and flow cytometry [19].  
The aim of this study was to investigate the in vitro effects of leptin and insulin on 
human sperm motility, viability, acrosome reaction, and NO production.  
 
Materials and methods 
 
Chemicals 
Wortmannin, Ham’s F10, leptin, N-nitro-L-arginine methyl ester (L-NAME), propidium 
iodide (PI), fluorescein isothiocyanate–Pisum sativum agglutinin, and progesterone 
were obtained from Sigma Chemical (St. Louis, MO, USA). Human insulin was 
purchased from Lilly France (Fegersheim, France). 4,5-Diaminofluorescein-
2/diacetate (DAF-2/DA) was from Calbiochem (San Diego, CA, USA).  
 
Preparation of sperm samples 
The 25 donors recruited in this study provided informed consent for a research 
protocol approved by the University of Stellenbosch Ethics Committee (Tygerberg, 
South Africa). Fresh semen samples were obtained by masturbation from healthy 
volunteers after a minimum of 2 days of sexual abstinence according to World Health 
Organization guidelines [20]. Samples were left to liquefy for 30 min before 
processing. Motile sperm fractions were retrieved from the samples using a double 
wash (400 × g, 5 min) swim-up technique in Hams medium containing 3 % bovine 
serum albumin (37 °C, 5 % CO2). After 1 h, the supernatant containing motile sperm 
was collected and divided into aliquots (5 × 106/mL).  
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Experimental procedure 
Insulin and leptin effects were blocked by inhibition of their intracellular effector, PI3K, 
by wortmannin (10 µmol) given 30 min prior to the addition of 10 µIU insulin and 
10 nmol leptin to the samples according to the concentrations described by Aquila et 
al. [1, 2]. 
 
Motility parameters 
Motility was measured by means of computer-assisted semen analysis using an Ivos 
motility analyzer (Hamilton Thorne Biosciences, Beverley, MA, USA) after 1, 2, and 
3 h of incubation (37 ˚C, 5 % CO2).  
 
Cell viability 
Sperm cells that had received different treatments were incubated (37 ˚C, 5 % CO2, 
120 min) and subsequently loaded with PI (1 µmol, 15 min). Living cells with an intact 
cell membrane and active metabolism will exclude PI, whereas cells with damaged 
membranes or impaired metabolism allow PI to enter the cell and stain the DNA. PI 
fluorescence was analyzed by fluorescence-activated cell sorting (FACS).  
 
Acrosome reaction 
Spermatozoa that received different treatments were left to capacitate for 3 h, after 
which they were induced to undergo the acrosome reaction by means of a 
physiological trigger, progesterone (1 µg/mL, 30 min), or left to undergo the 
spontaneous acrosome reaction (30 min). 
The extent of the acrosome reaction was assessed by placing samples on spotted 
slides and leaving them to air dry, then fixing them in cold ethanol [20]. Fluorescein 
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isothiocyanate–Pisum sativum agglutinin (125 µg/mL) was layered on the slides and 
they were incubated for 30 min in a dark humid atmosphere. Slides were 
subsequently rinsed with distilled water in order to eliminate excess probe, then 
observed under a fluorescence microscope. At least 200 cells were evaluated per 
spot. 
 
NO production 
NO production was measured as previously described [19]. Briefly, samples that had 
received different treatments were loaded with DAF-2/DA (10 µM) and incubated 
(120 min, 37 ºC) in the dark. Some of the samples were loaded with the NOS 
inhibitor, L-NAME (0.7 mmol), 30 min prior to DAF-2/DA loading. Care was taken to 
prevent exposure to light throughout the rest of the experiment as the probe is light-
sensitive. After incubation with DAF-2/DA the cells were analyzed by FACS.  
 
Flow cytometry 
A FACSCalibur analyzer (Becton Dickinson, San Jose, CA, USA) was used to 
quantify fluorescence (excitation wavelength 488 nm and emission wavelength 
530 nm) at a single-cell level and data were analyzed using CellQuest version 3.3 
(Becton Dickinson) software. The mean fluorescence intensity of the analyzed sperm 
cells was determined after gating the cell population by forward and side scatter 
signals. In total, 100 000 events were acquired, but non-sperm particles and debris 
were excluded by prior gating, thereby limiting undesired effects on overall 
fluorescence. The final gated populations usually consisted of 15 000–20 000 sperm 
cells.  
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Statistical analysis 
The results were analyzed on the Prism 4 statistical program (GraphPad, San Diego, 
CA, USA). All data are expressed as the mean ± SEM. Data were tested for normality 
with the Kolmogorov–Smirnov test. One-way ANOVA (with Bonferroni post hoc test if 
P < 0.05) was used for statistical analysis. DAF-2/DA fluorescence data are 
expressed as mean fluorescence (percentage of control, control adjusted to 100 %). 
Differences were regarded statistically significant if P < 0.05.  
 
Results 
 
Motility 
Total sperm motility, progressive motility, curvilinear velocity (VCL), and amplitude of 
lateral head displacement (ALH) were assessed after 1, 2, and 3 h of incubation 
(Figures 1–4, respectively). Leptin as well as insulin + leptin significantly increased 
total motility compared to the control (75.30 ± 0.57 % and 76.10 ± 2.53 % vs 
64.80 ± 2.74 %, respectively; P < 0.05) after 1 h of incubation. Similarly, progressive 
motility was significantly increased in the leptin and insulin + leptin groups compared 
to the control (51.60 ± 1.98 % and 52.30 ± 3.08 % vs 42.30 ± 2.84 %, respectively; 
P < 0.05). The increase in total motility and progressive motility in the insulin only 
treated group did not reach significant levels when compared to the control after 1 h 
of incubation. VCL was significantly increased in the leptin and leptin + insulin groups 
compared to the control (93.15 ± 2.26 µm/sec and 97.40 ± 1.88 µm/sec vs 
78.51 ± 3.48 µm/sec, respectively; P < 0.05), whereas ALH was significantly 
increased in the insulin + leptin group when compared to the control after 1 h of 
incubation (3.89 ± 0.11 µm vs 3.36 ± 0.13 µm; P < 0.05).  
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After 2 h of incubation, sperm cells incubated with insulin, leptin, or insulin + leptin 
had significantly increased total motility compared to the control (69.00 ± 2.22 %, 
72.20 ± 2.02 %, and 73.80 ± 2.81 % vs 54.30 ± 2.43 %, respectively; P < 0.05). 
Similar results were observed with progressive motility. Insulin, leptin, and insulin + 
leptin groups significantly increased progressive motility compared to the control 
(47.30 ± 3.81 %, 53.20 ± 3.00 %, and 54.80 ± 3.13 % vs 32.90 ± 3.83 %, 
respectively; P < 0.05). The main characteristics of hyperactivation (VCL and ALH) 
were also significantly increased after 2 h of incubation. VCL was significantly 
increased in the insulin, leptin, and insulin + leptin groups compared to the control 
(99.78 ± 2.07 µm/sec, 105.2 ± 1.87 µm/sec, and 106.6 ± 1.59 µm/sec vs 
84.97 ± 5.39 µm/sec, respectively; P < 0.05). However, ALH was significantly 
increased in the leptin and insulin + leptin groups when compared to the control 
(5.20 ± 0.24 µm and 5.40 ± 0.26 µm vs 4.23 ± 0.13 µm, respectively; P < 0.05). A 
similar trend of events was observed after 3 h of incubation. The insulin, leptin, and 
insulin + leptin groups had significantly increased total motility, progressive motility, 
and VCL, as well as ALH, when compared to the control. At all time points the 
addition of wortmannin did not affect motility, however, it was able to attenuate the 
effects of insulin/leptin on motility, progressive motility, VCL, and ALH when used as 
a cotreatment.  
 
Sperm cell viability 
We observed a trend of decreased PI fluorescence, interpreted as an increase in 
viability, for cells treated with insulin, leptin, and insulin + leptin, but it did not attain 
statistical significance (Figure 5).  
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Acrosome reaction  
Progesterone-stimulated samples had significantly more acrosome-reacted cells 
compared to spontaneous acrosome-reacted cells in all the groups (Figure 6). The 
addition of insulin, leptin, and insulin + leptin significantly increased spontaneous 
acrosome-reacted cells compared to the control (35.33 ± 1.73 %, 36.56 ± 1.93 %, 
and 41.78 ± 1.31 % vs 14.56 ± 0.64 %, respectively; P < 0.05). Similarly, insulin, 
leptin, and insulin + leptin significantly increased acrosome reaction in cells 
stimulated with progesterone when compared to the control (42.11 ± 2.05 %, 
42.89 ± 1.26 %, and 49.11 ± 1.18 % vs 20.00 ± 1.35 %, respectively; P < 0.05). The 
inhibition of PI3K with wortmannin did not affect the percentage of acrosome-reacted 
cells compared to the control in either spontaneous or progesterone-stimulated 
groups. Wortmannin, however, attenuated the stimulatory effects of insulin/leptin on 
acrosome reaction when used as a cotreatment. 
 
NO generation 
Figure 7 shows the effects of insulin and leptin on DAF-2/DA fluorescence. The NOS 
inhibitor, L-NAME, significantly reduced DAF-2/DA fluorescence compared to the 
control (81.01 ± 1.48 % vs 100 %; P < 0.05). Wortmannin, a PI3K inhibitor, also 
significantly reduced DAF-2/DA fluorescence compared to the control 
(91.58 ± 2.35 % vs 100 %; P < 0.05). Insulin, leptin, and insulin + leptin groups 
significantly increased DAF-2/DA fluorescence compared to the control 
(113.10 ± 1.25 %, 115.30 ± 3.24 %, and 120.80 ± 2.70 % vs 100 %, respectively; 
P < 0.05). The addition of insulin + leptin to the L-NAME and wortmannin treated 
groups did not reverse the situation.  
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Discussion 
 
The existence of insulin and leptin in human ejaculated spermatozoa was shown 
through their transcripts evaluated by reverse transcription–polymerase chain 
reaction, their protein content evidenced by Western blot analysis and through their 
localization by immunostaining analysis [1, 2]. The significance of leptin in influencing 
reproduction was evidenced by leptin-deficient female mice (ob mice) that are infertile 
[21]. However, treatment with leptin restores fertility in ob male mice, suggesting its 
role in reproduction [22]. The role of leptin in human spermatozoa function is not 
clearly elucidated. Most studies have indicated both positive and negative effects of 
leptin in gonadal function [23, 24]. Glander et al. [25] reported that seminal plasma 
leptin levels were significantly lower in patients with normal spermiogram parameters, 
compared with pathological semen samples, and showed a negative correlation with 
motility of human spermatozoa, suggesting that higher leptin concentration has 
negative effects on sperm function. However, Zorn et al. [26] found no correlation 
between leptin levels and sperm motility or morphology. 
The importance of insulin in spermatozoa physiology is indicated by men affected by 
diabetes mellitus type 1 who have sperm with severe structural defects, significantly 
lower motility [27] and lower ability to penetrate hamster eggs [28]. Our data has 
shown that insulin and leptin might play a role in enhancing human sperm motility 
parameters, as evidenced by increased total and progressive motility as well as the 
sperm hyperactivation characteristics, VCL and ALH (Figures 1–4).  
Insulin and leptin secretion was reported to be significantly increased in capacitated 
sperm than in non-capacitated sperm, suggesting the involvement of these hormones 
in capacitation. Capacitated sperm released up to approximately 18 µIU insulin and 
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4 ng/mL leptin [1, 2]. Lackey et al. [29] reported leptin concentration levels of 
approximately 1 ng/mL in human seminal plasma, whereas in female follicular fluid, 
leptin levels of approximately 16 ng/mL have been reported [30]. 
Studies have shown that capacitated sperm display an increase in metabolic rate, 
overall energy expenditure, intracellular ion concentrations, plasma membrane 
fluidity, intracellular pH, and reactive oxygen species, presumably to affect the 
changes in sperm signaling and function during capacitation [31, 32]. Sperm 
capacitation is a prerequisite step for sperm to undergo the acrosome reaction [33, 
34]. This possibly explains why insulin and leptin increased the percentage of 
spontaneous and progesterone acrosome-reacted cells in our study. It is not clear 
whether this increase is due to the agonists’ effect on capacitation or acrosome 
reaction itself. Further studies are recommended. However, the blockage of PI3K with 
wortmannin had no effect on the acrosome reaction status of the cells when 
compared to the control. This finding is consistent with results observed by Fisher et 
al. [35], in which wortmannin was found not to inhibit the acrosome reaction induced 
by A23187 or progesterone, as well as by du Plessis et al. [36], where LY294002, 
another PI3K inhibitor, also did not inhibit the acrosome reaction induced by A23187, 
progesterone, and solubilized zona pellucida. We speculate that the cellular 
pathways involved in the acrosome reaction induced by this agonist do not involve 
PI3K, or, alternatively, that the need for PI3K in the pathway is somehow by-passed. 
It has been reported that the signaling of insulin is a complex process that involves 
multiple signaling pathways that diverge at or near the activation of its tyrosine kinase 
receptor [37].  
Studies have reported that insulin and leptin enhance NO production in other cell 
types [38, 39]. Our study has, for the first time, shown that both insulin and leptin 
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enhance NO production in human spermatozoa and that this increase is possibly 
through the PI3K signaling pathway, as evidenced by reduction of NO production 
when the PI3K inhibitor, wortmannin, was given. However, it is still too early to make 
significant conclusions about the mechanism of action of insulin and leptin on NO 
production, as wortmannin has also been shown to inhibit phosphotidylinositol 4-
kinase [40]. The attenuation of NO production when the NOS inhibitor, L-NAME, was 
given confirms that the NO was derived from NOS (Figure 7).  
 
In conclusion, our study has shown that insulin and leptin might play a role in 
enhancing the fertilization capacity of human spermatozoa by increasing motility, 
acrosome reaction, and NO production.  
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Figure 1. Effects of insulin and leptin on human sperm total motility after 1, 2, and 3 h 
of incubation. Washed sperm samples were treated with insulin, leptin, insulin + leptin 
(Ins/Lep), insulin + leptin + wortmannin (Ins/Lep/Wort), or wortmannin (Wort). Values 
are the mean ± SEM of 10 replicates. *P < 0.05 vs control.  
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Figure 2. Effects of insulin and leptin on human sperm progressive motility after 1, 2, 
and 3 h of incubation. Washed sperm samples were treated with insulin, leptin, 
insulin + leptin (Ins/Lep), insulin + leptin + wortmannin (Ins/Lep/Wort), or wortmannin 
(Wort). Values are the mean ± SEM of 10 replicates. *P < 0.05 vs control.  
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Figure 3. Effects of insulin and leptin on human sperm curvilinear velocity (VCL) after 
1, 2, and 3 h of incubation. Washed sperm samples were treated with insulin, leptin, 
insulin + leptin (Ins/Lep), insulin + leptin + wortmannin (Ins/Lep/Wort), or wortmannin 
(Wort). Values are the mean ± SEM of 10 replicates. *P < 0.05 vs control.  
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Figure 4. Effects of insulin and leptin on human sperm amplitude of lateral head 
displacement (ALH) after 1, 2, and 3 h of incubation. Washed sperm samples were 
treated with insulin, leptin, insulin + leptin (Ins/Lep), insulin + leptin + wortmannin 
(Ins/Lep/Wort), or wortmannin (Wort). Values are the mean ± SEM of 10 replicates. 
*P < 0.05 vs control.  
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Figure 5. Effects of insulin and leptin on propidium iodide (PI) fluorescence. PI was 
used as a probe for non-viable cells. Spermatozoa were treated with insulin, leptin, 
insulin + leptin (Ins/Lep), insulin + leptin + wortmannin (Ins/Lep/Wort), or wortmannin 
(Wort). Data is expressed as the percentage of PI fluorescence.  
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Figure 6. Effects of insulin and leptin on sperm acrosome reaction. Spermatozoa 
were treated with insulin, leptin, insulin + leptin (Ins/Lep), 
insulin + leptin + wortmannin (Ins/Lep/Wort), or wortmannin (Wort). Cells were 
simulated to acrosome react with progesterone or left to undergo spontaneous 
acrosome reaction. *P < 0.05 vs spontaneous control; **P < 0.05 vs spontaneous; 
***P < 0.05 vs progesterone control.  
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Figure 7. Effects of insulin and leptin on 4,5-diaminofluorescein-2/diacetate (DAF-
2/DA) fluorescence. Spermatozoa were treated with N-nitro-L-arginine methyl ester  
(L-NAME), wortmannin, insulin, leptin, insulin + leptin (Ins/Lep), insulin + leptin + L-
NAME (Ins/Lep/L-N), insulin + leptin + wortmannin (Ins/Lep/Wort). Values are 
expressed as mean DAF-2/DA fluorescence percentage of the control (control 
adjusted to 100 %) of 10 replicates. *P < 0.05 vs control. 
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Summary 
Many studies have reported the effects of cytokines on human sperm function even 
though their role and mechanisms involved remain unclear. We assessed and 
compared the effects of increasing concentrations of TNF-α and IL-6 on human 
sperm motility, viability as well as investigated the possible mechanism involved. 
TNF-α and IL-6 significantly reduced progressive motility at higher concentrations in a 
dose- and time-dependent manner. No differences were observed in cell viability. 
Both cytokines increased nitric oxide production in a dose-dependent manner. TNF-α 
and IL-6 did not statistically differ in their detrimental effects on human spermatozoa. 
These results indicate that TNF-α and IL-6 have an effect on sperm function. The 
effect is possibly mediated via an increase in nitric oxide production. 
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Introduction 
 
The role of cytokines in male reproductive function has been widely reported (Diemer 
et al., 2003). Although the immune system may be the major source of cytokine 
production, various other cells in the male urogenital tract also secrete cytokines and 
have an effect on sperm function and fertility (Naz and Kaplan, 1994). Their 
production occurs in response to foreign antigen, pathogen and chronic inflammation 
(Huleihel et al., 1996). The defense strategies of the immune system against bacterial 
infections include the release of proinflammatory cytokines especially interleukin-1 
(IL-1), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) as primary or 
secondary signals (Metalliotakis et al., 1998). 
 
IL-6 is produced by fibroblasts, monocytes/macrophages and endothelial cells (Syed 
et al., 1995). It may serve as an autocrine and paracrine growth factor in a wide 
range of cell lines. In seminal plasma the prostate appears to be the main site of 
origin of IL-6 (Metalliotakis et al., 1998). IL-6 has been shown to be significantly 
elevated in patients with varicocele (Nallella et al., 2004).  
 
TNF-α is a key cytokine in the initiation and orchestration of the inflammatory 
response against invading microorganisms (Hales et al., 1999). It has been reported 
to be highly elevated in patients with chronic prostatitis/chronic pelvic pain syndrome 
(Alexander et al., 1998). 
 
Even though much is known about the pathophysiology of cytokines on human sperm 
function, the mechanisms involved are yet to be clearly elucidated. The aim of this 
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study was twofold (i) to assess and compare the effects of TNF-α and IL-6 on human 
sperm function and (ii) to investigate if the elevation of NO production is a possible 
potential pathological mechanism of sperm damage employed. 
 
Materials and methods 
 
Chemicals 
TNF-α, IL-6, Nw-nitro-L-arginine methyl ester (L-NAME) and propidium iodide (PI) 
were obtained from Sigma Chemical Co., (St Louis, MO, USA). 4,5-
diaminofluorescein-2/diacetate (DAF-2/DA) was purchased from Calbiochem, San 
Diego, CA, USA.  
 
Preparation of sperm samples 
This study was approved by the ethics committee board of our institution. Semen was 
collected from 15 normozoospermic donors by masturbation after 3-5 days of 
abstinence according to the World Health Organization (WHO) criteria (WHO, 1999). 
Only samples with sperm concentration ≥ 20 x 106 /mL, total motility ≥ 50%, 
progressive motility ≥ 40% were used. Samples were left to liquefy for 30 minutes 
before processing. Motile sperm fractions were retrieved from the samples using a 
double wash in Hams F-10 medium (400 x g, 5 min) swim-up technique (3% Hams F-
10-bovine serum albumin (BSA), 37˚C, 5% CO2). After 1 hour, the supernatant 
containing motile sperm was collected and divided into aliquots.  
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Experimental protocol 
Aliquots containing 5 x 106 spermatozoa were incubated (37˚C, 5% CO2) with 
increasing concentrations of TNF-α and IL-6 (0, 2, 5, 10, 20, 50, 100ng/mL) for 1, 3, 5 
hours in 1 mL Hams + BSA medium according to concentrations described by 
Perdichizzi et al., (2007). At the end of the incubation, the aliquots’ sperm motility, 
viability and intracellular nitric oxide production were evaluated.  
 
Sperm Motility 
Total motility and progressive motility were measured by means of computer assisted 
semen analysis (CASA) using Hamilton Thorne Ivos after 1, 3 and 5 hours of 
incubation (37˚C, 5% CO2).  
 
Flow cytometry 
A Becton Dickinson FACSCaliburTM analyzer was used to quantify fluorescence 
(excitation wavelength 488 nm and emission wavelength 530 nm) at a single-cell 
level and data were analysed using CellquestTM version 3.3 (Becton Dickinson, San 
Jose, CA, USA) software. The mean fluorescence intensity of the analysed sperm 
cells was determined after gating the cell population by forward and side scatter 
signals. In total 100 000 events were acquired, but non-sperm particles and debris 
were excluded by prior gating, thereby limiting undesired effects on overall 
fluorescence. The final gated populations usually consisted of 15 000-20 000 sperm 
cells.  
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Cell viability 
Sperm cells which had received different treatments were incubated (37˚C, 5% CO2, 
5hrs) and subsequently, loaded with PI (1µM, 15 min). Living cells with an intact cell 
membrane and active metabolism will exclude PI while cells with damaged 
membranes or impaired metabolism allow PI to enter the cell and stain the DNA. PI 
fluorescence was analyzed by fluorescence-activated cell sorting (FACS).  
 
Nitric oxide production 
Nitric oxide production was measured as previously described (Lampiao et al., 2006). 
Briefly, samples which had received different treatments were loaded with DAF-2/DA 
(10 µM) and incubated (5hrs, 37 ºC) in the dark. Some of the samples were loaded 
with the nitric oxide synthase (NOS) inhibitor, L-NAME (0.7mM), 30 min prior to DAF-
2/DA administration.  Care was taken to prevent exposure to light throughout the rest 
of the experimentation as the probe is light sensitive. After incubation with DAF-2/DA 
the cells were analyzed by FACS.  
 
Statistical analysis 
The results were analyzed on the GraphPad PrismTM 4 statistical program. All data 
are expressed as mean ± SEM. Student’s t-test or One-way analysis of variance 
(ANOVA) (with Bonferroni post hoc test if p < 0.05) was used for statistical analysis. 
Differences were regarded statistically significant if p < 0.05. 
 
Results 
Both TNF-α and IL-6 did not significantly reduce sperm total motility after 1, 3 and 5 
hours of incubation (Fig. 1) even though there was a trend of reduction in total motility 
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with increase in cytokines concentration but did not reach statistical significance (P > 
0.05). No statistically significant differences were observed between TNF-α and IL-6 
treated cells of similar concentration even though TNF-α treated cells had slightly 
lower total motility than IL-6 treated cells at all time points.  
 
 
 
Figure 1. Time-course and dose-response of the effects of TNF-α and IL-6 on total 
motility. Values are the mean ± SEM of 10 replicates. 
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Progressive motility showed to be more sensitive to the effects of both TNF- α and IL-
6 (Fig. 2). TNF-α significantly reduced progressive motility from the concentration of 
20 ng/mL while IL-6 suppressive effects were observed at 100 ng/mL 3 hours after 
incubation (p < 0.05 vs. TNF-α zero; IL-6 zero, respectively). After 5 hours of 
incubation TNF-α significantly reduced progressive motility from the concentration of 
10 ng/mL (p < 0.05 vs. TNF-α zero) whereas, IL-6 significantly reduced progressive 
motility from the concentration of 50 ng/mL (p < 0.05 vs. IL-6 zero). No significant 
differences were observed in progressive motility between TNF-α and IL-6 treated 
spermatozoa of corresponding concentrations (P > 0.05).  
 
 
Figure 2. Time-course and dose-response of the effects of TNF-α and IL-6 on 
progressive motility. Values are the mean ± SEM of 10 replicates. *, P < 0.05 vs. zero 
concentration.  
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Sperm cell viability was assessed by PI fluorescence. The increase in PI 
fluorescence was interpreted as an increase in non-viable cells. No significant 
differences in PI fluorescence (P > 0.05) were observed for both TNF-α and IL-6 dose 
response curve (Fig. 3).  
 
Figure 3. Effect of TNF-α and IL-6 on PI fluorescence. Cells were incubated with 
increasing concentrations of TNF-α and IL-6 and incubated for 5 hours. PI was used 
as a viability probe. Values are the mean ± SEM of 10 replicates. 
 
 
Three concentrations of TNF-α and IL-6 (5, 20 and 100ng) were chosen for the NO 
experiments. A significant increase in mean DAF-2/DA fluorescence was observed in 
cells treated with 5, 20, 100ng TNF-α compared to the untreated cells (109.00 ± 
2.29%; 119.20 ± 2.76%; 129.20 ± 4.25% vs. 100%; P < 0.05) respectiv ly, while the 
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addition of L-NAME siginificantly reduced fluorescence in all the groups (Fig. 4). IL-6 
significantly increased mean DAF-2/DA fluorescence at 20 and 100ng (115.40 ± 
2.29%; 123.10 ± 2.55% vs. 100%; P < 0.05) while the addition of L-NAME 
significantly reduced fluorescence in all the groups (P < 0.05) (fig. 5). 
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Figure 4 . Effect of TNF-α on DAF-2/DA fluorescence. Cells were incubated with 5, 
20 and 100ng/mL TNF-α in the presence or absence of L-NAME and incubated for 5 
hours with DAF-2/DA. Values are expressed as mean DAF-2/DA fluorescence 
percentage of control (control adjusted to 100%) of 10 replicates. #, p < 0.05; *, 
p=0.05 vs. Zero; **, p=0.001 vs. Zero. 
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Figure 5. Effect of IL-6 on DAF-2/DA fluorescence. Cells were incubated with 5, 20 
and 100ng/mL IL-6 in the presence or absence of L-NAME and incubated for 5 hours 
with DAF-2/DA. Values are expressed as mean DAF-2/DA fluorescence percentage 
of control (control adjusted to 100%) of 10 replicates. #, p < 0.05; *, p=0.05 vs. Zero; 
**, p=0.001 vs. Zero. 
 
 
Discussion 
Various proinflammatory cytokines are present in seminal plasma but their effect on 
sperm motility and viability is still unclear. Studies have demonstrated increased 
levels of IL-6 in seminal plasma of infertile men which was inversely correlated with 
total sperm number and motility (Naz and Kaplan, 1994). However, other in vivo 
studies did not show a reduction in sperm motility by TNF-α and IL-6 (Comhaire et 
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al., 1994; Hussenet et al., 1993). Our in vitro study has demonstrated that both TNF-
α and IL-6 negatively affected progressive motility in a dose and time dependent 
manner. Our TNF-α results are in agreement with the findings of Eisermann et al., 
(1989) and Perdichizzi et al., (2007) in which sperm motility was significantly reduced 
in a dose- and time-dependent manner. It appears from our results that TNF-α is 
more detrimental than IL-6 in reducing sperm progressive motility even though no 
statistical differences were observed. The sperm viability results show that increasing 
concentrations of TNF-α and IL-6 led to increase in non-viable cells even though the 
increase was not significant. 
 
Studies have reported that infertile patients with varicocele exhibited elevated levels 
of cytokines such as IL-6, IL-8 and TNF-α (Sakamoto et al., 2008; Nallella et al., 
2004). In experimental varicocele in rats, Sahin et al., (2006) reported elevated levels 
of IL-1α and IL-1β.  On the other hand, Aksoy et al., (2000) observed elevated levels 
of NO in seminal plasma of varicocele patients and concluded that the elevated NO 
levels influenced sperm production, motility and morphology in patients with 
varicocele. Oxidative stress due to NO and reactive oxygen species (ROS) in infertile 
patients with varicocele has been positively correlated with sperm DNA fragmentation 
(Sakamoto et al., 2008). Sperm DNA damage has been reported to be a possible 
cause of reduced fertilization rates and poor outcomes of assisted reproduction 
(Ozmen et al., 2007; Tarozzi et al., 2007). This study has demonstrated that both 
TNF-α and IL-6 increased NO oxide production in human spermatozoa which was 
reversed by L-NAME. The reduction of NO production by L-NAME validated that the 
NO was derived from NOS. We speculate that apart from other sources, the elevated 
NO levels observed in varicocele patients may be due to elevated levels of cytokines 
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such as IL-6.  It is known that NO can reduce adenosine triphosphate levels required 
for sperm motility by inhibiting glycolysis and the electron-transport chain (Dimmeler 
et al., 1992) while Weinberg et al., (1995) reported that NO was capable of inhibiting 
sperm motility in vitro. We therefore propose that elevated levels of TNF-α and IL-6 
possibly affect human spermatozoa function via the elevation of NO production. 
 
This study has demonstrated that TNF-α and IL-6 elevate NO production in human 
spermatozoa. In conclusion, this study has shown that TNF-α and IL-6 have an effect 
on human sperm function especially progressive motility and that their detrimental 
effects are not different even though TNF-α seems to affect sperm function more than 
IL-6. We have further demonstrated that this suppression of sperm function may be 
through the elevation of NO production.  
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Summary 
For human spermatozoa to successfully fertilize the oocyte they, need to undergo a 
timely acrosome reaction (AR). Factors which disturb the AR may lead to fertilization 
failure. The objective of this study was to investigate the effects of two cytokines 
namely tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) on the 
spontaneous, calcium ionophore-induced and progesterone-induced human sperm 
AR. Twenty-two normal semen samples were treated with increasing concentrations 
of TNF-α and IL-6 after spermatozoa were isolated by a double wash swim-up 
method. The AR was induced by calcium ionophore A23187 and progesterone. The 
AR was determined by using Fluorescein isothiacyanate Pisum sativum agglutinin 
(FITC-PSA) and observed under fluorescence microscope. Both TNF-α and IL-6 
could decrease the spontaneous, ionophore and progesterone-induced AR (p < 0.05) 
in a dose dependent manner. TNF-α showed a more potent inhibiting effect than IL-6 
by inhibiting the AR at lower concentrations. This study has demonstrated that TNF-α 
and IL-6 play a role in inhibiting both the non-physiological as well as physiologically 
elicited AR by calcium ionophore and progesterone respectively.  
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Introduction 
Sperm AR involves the fusion of the outer acrosomal membrane with the overlying 
plasma membrane (Yudin et al., 1988) and consequent exocytosis of acrosomal 
contents (Sabeur et al., 1996). Undergoing the AR is a prerequisite for normal 
fertilization and any disturbances thereof lead to fertilization failure. Interestingly, only 
a small subpopulation of spermatozoa is apparently able to undergo the AR (Benoff 
et al., 1996).  
 
Some of the cytokines which have been implicated to be involved in male fertility are 
TNF-α and IL-6 (Koçak et al., 2002). Studies have reported a contradictory role of 
cytokines on AR. IL-6 has been reported to enhance human sperm AR (Naz and 
Kaplan, 1994; Zi and Song, 2006). On the other hand, Carver-Ward et al., (1997) 
reported that IL-6 led to a reduction in AR. Naz and Kaplan, (1994) used 
concentrations ranging from 6-600pg/100µl of sperm suspension whereas Carver-
Ward et al., (1997) used concentrations ranging from 5-160 pg/ml sperm. TNF-α has 
been reported to have an inhibitory effect on the AR (Dimitrov and Petrovská, 1996; 
Bian et al., 2007). In all these studies, calcium ionophore was used to examine the 
induced AR. This agent is considered as an unphysiologic stimulus, because it 
circumvents the natural pathway of AR, potentially yielding false-positive results (Liu 
and Baker, 1996). Therefore, it would be more applicable to use a physiologic 
inducer i.e. progesterone to measure the effects of cytokines on the AR. 
Progesterone which is secreted by the oocyte and steroidogenic cumulus cells that 
surround it (Osman et al., 1989; Hartshorne, 1989) initiates AR in vitro (Oehninger, et 
al., 1994; Bronson et al., 1999; Muratori et al., 2008).  
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The aim of this study was to investigate and compared the effects of TNF-α and IL-6 
on the AR by using calcium ionophore as well as the physiologic stimulus 
progesterone. In this study 0, 2, 5, 20, 50, 100pg/mL concentrations of TNF-α and IL-
6 were used. The concentrations were chosen to cover TNF-α and IL-6 levels 
detected in the seminal plasma and female follicular fluid (Koçak et al., 2002; Eggert-
Kruse et al., 2007; Amato et al., 2003; Wunder et al., 2006). 
 
Materials and methods 
Donors recruited in this study provided informed consent for a research protocol 
approved by the University of Stellenbosch Ethics Committee. Fresh semen samples 
were obtained by masturbation from healthy volunteers after a minimum of 2 days of 
sexual abstinence according to the World Health Organization (WHO, 1999).  
 
After 30 minutes liquefaction, motile sperm fractions were retrieved from the samples 
using a double wash in Hams F-10 medium (400 x g, 5 min) swim-up technique (3% 
Hams F-10-bovine serum albumin, 37˚C, 5% CO2) as previously described (Lampiao 
and du Plessis, 2006).  Aliquots containing 5 x 106 spermatozoa were incubated for 3 
hours and then exposed to increasing concentrations of TNF-α and IL-6 (0, 2, 5, 20, 
50, 100pg/mL) for 30 minutes. The cytokines remained present until stimulation with 
the agonists to mimic the environment in the female genital tract. Each aliquot was 
split into three fractions: one for analysis of the spontaneous AR (30 minutes), the 
second for exposure to calcium ionophore A23187 (10 µmol/L, 30 minutes; Sigma 
Chemical Co., St Louis, MO, USA) and the third for exposure to progesterone (1 
µmol/mL, 30 minutes; Sigma Chemical Co., St Louis, MO, USA).  
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The extent of the AR was assessed by placing samples on spotted slides and left to 
air dry after which they were fixed in cold ethanol for 30 sec. FITC-PSA (125µg/mL; 
Sigma Chemical Co., St Louis, MO, USA) was layered on the slides and they were 
incubated for 30 minutes in a dark humid atmosphere. Slides were subsequently 
rinsed with distilled water in order to eliminate excess probe, and then observed 
under a fluorescence microscope. At least 200 cells were evaluated per spot. 
 
Results  
Figure 1 shows the effect of TNF-α on calcium and progesterone-induced AR as well 
as spontaneous AR. TNF-α significantly reduced the ability of human spermatozoa to 
undergo spontaneous AR at the concentrations of 20 pg/mL, 50 pg/mL and 100 
pg/mL when compared to the spontaneous control (5.80 ± o.29%; 4.75 ± 0.26%; 3.90 
± 0.17% vs. 13.75 ± 0.54%; p < 0.05). The calcium ionophore-induced AR was 
significantly reduced by TNF-α at the concentrations of 5 pg/mL, 20 pg/mL, 50 pg/mL 
and 100 pg/mL when compared to the calcium ionophore-induced control (31.70 ± 
1.87%; 24.20 ± 1.25%; 20.40 ± 0.84%; 17.35 ± 0.73% vs. 46.30 ± 2.08%; p < 0.05). 
TNF-α also significantly reduced the progesterone-induced AR at the concentrations 
of 20 pg/mL, 50 pg/mL and 100 pg/mL when compared to the progesterone-induced 
control (14.30 ± 1.14%; 12.50 ± 0.73%; 9.60 ± 0.76% vs. 29.10 ± 1.91%; p < 0.05).  
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Figure 1. The effects of TNF-α on AR. Human spermatozoa were treated with 0, 2, 5, 
20, 50 and 100 pg/mL TNF-α before stimulated to undergo AR with calcium 
ionophore A23187 (10 µmol/L), progesterone (1 µmol/mL) or left to undergo the 
spontaneous AR. *, p < 0.05 vs. spontaneous control; #, p < 0.05 vs. A23187 control; 
●, p < 0.05 vs. progesterone control.  
 
IL-6 significantly reduced spontaneous AR at the concentration of 100 pg/mL when 
compared to the spontaneous control (5.30 ± 0.19% vs. 13.75 ± 0.54%; p < 0.05) 
(Fig. 2). On the other hand, IL-6 significantly reduced the calcium ionophore-induced 
AR at the concentrations of 20 pg/mL, 50 pg/mL and 100 pg/mL when compared to 
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the calcium-induced control (27.30 ± 1.93%; 23.80 ± 1.09%; 17.85 ± 0.85% vs. 46.30 
± 2.08%; p < 0.05). The progesterone-induced AR was significantly reduced by IL-6 
at the concentrations of 50 pg/mL and 100 pg/mL when compared to the 
progesterone-induced control (13.70 ± 0.98%; 11.85 ± 0.92% vs. 29.10 ± 1.91%; p < 
0.05).  
 
 
Figure 2. The effects of IL-6 on AR. Human spermatozoa were treated with 0, 2, 5, 
20, 50 and 100 pg/mL IL-6 before stimulated to undergo AR with calcium ionophore 
A23187 (10 µmol/L), progesterone (1 µmol/mL) or left to undergo the spontaneous 
AR. *, p < 0.05 vs. spontaneous control; #, p < 0.05 vs. A23187 control; ●, p < 0.05 
vs. progesterone control.  
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Discussion 
Cytokines appear as the natural components of seminal plasma (Maegawa et al., 
2002) since they are produced physiologically by the testis and are involved in the 
normal function of the organ (Hales et al.,  1999; Soder et al., 2000; Diemer et al., 
2003). It has been shown that sperm-derived hyalauronidase stimulate IL-6 
production in the cumulus cells which enhances fertilization (Shimada et al., 2008). 
The participation of cytokines in the regulation of fertility is dependent upon their 
concentration (Gruschwitz et al., 1996). TNF-α and IL-6 concentration levels have 
been reported to significantly increased in the seminal plasma of men with 
inflammatory genital diseases (Koçak et al., 2002) and in the peritoneal fluid of 
females with endometriosis (Eisermann et al., 1988). Their presence at high 
concentrations in seminal plasma or around the egg may result in defective AR either 
by inducing premature acrosome loss or insufficient acrosome response. TNF-α and 
IL-6 concentration levels of up to 61.3 pg/ml and 152.7 pg/ml respectively have been 
reported in seminal plasma of men with accessory gland infection (Koçak et al., 
2002). In the follicular fluid of females with endometriosis, TNF-α and IL-6 
concentration levels of up to 41.8 pg/ml and 30.8 pg/ml respectively have been 
reported (Wunder et al., 2006).  This study has demonstrated that both TNF-α and IL-
6 can inhibit sperm from undergoing the AR. At the moment, the mechanism through 
which the inhibition is achieved is not known. Possibly this inhibiting effect could be 
attributed to their influence on the activities of Na+-K+-ATPase, sodium dismutase and 
nitric oxide concentration (Bian et al., 2007). The TNF-α results are in agreement with 
the findings of Dimitrov and Petrovská, (1996), and Bian et al., (2007) where TNF-α 
was reported to decrease both spontaneous and ionophore-induced AR. On the other 
hand, our finding about the inhibitory effect of IL-6 on AR is contradictory to previous 
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findings by Naz and Kaplan, (1994), and Zi and Song, (2006) but in agreement with 
Carver-Ward et al., (1997). These contradictions may be due to different 
concentrations of cytokines, methods of sperm selection as were as other 
methodological differences used, by the different groups.  
 
The finding that TNF-α and IL-6 also inhibit physiologically induced AR by 
progesterone is a novel finding since previous studies only used the unphysiologic 
inducer, calcium ionophore. This inhibitory effect seems to be dose dependent. In 
conclusion, the increase in concentration of these hormones in the male and female 
reproductive tracts may be a source of fertilization failure as they may lead to 
insufficient acrosome response to the stimulants.  
 
Acknowledgements 
We would like to thank the Harry Crossly Foundation, University of Stellenbosch and 
Malawi College of Medicine NORAD project for funding.  
 
 
 
 
 
 
 
 
 
 
 253
References 
1. Amato, G., Conte, M., mazziotti, G., Lalli, E., Vitolo, G., Tucker, A.T., 
Bellastella, A., Carella, C., & Izzo, A. (2003) Serum and follicular fluid 
cytokines in polycystic ovary syndrome during stimulated cycles. The 
American College of Obstetricians and Gynecologists, 101, 1177-1181. 
2. Bian, S.L., Jin, H.B., Wang, S.Z., Zhang, H.F., Gu, C.R., Zhang, W., & Yu, 
X.G. (2007) Effects of interferon-gamma and tumor necrosis factor-alpha on 
the fertilizing capacity of human sperm and their mechanisms. Zhonghua Nan 
Ke Xue, 13, 681-684. 
3. Benoff, S., Barcia, M., Hurley, I.R., Cooper, G.W., Mandel, F.S., Heyner, S., 
Garside, W.T., Gilbert, B.R., & Hershlag, A. (1996) Classification of male factor 
infertility relevant to in vitro fertilization insemination strategies using mannose 
ligands, acrosome status and anti-cytoskeletal antibodies. Human 
Reproduction, 11, 1905-1918. 
4. Bronson, R.A., Peresleni, T., & Golightly, M. (1999) Progesterone promotes 
the acrosome reaction in capacitated spermatozoa as judged by flow 
cytometry and CD46 staining. Molecular Human Reproduction, 5, 507-512. 
5. Carver-Ward, J.A., Einspenner, M., Quinn, P., Lydic, M., & Brody, S.A. (1997) 
Effects of cytokines on the human acrosome reaction: a possible explanation 
for infertility caused by hostile cervical mucus. Fertility and Sterility, 68, 186. 
6. Diemer, T., Hales, D.B., & Weidner, W. (2003) Immune-endocrine interactions 
and Leydig cell function: the role of cytokines. Andrologia, 35, 55-63. 
7. Dimitrov, D.G., & Petrovská, M. (1996) Effects of products of activated immune 
cells and recombinant cytokines on spontaneous and ionophore-induced 
 254
acrosome reaction. American Journal of Reproductive Immunology, 36, 150-
156.  
8. Eggert-Kruse, W., Kiefer, I., Beck, C., Demirakca, T., & Strowitzki, T. (2007) 
Role of tumor necrosis factor alpha (TNF-α) and interleukin 1-beta (IL-1β) 
determination in seminal plasma during infertility investigation. Fertility and 
Sterility, 87, 810-823. 
9. Eisermann, J., Gast, M.J., Pineda, J., Odem, R.R., & Collins, J.L. (1988) 
Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic 
surgery. Fertility and Sterility, 50, 573-579. 
10. Gruschwitz, M.S., Brezinschek, R., & Brezinschek, HP. (1996) Cytokine levels 
in the seminal plasma of infertile males. Journal of Andrology, 17, 158-163. 
11. Hales, D.B., Diemer, T., & Hales, K.H. (1999) Role of cytokines in testicular 
function.  Endocrine, 10, 201-217. 
12. Hartshorne, G.M. (1989) Steroid production by the cumulus: relationship to 
fertilization in vitro. Human Reproduction, 4, 742-745. 
13. Koçak, I., Yenisey, C., Dündar, M., Okyay, P., & Serter, M. (2002) Relationship 
between seminal plasma interleukin-6 and tumor necrosis factor α levels with 
semen parameters in fertile and infertile men. Urological Research, 30, 263-
267. 
14. Lampiao, F., & du Plessis, S.S. (2006) Comparing the Multi-ZSC one-step 
standardized swim-up method to the double wash swim-up method with regard 
to the effect of sperm separation on morphology, head morphometry and 
acrosome reaction inducibility. Fertility and Sterility, 86, 739-741. 
 
 255
15. Liu, D.Y., & Baker, H.W. (1996) Relationship between the zona pellucida (ZP) 
and ionophore A23187-induced acrosome reaction and the ability of sperm to 
penetrate the ZP in men with normal sperm-ZP binding. Fertility and Sterility, 
66, 312-315. 
16. Maegawa, M., Kamada, M., Irahara, M., Yamamoto, S., Yoshikawa, S., Kasai, 
Y., Ohmoto, Y., Gima, H., Thaler, C.J., & Aono T. (2002) A repertoire of 
cytokines in human seminal plasma. Journal of Reproductive Immunology, 54, 
33-42. 
17. Muratoli, M., Luconi, M., Marchiani, S., Forti, G., & Baldi, E. (2008) Molecular 
markers of human sperm function. International Journal of Andrology, Epub. 
18. Naz, R.K., & Kaplan, P. (1994) Interleukin-6 enhances the fertilizing capacity 
of human sperm by increasing capacitation and acrosome reaction. Journal of 
Andrology; 15, 228-233. 
19. Oehninger, S., Sueldo, C., Lanzendorf, S., Mahoney, M., Burkman, L.J., 
Alexander, N.J., & Hodgen., G.D. (1994) A sequential analysis of the effect of 
progesterone on specific sperm functions crucial to fertilization in vitro in 
infertile patients. Human Reproduction, 9, 1322-1327.  
20. Osman, R.A., Andria, M.L., Jones, A.D., & Meizel, S. (1989) Steroid-induced 
exocytosis: the human sperm acrosome reaction. Biochemical and Biophysical 
Research Communication, 160, 828-833. 
21. Sabeur, K., Edwards, D.P., & Meizel, S. (1996) Human sperm plasma 
membrane progesterone receptor (s) and the acrosome reaction. Biology of 
Reproduction, 54, 993-1001. 
 
 256
22. Shimada, M., Yanai, Y., Okazaki, T., Noma, N., Kawashima, I., & Richards, 
J.S. (2008) Hyaluronan fragments generated by sperm-secreted hyaluronidase 
stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in 
cumulus cells of ovulated COCs, which may enhance fertilization. 
Development, 135, 2001-2011. 
23. Soder, O., Sultana, T., Jonsson, C., Wahlgren, A., Petersen, C., & Holst, M. 
(2000) The interleukin-1 system in the testis. Andrologia, 32, 52-55. 
24. World Health Organization (1999) WHO laboratory manual for the examination 
of human semen and sperm-cervical mucus interaction, Cambridge University 
Press, Cambridge. 
25. Wunder, D., Mueller, M.D., Birkhauser, M.H., & Bersinger, N.A. (2006) 
Increased ENA-78 in the follicular fluid of patients with endometriosis. Acta 
Obstetricia et Gynecologica, 85, 336-342. 
26. Yudin, A.I., Gottlieb, W., & Meizel, S. (1988) Ultrastructural studies of the early 
events of human sperm acrosome reaction as initiated by human follicular 
fluid. Gamete Research, 20, 11-24. 
27. Zi, J., & Song, P. (2006) Mechanism of IL-6 on acrosome reaction in human 
sperm. Zhonghua Nan Ke Xue, 12, 528-530.  
 
 
 
 
